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ABSTRACT 
MODELLING THE PREVALENCE OF DOWN SYNDROME 
WITH APPLICATIONS OF MARKOV CHAIN MONTE CARLO 
METHODS 
ISABELLE CELlA BRAY 
This thesis was motivated by applications in the epidemiology of Down syndrome and 
prenatal screening for Down syndrome. Methodological problems arising in these 
applications include under-ascertainment of cases in livebirth studies, double-sampled data 
with missing observations and coarsening of data. These issues are considered from a 
classical perspective using maximum likelihood and from a Bayesian viewpoint employing 
Markov chain Monte Carlo (MCMC) techniques. 
Livebirth prevalence studies published in the literature used a variety of data collection 
methods and many are of uncertain completeness. In two of the nine studies an estimate of 
the level of under-reporting is available. We present a meta-analysis of these studies in 
which maternal age-related risks and the levels of under-ascertainment in individual studies 
are estimated simultaneously. A modified logistic model is used to describe the relationship 
between Down syndrome prevalence and maternal age. The model is then extended to 
include data from several studies of prevalence rates observed at times of chorionic villus 
sampling (CVS) and amniocentesis. New estimates for spontaneous loss rates between the 
times" of CVS, amniocentesis and live birth are presented. 
The classical analysis of live birth prevalence data is then compared with an MCMC analysis 
which allows prior information concerning ascertainment to be incorporated. This approach 
is particularly attractive since the double-sampled data structure includes missing 
observations. The MCMC algorithm, which uses single-component Metropolis-Hastings 
steps to simulate model parameters and missing data, is run under three alternative prior 
specifications. Several convergence diagnostics are also considered and compared. 
Finally, MCMC techniques are used to model the distribution of fetal nuchal translucency 
(NT), an ultrasound marker for Down syndrome. The data are a mixture of measurements 
rounded to whole millimetres and measurements more accurately recorded to one decimal 
place. An MCMC algorithm is applied to simulate the proportion of measurements rounded 
to whole millimetres and parameters to describe the distribution of NT in unaffected and 
Down syndrome pregnancies. Predictive probabilities of Down syndrome given NT and 
maternal age are then calculated. 
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1.1 Overview 
Chapter 1 
Introduction 
The work described in this thesis was motivated by applications in the epidemiology of 
Down syndrome and prenatal screening for Down syndrome. From a methodological 
perspective the work largely involves problems of missing and coarsened data that arise in 
these applications. These problems have been considered from a classical perspective 
using maximum likelihood (ML) and from a Bayesian viewpoint employing Markov chain 
Monte Carlo (MCMC) techniques. We begin the remainder of this introductory chapter 
with Section 1.2 which presents a review of scientific findings on Down syndrome and 
Down syndrome screening. In the later sections we present some problems involved in the 
estimation of Down syndrome risks and outline how these are tackled in the following 
chapters. In Section 1.3 we give a brief description of the problem of under-ascertainment 
in livebirth prevalence studies and Section 1.4 discusses the spontaneous loss rates of 
Down syndrome fetuses. Finally, Section 1.5 describes the problem of rounding of 
measurements of an ultrasound marker for Down syndrome known as the nuchal fold or 
nuchal translucency (NT). 
1.2 Review 
1.2.1 Down Syndrome 
Down syndrome is the most frequently occurring genetic disorder in pregnancies and the 
most common cause of severe mental retardation. In 1866 the condition was described as 
'mongolian idiocy' by John Langdon Down. Although some earlier works give 
descriptions of patients suggestive of Down syndrome, Down is generally credited with the 
discovery of this clinical condition (Penrose and Smith, 1966). There seem to be no 
publications after Down ( 1866) until Fraser and Mitchell (1876) who noted the association 
with maternal age. Until the introduction of biochemical tests, following the publication of 
Merkatz et al. (1984), maternal age was the only factor used to assess risk and present-day 
biochemical screening still relies heavily on the underlying age-related risks. 
In addition to the characteristic physical appearance and mental retardation of varying 
severity of Down syndrome sufferers, the condition is associated with compromised 
immunity systems, and the main cause of death amongst people with Down syndrome is 
respiratory infection leading to pneumonia. The condition is also associated with 
congenital heart disease and malformation of the intestines. Although physical 
development is slow, premature ageing after 35 years has been observed with symptoms 
and sometimes progressive development of Alzheimer's disease. Life expectancy is now 
in the region of 50 to 60 years. 
1.2.2 Screening 
Screening for Down syndrome involves the selection from the population of pregnant 
women of those at high enough risk to warrant diagnostic procedures that are too 
hazardous and expensive to offer to all. Two diagnostic tests- chorionic villus sampling 
(CVS) and amniocentesis - are described in Section 1.2.3. While biochemical screening 
tests indicate the risk of a Down syndrome pregnancy, CVS, amniocentesis or a 
sophisticated ultrasound scan are needed for a firm diagnosis. One of the objectives of 
prenatal screening and diagnosis is "allowing the widest possible range of informed choice 
to women and couples at risk of having a child with an abnormality" (Marteau, 1994). 
Pregnant women must decide whether to have the test and, if the test result is positive, 
2 
whether to continue with the pregnancy. Approximately 8% of people in the UK are 
opposed to prenatal diagnosis but the majority are in favour and biochemical screening has 
become widely available in the UK (Macintosh, 1994). More recently, ultrasound markers 
for Down syndrome are also being employed in the assessment of risk. 
1.2.3 Diagnostic Tests 
Down syndrome can be diagnosed with certainty using surgical procedures, such as CVS 
and amniocentesis. In 1959 Lejeune discovered the extra chromosome which causes Down 
syndrome in affected individuals. In normal cells there are 23 pairs of chromosomes. A 
Down syndrome embryo is conceived with an extra chromosome 21 (hence the synonym 
trisomy 21 ). Karyotyping of amniotic fluid cells is a deterministic test for Down 
syndrome. Trans-abdominal amniocentesis, performed in the second trimester (normally 
between 15 and 21 weeks), was developed in the late 1960's but offered only to older 
women because of the risk of miscarriage associated with the procedure. Cells are 
removed from the amniotic fluid and grown in a laboratory, requiring two to three weeks' 
culturing. The risk of spontaneous abortion following amniocentesis has been estimated at 
I in I 00 (Halliday et al., 1992). 
In 1983 CVS was introduced, enabling first-trimester diagnosis (Brambati and Simoni, 
1983). This test involves the karyotyping of uncultured chorionic villi obtained from the 
placenta and the risk of miscarriage associated with this procedure is higher than with 
amniocentesis. Halliday et al. ( 1992) observed a total spontaneous loss rate of 3%, and 
reported that early spontaneous loss (within three weeks of the procedure) was significantly 
associated with the experience of the operator (P=0.003). The procedure is normally 
carried out at around 11 to 12 weeks' gestation and the result is available within a few 
days. 
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1. 2.4 Assessing Risk 
The association between maternal age and Down syndrome has long been established 
(Fraser and Mitchell, 1876; Shuttleworth, 1909). On the basis of this association a 
government report published in 1976 (DHSS, Black Report, 1976) recommended that 
amniocentesis should be offered to all women above a certain cut-off age. By the early 
1980's this policy had been implemented by all health authorities in the UK, with age cut-
offs varying from 35 to 40 years. Despite the dramatic increase in risk with maternal age, 
the maternal age distribution of livebirths means that some 70% of Down syndrome 
pregnancies occur in the under 35 age group (Mutton et al., 1993) and a cut-off of 40 years 
misses about 80% of women carrying Down syndrome fetuses. Therefore these screening 
progran1mes based on advanced maternal age were not very effective, and had limited 
impact on the prevalence of Down syndrome at birth. 
The efficiency of a Down syndrome screening test is usually measured in terms of the 
detection rate (percent positive among Down syndrome pregnancies), false-positive rate 
(percent positive among unaffected pregnancies) and positive predictive value (proportion 
of women with positive test results who are correctly diagnosed). If a 100% uptake of 
amniocentesis is assumed then a screening programme based on maternal age alone, with a 
cut-off of 35 years and false-positive rate of 5%, would achieve a detection rate of only 
30%. In practice this detection rate is vastly reduced by the fact that less than half these 
women opt for amniocentesis (Wald et al., 1988). 
In the mid 1980's it was found that information on concentrations of certain maternal 
serum markers could be used in addition to maternal age to improve detection rates. 
During the second trimester of pregnancy Down syndrome fetuses are associated with high 
levels of most placental markers and low levels of those markers which depend on the 
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presence of the fetus. Results demonstrating the association between low second-trimester 
alpha-feto protein (AFP) and fetal chromosome abnormalities, including Down syndrome, 
were first published in 1984 by Merkatz et al. and were subsequently confirmed by Cuckle 
et al. (1987). Biochemical screening using AFP alone, however, yielded detection rates of 
only 20-25% when screening women under the age of 35 years (Macri, 1994). Bogart et 
al. ( 1987) showed that maternal serum levels of total human chorionic gonadotrophin 
(hCG) were increased in Down syndrome pregnancies and Canick et al. ( 1988) 
demonstrated an association between low levels of unconjugated oestriol (uE3) and Down 
syndrome, although the benefit of this marker remains controversial (Crossley et al.. 1993; 
Macri et al., 1990). Wald et al. (1988) found that using hCG in addition to AFP increases 
detection efficiency for Down syndrome to approximately 55% at a false-positive rate of 
5%, and that using a combination of AFP, hCG and uE3 can identify 60% of Down 
syndrome pregnancies with the same false-positive rate. Many other potential biochemical 
markers have been reported (Cuckle, 1992). 
Although most screening centres in Britain use an algorithm based on the publication of 
Wald et al. ( 1988) there is considerable variation in the combination of markers used. 
Some NHS hospitals still rely on maternal age alone and only offer amniocentesis to 
women above a certain age (35-3 7 years). Other hospitals offer a serum test to all women 
and thus can identify many more high-risk pregnancies. Another approach sometimes 
adopted to reduce the number of serum tests carried out is to provide biochemical 
screening only for those women above a certain age. 
Ultrasound scans are produced by passing soundwaves through the mother's abdomen to 
reproduce an image of the fetus. Over the last twenty years the use of ultrasound scans for 
ante-natal screening and testing has become increasingly important. In particular, scans at 
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between 10 and 14 weeks' gestation are used to measure NT, which looks like a roll of fat 
at the back of the fetus's neck. Increased NT thickness in the first trimester is a common 
feature of many fetuses affected by chromosomal defects. The NT measurement can be 
used along with maternal age and serum markers to calculate an overall risk of Down 
syndrome. 
1.3 Under-Ascertainment in Livebirth Prevalence Studies 
Estimates of the natural maternal age-specific prevalence of Down syndrome should relate 
to populations of women who are not subjected to prenatal screening. In the published 
literature this is achieved by using data collected before the widespread use of prenatal 
screening or by using recent data on women who had not received prenatal screening. Due 
to poor methods of data collection many of the data sets available, particularly those which 
are less recent, did not achieve complete ascertainment of Down syndrome cases. This 
problem of under-ascertainment has been recognised in the literature but has not been dealt 
with satisfactorily in the statistical models used to estimate livebirth prevalence. The 
approaches adopted in the literature have either used ad hoc corrections for under-
ascertainment or have been restricted to data sets in which ascertainment is assumed to be 
complete. 
In Chapter 2 published studies of livebirth prevalence of Down syndrome are reviewed and 
re-analysed. A model which takes explicit account of under-ascertainment is developed 
and applied to data from nine published studies. Ascertainment and maternal age-specific 
prevalence of Down syndrome are estimated jointly using ML. The primary aim of the 
analysis is to provide an improved model for livebirth prevalence. A secondary aim is to 
examine the ascertainment rates in the various published studies. Alternative models in the 
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literature are considered and rates are compared with those derived from published studies 
of uncertain completeness (Cuckle et al., 1987) and those from data sets believed to be 
complete (Halliday et al., 1995; Hecht and Hook, 1994, 1996). In general the results 
obtained agree closely with those of the latter, but achieve greater precision because of the 
inclusion of additional data. The rates derived in Chapter 2 are considerably higher than 
those of Cuckle et al. ( 1987), which are embedded in many computer systems for 
generating risks. 
In Chapter 5 we re-visit the problem of under-ascertainment in livebirth prevalence studies 
from a Bayesian perspective. The structure of the data is amenable to MCMC methods, 
which are described in Chapter 4. Recent years have seen the increasingly widespread 
application of MCMC techniques in statistical analysis (see, for example, Gilks et al., 
1996). These computer intensive methods are particularly useful when considering 
complicated Bayesian models which would otherwise be intractable. In this case a 
Bayesian approach is attractive as it allows sensible prior beliefs concerning levels of 
ascertainment achieved in the various studies to be included, rather than making unrealistic 
assumptions. Three different prior specifications are considered and the resulting 
predictive probabilities of Down syndrome are compared. 
1.4 Spontaneous Loss Rates of Down Syndrome Fetuses 
Since the introduction of amniocentesis and CVS it has been noted that rates of Down 
syndrome in the first and second trimesters of pregnancy are higher than those at birth. 
This is because spontaneous loss rates are higher among chromosomally abnormal fetuses 
than unaffected fetuses. Therefore, in the assessment of risk of Down syndrome (and other 
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chromosomal abnormalities), gestational age should be considered as well as maternal age 
(Snijders and Nicolaides, 1996, page 80). 
The effect of fetal loss on the calculation of detection rates is an important application of 
this problem. As new screening programmes are introduced at earlier stages of gestation it 
is necessary to compare the detection rates with those of existing programmes. While 
various studies have given approximate numerical adjustments, attempts to estimate 
spontaneous loss rates of Down syndrome fetuses between the times of CVS, 
amniocentesis and livebirth have led to inconclusive results. For example, K.ratzer et al. 
( 1992) found that the loss rate between CVS and amniocentesis was dependent on maternal 
age and reported a range of spontaneous loss rates from 13% at age 35 to 47% at age 44, 
while other authors have found no significant interaction between maternal age and 
gestational age. Estimates of loss between amniocentesis and livebirth range from 18% 
(Halliday et al., 1995) to 50% (Hook et al., 1995). These discrepancies can be partially 
explained by the variety of methods and data sets employed. 
Chapter 3 reviews publications concerning the prevalence of Down syndrome at different 
stages of gestation. As a preliminary analysis the model presented by Halliday et al. 
(1995) is refitted using additional data. Then the model developed in Chapter 2 is extended 
by the inclusion of a multiplicative term for the relative prevalence (compared to livebirth) 
as a smooth function of gestational age. In the final model all available livebirth and 
gestational data are analysed. The estimates of loss obtained in Chapter 3 are generally 
lower than those presented in the literature and reasons for this are discussed. 
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1.5 Rounding of Nuchal Translucency Measurements 
On an ultrasound scan the NT appears as a dark region behind the neck. Large NT 
measurements in the first trimester of pregnancy indicate an increased risk of Down 
syndrome. A problem associated with the use of this ultrasound marker is that 
measurements are made to differing degrees of precision; some are recorded to the nearest 
millimetre while others are recorded to the nearest tenth of a millimetre. The precision 
depends on the machine used and the operator, and rounding is particularly common in 
older data sets. 
In Chapter 6 MCMC techniques are applied to the problem of rounding in NT data. NT 
increases with gestation, which is measured by crown rump length (CRL), and we use 
models that allow log(NT) to depend linearly on CRL. Initially we consider only data for 
unaffected pregnancies, sampling the unrounded observations, the proportion of 
observations rounded to whole millimeteres and distribution parameters for log(NT). We 
then extend the algorithm to deal with Down syndrome pregnancies. The regression of 
log(NT) on CRL in this group is assumed to have the same slope as that for unaffected 
pregnancies, but a different intercept and variance. Finally, we incorporate the maternal 
age-specific risks derived in Chapter 2 and calculate predictive probabilities of Down 
syndrome given NT, CRL and maternal age. 
Chapter 7 provides a critical review of the work contained in this thesis. Each chapter is 
summarised and drawbacks are discussed. Possible improvements to the work are 
suggested and ideas are outlined for further work which could be carried out if time 
allowed. 
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Chapter 2 
Maximum Likelihood Approach to Modelling Maternal Age-
Specific Prevalence of Down Syndrome 
2.1 Introduction 
Maternal age-specific prevalence of Down syndrome refers to the proportion of livebirths 
affected by the condition for a given maternal age (in years). This proportion is often 
given as a rate per thousand livebirths or expressed as an odds (affected to unaffected). We 
note that the term prevalence, rather than incidence, is appropriate since incidence would 
be used to refer to the occurrence of Down syndrome at conception (see Halliday et al .. 
1995). Accurate estimates of maternal age-specific prevalence of Down syndrome are 
important for the assessment of risk, for counselling and for monitoring the effectiveness of 
screening programmes. Over the last two decades or so the widespread introduction of 
prenatal screening and selective termination of affected pregnancies means that livebirth 
data no longer reflect the true birth prevalence. Historically collected data on birth 
prevalence are therefore of unique value in estimating the natural birth prevalence. 
This chapter presents a meta-analysis of nine published data sets. The primary objective of 
the analysis is to produce improved estimates of maternal age-specific prevalence by taking 
explicit account of under-ascertainment in all studies. A secondary objective is to estimate 
the ascertainment rates in these nine studies. Section 2.2 reviews literature in the area and 
the various published models of Cuckle el al. (1987), Hecht and Hook (1994, 1996) and 
Halliday et al. (1995) are discussed. In Section 2.3 the data sources are described and in 
Section 2.4 a double-sampling approach is proposed. A modified logistic model is used to 
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describe the increasing prevalence with maternal age. The assumption of full 
ascertainment made by previous authors is examined and bootstrapping is applied to obtain 
standard errors (SEs) and confidence intervals (Cis). In Section 2.5 alternative models are 
considered and Section 2.6 compares the results obtained in this chapter with those 
published in the literature. The chapter concludes with a discussion of factors other than 
maternal age which may affect Down syndrome prevalence. 
2.2 Review 
The association between birth prevalence of Down syndrome and maternal age was 
reported by Fraser and Mitchell in 1876. Exponential models for this relationship were 
considered by Jenkins (I 933) and Penrose and Smith (I 966). The first large study to 
publish observed rates of Down syndrome for individual years of maternal age was carried 
out by Hook and Chambers (1977). Since then numerous studies have been undertaken 
and various models have been fitted to predict birth prevalence (see Lamson and Hook, 
I 980, I 981) for a description of the early work in this area. 
Cuckle et al. (1987) and Hecht and Hook (I 994) describe meta-analyses of eight published 
studies (Hook and Chambers, I 977; Hook and Lindsjo, I 978; Hook and Fabia, 1978; 
Trimble and Baird, 1978; Sutherland et al., I 979; Young, Williams and Newcombe, I 980; 
Koulischer and Gillerot, I 980; Huether et al., 1981 ). Most of the published data sets are 
based on multiple sources of ascertainment. These include birth certificates, national 
registers, community sources and records of public institutions (hospitals, mental health 
institutions, special schools, sheltered workshops, medical practices). The original 
publications give varying degrees of detail about the different sources used. However, 
apart from the two North American studies of Hook and Chambers (1977) and Huether et 
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al. (1981), which give double-sampling information on birth certificates and cytogenetic 
records, the data available from these studies contain only aggregated counts of the number 
of Iivebirths and livebirths recorded as Down syndrome for each year of maternal age. 
Together the studies, that were carried out prior to the widespread use of prenatal 
screening, include a total of over three million live births of which 4,545 were recorded as 
Down syndrome (Hecht and Hook, 1994). 
The two North American studies were based on birth registrations and in these studies 
about two thirds of Down syndrome births were falsely recorded as unaffected. Data on 
the level of under-ascertainment in these two studies is available in the form of a sample of 
cytogenetically diagnosed Down syndrome births classified according to whether or not 
they were reported as Down syndrome on the birth certificates. Cuckle et al. ( 1987) 
correct the birth registration data for under-ascertainment by dividing the observed number 
of Down syndrome cases in each maternal age group by the overall proportion of 
cytogenetically diagnosed cases registered as Down syndrome. They then calculate a 
combined risk for each year of maternal age by taking a weighted average of estimates 
derived from each of the studies. Hecht and Hook (1994) adjust the number of livebirths 
by multiplying the livebirth counts for each maternal year by the proportion of Down 
syndrome cases ascertained in the cytogenetic sample. They then add the adjusted counts 
to those from the remaining six studies, which were assumed to be complete, to form a 
single Down syndrome count and livebirth count for each year of maternal age. Constant 
plus exponential (CPE) models of the form given in (2.1) were then fitted to obtain 
estimates of the proportion 1[ of live births affected by Down syndrome for each year m of 
maternal age: 
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(2.1) 
This model reflects the low and almost constant prevalence amongst younger mothers 
followed by the rapidly increasing prevalence with maternal age that prevails beyond the 
age of about 35. Cuckle et al. (1987) use a linear (k=l) term in the exponent of (2.1) whilst 
Hecht and Hook (1994) consider linear and cubic (k=3) terms. 
Both Cuckle et al. {1987) and Hecht and Hook ( 1994) assume complete ascertainment in 
all studies except the birth certificate studies of Hook and Chambers ( 1977) and Huether et 
al. ( 1981 ). However, this assumption is questionable and Hecht and Hook ( 1996) perform 
an extensive review of the original sources of data focusing on their completeness. They 
then extend and modify the data where appropriate and fit a variety of models to the pooled 
data from those studies judged to be most complete. They propose a model of the form 
(2.1) with a quartic (k=4) term in the exponent. We give details of these studies in Section 
2.3.1. 
Halliday et al. (1995) consider a single data set comprising women aged 36 and over. 
Three groups of pregnancies were included in this study according to the stage at which it 
was classified as Down syndrome or unaffected. These stages correspond to investigation 
by CVS, amniocentesis and livebirth. The median gestational ages of these three groups 
were reported as I 0, 16 and 39 weeks respectively. Because the rate of miscarriage is 
generally higher in affected pregnancies than in unaffected pregnancies the prevalence is 
higher at the earlier stages in pregnancy. A logistic regression model was fitted including 
maternal age as a variate and the stage of pregnancy as a factor. 
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Leaving aside possible environmental and racial differences in prevalence, covered in the 
discussion at the end of this chapter, the published work summarised above raises a 
number of issues. Firstly, there is the question of how to deal with under-ascertainment for 
the birth registration studies, where data are available on cytogenetically diagnosed cases, 
and for other studies where some degree of under-ascertainment might be expected. 
Secondly, there is the question of the functional form adopted for maternal age-specific 
prevalence. The CPE model may exhibit biologically implausible behaviour at extremes of 
maternal age. The logistic model of Halliday et al. (1995) appears reasonable in this 
regard for the restricted range of maternal ages over 35. However, logistic models of this 
forn1 fail to reflect the behaviour over the full range of maternal ages. 
We propose a double-sampling approach that uses all the available data to estimate the 
proportion of ascertainment in each study. Traditionally, double-sampling refers to data 
which has been sampled by two methods - the first being subject to error, while the second 
is accurate but more expensive or less practical, so that only a small subsample is classified 
by the second method. All the data is used to estimate the accuracy of the first method and 
the proportion of interest. Chen ( 1979) presents a ML approach to modelling such data. 
Nedelman (1988) and Lie et al. (1994) consider the problems arising when the second 
method is also subject to error. York et al. ( 1995) developed a Bayesian double-sampling 
approach for analysing Down syndrome data from Norway collected using both a national 
birth registry and a regional registry, neither being infallible. They found that the 
estimated rate of error was substantial in both registries. This analysis is described in 
Section 4.7. More recently, Madigan and York (1997) considered spina bifida data 
obtained from three administrative lists. Using hierarchical log-linear models they present 
a Bayesian methodology for estimating the number of individuals missed by all three lists. 
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The cytogenetic samples available for the birth certificate data of Hook and Chambers 
(1977) and Huether et al. (1981) provide estimates of the level of ascertainment and are 
analogous to the information obtained by classifying a subsample of the data by a second 
method. This information, which is assumed to be error-free, is only available for two of 
the nine studies. 
2.3 Data Sources 
2.3.1 Selection of Studies 
The meta-analysis described in this chapter involves the nine data sets, summarised in 
Table 2.1, obtained from the literature outlined above. These include the birth certificate 
studies of Hook and Chambers (1977) and Huether et al. (1981) (studies 1 and 2), the study 
of Trimble and Baird (1978), excluded from Hecht and Hook ( 1996) on the grounds of 
incomplete ascertainment (study 3), five data sets revised by Hecht and Hook (1996) 
(studies 4, ... ,8) and the recent data from Halliday et al. (1995) (study 9). The full data sets 
can be found in Table 2.2. Two studies which were analysed by Cuckle et al. (1987) and 
Hecht and Hook (1994) are omitted from our analysis. There were originally presented by 
Hook and Fabia (1978) and Young, Williams and Newcombe (1980). In these studies 
livebirth totals were only available for five-year intervals. Cuckle et al. (1987) and Hecht 
and Hook (1994) use livebirth data from other studies to distribute the observed livebirth 
totals over single years of maternal age. We chose to exclude the data from these studies 
rather than rely on this approximation. 
2. 3. 2 Down Syndrome Cases Diagnosed Prenatally 
In four of the studies (Lindsten et al., 1981; Huether et al., 1981; Staples et al., 1991; 
Koulischer et al., 1991) prenatal diagnosis had led to a small number of selective abortions 
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Region Maternal Down Livebirths1 Data on 
Source Period Age (years) Syndrome I Ascertainment' 
Included 
I. Hook and Chambers (1977) New York 
1963-74 16-50 932 1724280 113/301=0.375 
2. Huether et al. ( 1981) Ohio 
1970-79 16-48 649.1 1439915 319/875=0.365 
-3."Triffibiealid"8airCi(1978) _________________________ 8riti5h-colum"bia ________________________________________ _ 
4. Staples eta/. (1991) 
1961-70 18-45 496 341076 
S. Australia 
1965-89 16-49 592 497743 
-5.Ho~andCi~~509~)-------------------------swe~li----------------------------------------------
6. Lindsten et al. ( 1981) 
7. Data compiled by Hecht and Hook (1996): includes data from 
Koulischer and Gillerot ( 1980) and Koulischer et al. ( 1991) 
8. Data compiled by Hecht and Hook (1996): 'Intensive Newborn Studies' 
- includes data from Hamerton et al. {1975) and Jacobs et al. ( 1974) 
9. Halliday et al. (1995) 
Total 
1968-7o 16-50 438 330423 
Sweden 
1971-77 
S. Belgium 
1971-90 
Winnipeg, Canada 
1970-73 
Edinburgh, Scotland 
1967-1972 
Victoria 
1987-91 
16-47 
16-49 
16-47 
36-49 
959 
656.7 
31 
71 
4824.8 
737139 
520776 
25572 
12920 
5629844 
1 Total for all individually recorded years of maternal age between 16 and 50. Decimals are due to adjustments for selective termination 
2 Estimate of completeness of reporting of Down syndrome- available for two studies which relied solely on birth certificates to ascertain cases 
Table 2.1. Summary of the data sets included in the analysis 
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;\lalernal Age Data Set 
Hook ami Huether et al. Trimble and Staples et al. llook and Lindsten et al. Koulischer et al. I ntcnsivc Newborn Halliday et al. 
Chambers (1977) (1981)'·' Baird (1978) (1991) Lindsjii (I 978) (1981)1 (1991) I Studies (1974, 1975) (1995) 
16 4(12524) 5 (24404) 4 (3648) 1 (1979) 0 (3321) 0 (2681) 0 (228) 
17 7 (27701) 11(45190) 4(8019) 3 (5265) 3 (8883) 4 (5834) 0 (457) 
18 14 (51057) 12 (65802) 15 (13675) 6.1 ( 13069) 10(9212) 8 (15891) 5(10664) 0 (799) 
19 16 (80075) 23 (84721) 16 (18752) 13 (18017) 4 (13433) 23 (25262) 9(18405) I (1013) 
20 18 (100524) 19 (93279) 22 (22005) 12 (22687) 10 ( 17267) 17 (33269) 15.4 (24929) I (1288) 
21 24 (115428) 35 (I 0 I 060) 16 (23896) 24 (28203) 16(21133) 30 (41193) 33 (31302) 2 (1539) 
22 32 ( 123769) 27 (108644) 12 (24667) 18 (32919) 19 (24584) 35 (48391) 27 (36613) 0 ( 1727) 
23 29 (129108) 24 (113790) 17 (24807) 24 (37717) 23 (26862) 32(54114) 27 (41692) 0 (1909) 
24 42 (128648) 38 (112303) 22 (23986) 35.1 (40204) 19 (27747) 49 (58911) 32 ( 44895) 0 (2146) 
25 40 ( 124718) 36 (107615) 15 (22860) 31.1 (41008) 22 (27525) 46 (62167) 29.7 (44385) I (2113) 
26 42 (115869) 39 (I 00045) 14(21450) 32.7 (39812) 23 (250 16) 44 (61323) 34(43811) I (1945) 
27 45(105611) 35 (90732) 27 ( 19202) 25 (36590) 16 (21694) 59 (57882) 47.7 (38488) I (1771) 
28 33 (92588) 27 (79058) 14(17450) 34.5 (32964) 18 (18623) 51 (52352) 23 (33604) 4 (1594) 
29 27 (80967) 27 (66600) 9 (15685) 17.7 (28605) 17 (15888) 60 ( 45452) 35 (28804) I (1333) 
30 26 (70899) 28 (54346) 12 (13954) 24.7 (23902) 11 (13835) 55 (37424) 28.4 (23932) 2 ( 1113) 
31 25 (60403) 23 ( 43077) 12(11987) 26 (19819) 21 (11541) 44 (30316) 15 (18342) I (883) 
32 33 (52938) 20 (33634) 18 (10983) 17 (15810) I 0 (9578) 49 (241 08) 24.1 ( 15369) 2 (748) 
33 26 (45447) 20 (26298) 13 (9825) 22.4 (12563) 16(7861) 23 ( 18859) 15 ( 13082) I (598) 
34 30 (40212) 14 (21050) 11 (8483) 26.4 (10083) 14 (6672) 32 ( 14957) 26.7 (I 0672) 0 ( 488) 
35 42 (35225) 17.3 (16722) 23 (7448) 21.5 (8345) 11(5413) 30.8 ( 11459) 22 (8802) 0 (400) 
36 37 (29887) 20.5 ( 13420) 13 (6628) 22.5 (6248) 12(4648) 27.7 (8877) 33.2 (6465) I (331) 22 (6330) 
37 39 (25235) 17(10440) 17 (5780) 21.5 ( 4840) 18 (3917) 35.8 (6657) 26.8 (4755) I (307) 11 (2582) 
38 45 (21280) 25.5 (8084) 15 (4834) 31.6 (3880) 16(3129 37.8 (5069) 33.2 (4415) 0 (260) 7 (1659) 
39 48 (17172) 20.3 (6337) 30(3961) 12.8 (2935) 16(2415) 35.9 (3832) 19.1 (3030) 3 ( 192) 8 (1012) 
40 50(13119) 23.5 (4707) 31 (2952) 23.2 (2043) 22 (1805) 29.7 (2648) 29.7 (2069) 0 (144) 7 (580) 
41 45 (9162) 10.5 (3349) 33 (2276) 15.1(1466) 17(1343) 21.2 (1776) 13 (1700) 2 (96) 4 (333) 
42 48 (6636) 14.3 (2307) 20 (1589) 12 (941) 15 (845) 28.4 ( 1230) 19.7 (921) 2 (61) 5 ( 187) 
43 24 (4095) 11.3 ( 1404) 16 (1018) 16.4 (659) 6 (527) 21.8 (765) 10(625) 0 (49) 5 ( 117) 
44 10 (2083) 12.8 (809) 22 (596) 8.7 (367) 13 (360) 15.5 (388) I 0 (292) 0 (12) I (55) 
45 15(1111) 6 ( 405) 11 (327) 5 (206) 9 (161) 9.4(217) 4 (112) 2 ( 19) 0 (20) 
46 10(514) 6 (188) 2 (Ill) 7 (82) 5 (l 05) 3 (74) I (7) 0 (23) 
47 3 (183) 1.3 (77) 1 (34) I (35) 0 (41) I (3) I (2) I ( 14) 
48 I (65) 0 (18) 1 ( 18) 2 ( 19) I (6) 0 (5) 
49 I (22) 0 (0) 0 (11) 0 (7) 0 (3) 0 (3) 
50 I (5) 0 (0) 0 (2) 
Total 932 (I 724280) 649.1 (1439915) 496 (341076) 592 (497743) 438 (330423) 959 (737139) 656.7 (520776) 31 (25572) 71 (12920) 
'Decimals are due to adjustments for selective termination 1Givcn to one decimal place only 
Table 2.2. The number of cases of Down syndrome (with total number of pregnancies in parentheses) for individual years of maternal age 
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of Down syndrome cases. Huether et al. ( 1981) multiplied 24 terminations by the 
probability that the pregnancy would have survived to term (taken to be 0.75) and the 
estimated probability that it would have been recorded on the birth certificate (0.365). In 
our analysis we adjust the data from this study using the estimate for the probability of 
survival of 0.7 (Hook, 1983) and multiply this by 0.365. Information given in the other 
three papers was used by Hecht and Hook (1996) to adjust the data for selective abortion 
using the estimate of 0. 7 for the probability of survival. We have therefore used the data 
from these studies as it appears in their paper. We justify this by carrying out separate 
analyses in which the effects of counting these cases as zero or one were examined. This 
sensitivity analysis demonstrates that the effect of these prenatally diagnosed cases and the 
assumptions concerning survival are of no practical consequence. 
2.4 Modelling Maternal Age-Specific Livebirth Prevalence and 
Ascertainment 
2.4. 1 Model Formulation 
In this chapter we adopt a ML approach and perform a meta-analysis of livebirth 
prevalence data using models that take explicit account of under-ascertainment (Bray et al., 
1998). In addition to the CPE model (2.1) we consider the modified logistic model (2.2). 
1- a 1r( m) = a + ------,---,--------,---
1 +exp{-(Po + .81m)} (2.2) 
Similar models were used by Morton et al. (1988) and Lie et al. (1991) to assess age-
independent and age-dependent factors. Lie et al. (1991) describe this type of logistic 
model as 'the theoretically more correct logistic analogue' of the CPE model. With a = 0 
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equation (2.2) reduces to a logistic regression model of the form used by Halliday et al. 
(1995). More generally, with 0::;; a< I, the prevalence rises from a lower limit of 
approximately a to an upper limit of one as maternal age increases. 
We assume that Down syndrome births are correctly ascertained in study i, independently 
of maternal age, with probability rp1 • For studies i= I ,2 in which a sample of 
cytogenetically diagnosed cases is available, Down syndrome births are assumed to be 
included in the sample independently of maternal age and ascertainment at birth 
registration with probability B,. In this framework the cytogenetic sample data are critical 
to the model fitting procedure in that they provide a reference point for the estimation of 
the ascertainment probabilities in all nine studies in the model. With these assumptions the 
probabilities associated with various outcomes are given in Table 2.3. Note that we 
exclude the possibility of an unaffected birth being classified as having Down syndrome. 
True Registered as Down Syndrome Registered as Unaffected 
Outcome Included Excluded Included Excluded 
Down Tr(m)rp1{), Tr(m)rp1 (I-(),) Tr(m)(l- rp1 )(), Tr(m)(l-((J; )(1-11;) 
Syndrome 
Unaffected 0 0 0 1- Tr(m) 
Table 2.3. Model for birth prevalence, registration and inclusion in cytogenetic sample 
(for studies I and 2) 
Data for model fitting comprise counts of the number of Down syndrome births recorded 
r1111 and the total number of births n1111 for each maternal age m and study i. The 
corresponding totals over maternal age m in study i are denoted by r1 and n1.• The 
cytogenetic data, available for studies i= I ,2, comprise the total number of cases x1 
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included in the cytogenetic sample that were registered as Down syndrome on birth 
certificates and the total number Y; of cases in the cytogenetic sample registered as 
unaffected on birth certificates. The corresponding maternal age-specific counts, denoted 
by X;, and Y;,, represent missing data. The structure of a data set including cytogenetic 
data (i=l ,2) is illustrated in Table 2.4. 
The m1ssmg observations in Table 2.4 suggest the application of the EM algorithm 
(Dempster et al., 1977) or MCMC methods (see, for example, Gilks et al., 1996). 
However, the form of the data enables a convenient approximate expression for the 
likelihood to be obtained. In the following sections we obtain ML estimates by 
maximising the approximate likelihood. We examine the assumptions of full 
ascertainment in the studies identified as complete by Hecht and Hook ( 1996) and in that 
of Halliday et al. (1995). 
Maternal Registered as Down Syndrome Registered as Unaffected 
Age Included Excluded Total Included Excluded Total 
16 * * ri.l6 * * ni,It> - ri,J6 
17 * * ri.i7 * * 11i.l7 - 'i.11 
50 * * * * 
Total x. 
'· 
r -x. 
I. L 
r. 
' 
n. -r. 
I. I. 
Table 2.4. Data for studies I and 2, asterisks denote unobserved data 
20 
2.4. 2 Maximum Likelihood 
We consider the likelihood L as the product of the probability of the births registered as 
Down syndrome R={r;m} and the conditional probability of the cytogenetic sample data 
given these counts. 
In equation (2.3), Pr(r1,la,f30 ,/J"rp;) is a probability from a binomial distribution with 
index parameter n1, and probability parameter rp1tr(m). For studies I and 2 and maternal 
age m, the number of pregnancies registered as Down syndrome included in the 
cytogenetic sample has, conditionally on the births registered as Down syndrome, a 
binomial distribution with index r1, and probability (), so Pr(x,IR,a,f30 ,fl"rp1,81 ) m 
(2.3) is the probability from a binomial distribution with index r, and probability (),. 
Given the births registered as Down syndrome R, the number of Down syndrome births 
y 1, from mothers of age m registered as unaffected that are included in the ascertainment 
sample has a binomial distribution with index n,, - r,"' and probability 
tr(m)81(l- rp 1 ) I {I- rp 1tr(m)} . The total y1. is thus the sum of binomial random variables 
with different probability parameters. However, these probability parameters are small and 
the index parameters are large so the distribution of the total can be well approximated by a 
Poisson distribution with mean ~)n1,-r1,)tr(m)81 (l-rp 1 )1{l-rp 1tr(m)}. Simulation 
studies to demonstrate the adequacy of this approximation were complicated by 
inaccuracies in the S- Plus routines for random generation from the binomial distribution. 
However, comparison of the rates estimated using this approach (Table 2.6) with those 
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obtained from the Bayesian approach in Chapter 5 (which did not rely on this 
approximation) indicates no notable discrepancies. 
From the explicit expression for the likelihood (2.3) standard numerical methods can be 
applied to obtain ML estimates and fit statistics. For the analysis described above we used 
s- Plus's function nlminb (MathS oft, 1996). SEs and Cls were obtained by 
bootstrapping. The methods used are outlined below. For further details see, for example, 
Efron and Tibshirani (1993). 
2. 4. 3 Boo/strapping 
Since the data structure is not amenable to non-parametric bootstrapping, the parametric 
bootstrap was applied to obtain SEs and Cls. Three thousand replications of r;,., x; and Y; 
were generated for each study i and maternal age m according to the model described 
above. Bootstrap SEs of each parameter estimate were obtained by taking the standard 
deviation (SD) of the bootstrap replications of that parameter estimate. Several methods 
were considered for constructing Cls for the predicted risks. These included the percentile 
and BCa methods (see Efron and Tibshirani, 1993, Chapters 13 and 14). No appreciable 
differences were found between the intervals resulting from the two methods and the 
results presented are those obtained using the simpler percentile method. 
2. 4. 4 Filled Models 
ML estimates and fit statistics for the full model and a constrained model are given in 
Table 2.5. The Chi-squared goodness-of-fit statistics are likelihood ratio (LR) statistics 
companng the fully saturated model with the given model (see McCullagh and 
Nelder, 1989, Section 2.3). The P values give the significance associated with these fit 
statistics. In the constrained model ascertainment probabilities are fixed at one for studies 
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i=5, ... ,9 to reflect the assumptions of full ascertainment made by Hecht and Hook (1996) 
and Halliday et al. ( 1995). For the practical use of the equation presented in (2.2) it is 
imp011ant to recognise that the data relate to maternal age in completed years. In practice, 
for a woman with an expected maternal age at delivery of m, in years and fractions of 
years, the equation 
' ' 
with estimates from Table 2.5 substituted for a, /30 and /31 should be used to calculate the 
estimated risk ir( m). 
Parameter All rp;s Estimated Constrained rp;s 
Estimate SE Estimate SE 
a 0.0006990 0.00003 0.0006810 0.00002 
' 
-16.243166 0.2438 -16.26373 0.2497 flo 
/31 0.2904438 0.0062 0.2901614 0.0064 
(}I 0.110 0.0068 0.113 0.0068 
()2 0.500 0.0173 0.508 0.0162 
i;1 Hook and Chambers ( 1977) 0.341 0.0139 0.351 0.0129 
cj;, Huether et al. ( 1981) 0.371 0.0150 0.377 0.0143 
cj;, Staples et al. ( 1991) 0.874 0.0421 0.899 0.0398 
cj;4 Trimble and Baird ( 1978) 0.860 0.0421 0.885 0.0422 
i;5 Hook and Lindsjo ( 1978) 0.922 0.0330 
cj;6 Lindsten et al. (1981) 0.996 0.0312 
cj;7 Koulischer et al. ( 1980,1991) 0.951 0.0421 
cj;8 Intensive Newborn ( 1975, 1974) 0.854 0.1224 
cj;9 Halliday et al. ( 1995) 0.926 0.0859 
x' (d.f.) 308.11 (265) 311.63 (270) 
p 0.035 0.041 
Table 2.5. ML estimates and bootstrap SEs 
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We note that the difference in the o/ fit statistics for these two models is 3.52 and that this 
is less than the change in degrees of freedom (d.f.). This suggests that the data are quite 
consistent with the assumptions of full ascertainment for the study of Halliday et al. (1995) 
and the selected studies of Hecht and Hook (1996). Together with the strong prior 
evidence of full ascertainment, this leads us to prefer the more parsimonious model with 
ascertainment probabilities constrained to one for these studies. We remark that the formal 
assumptions for a generalised LR test require that the null value is an interior point of the 
parameter space (Cox and Hinkley, 1974, page 312). Clearly that is not the case here and 
the test statistic is therefore interpreted in a qualitative way. 
Livebirth prevalence rates for the reduced model are given in Table 2.6. Risks are also 
expressed as odds of I : u where u is the number of unaffected births that occur for each 
Down syndrome birth for each year of maternal age. We would urge caution in the use of 
rates at maternal ages above 45 on the grounds of paucity of data at these ages. Of course, 
the uncertainty in estimation is reflected in the Cls but the correctness of the functional 
form adopted here is not. 
The work described above was reviewed by Ernest B. Hook. He made two points 
concerning the birth certificate studies of Hook and Chambers ( 1977) and of Huether el al. 
( 1981 ). Firstly, on collection of further data and further refinement, Hook and Cross 
( 1982) estimated the proportion of cases in the ascertainment sample registered as having 
Down syndrome on birth certificates to be 33.6% in the study of Hook and Chambers 
( 1977). This suggests a slightly lower rate of ascertainment than that given in the original 
paper (37.5%) and implies that only 101, rather than 113, of the 301 cytogenetically 
diagnosed cases included in the sample were recorded on birth certificates. We note that 
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Maternal Age Odds Rate per 1,000 90%CI 
16 1:1448 0.69 (0.65,0.72) 
17 1:1442 0.69 (0.65,0.72) 
18 1:1434 0.70 (0.66,0.73) 
19 1:1423 0.70 (0.66,0.73) 
20 1:1408 0.71 (0.67,0.74) 
21 1:1389 0.72 (0.68,0.75) 
22 1:1365 0.73 (0. 70,0. 76) 
23 1:1333 0.75 (0. 72,0. 78) 
24 1:1294 0.77 (0.74,0.80) 
25 1:1244 0.80 (0. 77 ,0.83) 
26 1:1184 0.84 (0.82,0.88) 
27 1:1111 0.90 (0.87,0.93) 
28 1:1027 0.97 (0.94,1.01) 
29 1:933 1.07 (1.04, 1.12) 
30 1:831 1.20 (1.17,1.26) 
31 1:725 1.38 (1.34,1.45) 
32 1:620 1.61 (1.56,1.69) 
33 1:519 1.92 (1.86,2.03) 
34 1:426 2.34 (2.26,2.47) 
35 1:344 2.90 (2.79,3.05) 
36 1:273 3.64 (3.51,3.82) 
37 1:215 4.64 (4.46,4.86) 
38 1:167 5.96 (5.73,6.23) 
39 1:128 7.73 (7.40,8.05) 
40 1:98 10.08 (9.60,10.50) 
41 1:75 13.20 (12.50,13.77) 
42 1:57 17.35 (16.29,18.12) 
43 1:43 22.83 (21.24,23.96) 
44 1:32 30.07 (27.69,31.75) 
45 I :24 39.58 (36.06,41.99) 
46 1:18 52.00 (46.89,55.39) 
47 1:14 68.11 (60.89,72.82) 
48 1:10 88.81 (78.72,95.29) 
49 1 :8 115.08 (1 0 1.12, 124.00) 
50 1:6 147.92 (129.04, 159.74) 
Table 2.6. Fitted rates and 90% Cls from the constrained model in Table 2.5 
the actual number of cases in the ascertainment sample found by Hook and Cross (1982) to 
be registered as having Down syndrome on birth certificates was not available. The second 
point to be addressed is that raised by Johnson et al. (1985). They investigated the 
possibility of false-positive reporting of Down syndrome on birth certificates and estimated 
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the rates to be 4.5% and 5.9% respectively in the studies of Hook and Chambers ( 1977) 
and Huether et al. ( 1981 ). Again, this information is anecdotal with no hard data. We 
carried out a sensitivity analysis to assess the influence of these factors on the predicted 
risks derived from our preferred model. Having adjusted the number of cases in Hook and 
Chambers' ascertainment sample registered as having Down syndrome, and multiplied the 
cases in the birth certificate studies by the appropriate factors of 0.955 and 0.941, predicted 
risks were found to be barely affected. The greatest percentage differences in rates 
occurred at the lower end of the maternal age range. The latter point concerning false-
positive rates suggests a possible extension to the model in which two additional 
parameters denote the probability of an unaffected pregnancy being falsely recorded as 
Down syndrome in the birth certificate studies of Hook and Chambers ( 1977) and Huether 
et al. (1981). 
2. 4. 5 Goodness of Fit 
Estimates of the proportions of livebirths ascertained as having Down syndrome were 
obtained for each data set by multiplying the estimated rate from our preferred model 
(Table 2.6) by the estimated probability of ascertainment (Table 2.5). The observed and 
fitted proportions of livebirths registered as Down syndrome for this model are shown in 
Figure 2.1 (on a log scale). The total numbers of Down syndrome cases r; observed in 
each data set are superimposed. The smooth curves represent the fitted model whilst the 
points represent the observed rates. The observed data from the Intensive Newborn Studies 
have been grouped by five-year intervals due to the small number of Down syndrome cases 
(on average less than one case for each year of maternal age). Since zero rates cannot be 
plotted on a log scale this grouping gives a truer representation of the observed data. The 
observed rates scatter about the fitted rates with no suggestion of any systematic departure 
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Figure 2.1. Fit of the reduced model to the individual data sets 
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in any of the studies and, on the basis of Figure 2.1, it appears that the model reflects the 
observed proportions well in all nine studies. However, for both models the Chi-squared 
fit statistic provides evidence of lack of fit. Examination of contributions to the fit 
statistics from different data sets suggests that the study of Trimble and Baird (1978) and 
the compiled data from Koulischer and Gillerot ( 1980) and Koulischer et al. ( 1991) 
account for the lack of fit whilst the other seven studies are quite consistent with the fitted 
model. Anscombe residuals (see McCullagh and Nelder, 1989, page 38) for these two data 
sets are shown plotted against maternal age in Figure 2.2. In both cases there are a number 
of large residuals that would account for the lack of fit. For the compiled data from 
Koulischer and Gillerot ( 1980) and Koulischer et al. ( 1991) there is nothing to suggest any 
systematic departure from the assumed forn1 for ;r(m). However, with the data from 
Trimble and Baird ( 1978) there seems to be a predominance of large negative residuals 
over the maternal age range 28 to 38 and a predominance of positive residuals at younger 
ages. 
On the basis of this we refitted the model excluding Trimb1e and Baird (1978). There is 
very little to choose between the model fitted to all nine data sets and that fitted to the eight 
remaining after excluding Trimble and Baird (\ 978). The fitted rates and bootstrap Cls 
were practically the same as those obtained with all nine studies (there are no discernible 
differences between the graphs of observed and fitted proportions) and the absolute 
differences are small relative to the magnitude of the sampling errors. It is worth noting 
that, excluding Trimble and Baird (1978), the lack of fit of the two models presented in 
Table 2.5 is not significant (P>0.15 in both cases). We also note that, having excluded the 
data of Trimble and Baird (1978), the LR test comparing the full and reduced models 
remains non-significant. Table 2.7 gives the results of this test for all nine studies and 
excluding Trimble and Baird ( 1978). 
28 
Trimble and Baird 
N 
20 30 40 50 
maternal age (yrs) 
Koulischer et al. 
N 
20 30 40 50 
maternal age (yrs) 
Figure 2.2. Scatter plots of Anscombe residuals against maternal age for the data sets 
from Trimble and Baird ( 1978) and Koulischer et al. ( 1980, 1991) 
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2 
X s 
p 
Including Trimble and Baird (1978) Excluding Trimble and Baird (1978) 
3.52 
0.62 
3.68 
0.60 
Table 2.7. LR tests comparing full (all (/J; estimated) and reduced ((/J; estimated for i=1, .. .,4 
only) models 
2.5 Alternative Models for Maternal Age-Specific Prevalence 
2. 5.1 Model Fitting 
In this section various alternative functional forms for ;r(m) are considered. These include 
the three parameter CPE model (2.1 ), considered by Cuckle et al. ( 1987), and the five 
parameter extension of this model, considered by Hecht and Hook (1994). We also 
consider a more general logistic model of the form 
y-a 
;r(m) = a+ -------c----...,.-
l+exp{-(/30 +fJ1m)} 
(2.4) 
so that the risk rises from the lower limit a to an upper limit y . With y = I this reduces 
to the model (2.2) used in the main analysis. LR tests were used to test hypotheses about 
the model parameters, both including and excluding the study of Trimble and Baird ( 1978). 
2.5.2 Results 
The addition of the quadratic and cubic terms in the CPE models does not significantly 
improve the fit of the model and the logistic model with lower and upper thresholds (2.4) 
offered no significant improvement in fit over the logistic model with lower threshold only 
(2.2). Results of these LR tests are shown in Table 2.8 for both the full (ascertainment 
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proportion estimated for all studies) and reduced (full ascertainment assumed in studies 
i=5, ... ,9) models. The test statistics decrease when the data of Trimble and Baird (1978) 
are excluded. 
Including Trimble and Baird (1978) Excluding Trimble and Baird (1978) 
Full Model Reduced Model Full Model Reduced Model 
2 p 2 p 2 p 2 p X (d.r.) X (d.I.J X (d.I.J X (d.I.J 
CPE Model; 
3 v 5 Parameter 5.62 (2) 0.060 5.56(2) 0.062 4.82(2) 0.090 4.76(2) 0.093 
Logistic Model; 
a v a and r 3.1 0(2) 0.078 3 .12(1) 0.077 2.42(1) 0.120 2.40(1) 0.121 
Table 2.8. Results of LR tests comparing the 3 and 5 parameter CPE models, and the 
logistic models with lower threshold only and lower and upper thresholds 
Table 2.9 gives estimated ascertainment probabilities and goodness-of-fit statistics for the 
three alternative models, with and without the assumption of full ascertainment in studies 5 
to 9 in Table 2.1. Results of fitting these models to the eight data sets remaining after the 
exclusion of Trimble and Baird ( 1978) were similar. As in Section 2.4.5, we note here that 
with all nine data sets included, the lack of fit is significant (P<0.05) for each of the three 
alternative models considered. Excluding the study of Trimble and Baird ( 1978) the 
alternative models all provide an acceptable fit to the data from the remaining eight studies 
(?>0.14 ). There is a remarkable degree of consistency between the results for the different 
functional forms of ll'(m) considered and there is very little on the basis of the goodness-
of-fit statistics to choose between them. In comparing the three parameter CPE model and 
the logistic model with lower threshold only, which also has three parameters, we note that 
the logistic model fits the data marginally better. Moreover, this model seems to be more 
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Three Parameter CPE Model 
Data Set 
Hook and Chambers (1977) 
Huether et al. (1981) 
Trimble and Baird ( 1978) 
Staples et al. (1991) 
Hook and Lindsjo (1978) 
Lindsten et al. (1981) 
Koulischer et al. (1980,1991) 
Intensive Newborn (1975,1974) 
Halliday et al. (1995) 
2 X (d.f.) 
p 
Full Model 
0.342 
0.371 
0.861 
0.874 
0.922 
0.997 
0.951 
0.855 
0.927 
309.55 (265) 
0.031 
Five Parameter CPE Model 
Data Set 
Hook and Chambers ( 1977) 
Huether et al. (1981) 
Trimble and Baird (1978) 
Staples et al. (1991) 
Hook and Lindsjo (1978) 
Lindsten et al. (1981) 
Koulischer et al. (1980,1991) 
Intensive Newborn (1975,1974) 
Halliday et al. (1995) 
2 X (d.f.) 
p 
Full Model 
0.341 
0.371 
0.858 
0.877 
0.924 
0.999 
0.952 
0.855 
0.922 
303.93 (263) 
0.042 
Reduced Model 
0.351 
0.377 
0.886 
0.899 
1 
1 
1 
313.01 (270) 
0.037 
Reduced Model 
0.350 
0.377 
0.882 
0.901 
1 
1 
1 
307.45 (268) 
0.049 
Logistic model with upper and lower thresholds 
Data Set 
Hook and Chambers (1977) 
Huether et al. ( 1981) 
Trimble and Baird ( 1978) 
Staples et al. (1991) 
Hook and Lindsjo (1978) 
Lindsten et al. ( 1981) 
Koulischer et al. ( 1980,1991) 
Intensive Newborn (1975,1974) 
Halliday et al. (1995) 
2 X (d.f.) 
p 
Full Model 
0.342 
0.371 
0.858 
0.878 
0.925 
1.000 
0.953 
0.855 
0.922 
305.01 (264) 
0.042 
Reduced Model 
0.350 
0.377 
0.881 
0.901 
1 
1 
1 
308.51 (269) 
0.049 
Table 2.9. Estimated ascertainment rates and fit statistics for the alternative models 
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plausible than the CPE model; risks predicted by exponential models soon rise above one 
after the age of 50, whereas the logistic model approaches an asymptote of one. 
2.5.3 Logistic Models Filled Separately to Each Study 
The proposed model was further validated by performing LR tests to confirm that a 
significant improvement in fit was not obtained by fitting logistic models individually to 
each data set rather than assuming common logistic parameters across all studies. In order 
for the models presented in Table 2.5 to be nested within this more general model it was 
necessary to fit the logistic model with both upper and lower thresholds (2.4) to each study. 
After reparameterization it is clear that the two models in Table 2.5 are special cases of this 
model. These LR tests can be viewed in a logical sequence with other hypothesis tests in 
this chapter to provide a thorough validation of our proposed model: 
I. H0: Common logistic model (2.4) for all studies, I{J; estimated for all studies 
H 1: Separate logistic models (2.4) fitted to each individual study (Table 2.10 below) 
2. H0: Common logistic model (2.2) for all studies, I{J; estimated for all studies 
H 1 : Common logistic model (2.4) for all studies, I{J; estimated for all studies (Table 2.8) 
3. H0: Common logistic model (2.2) for all studies, I{J; estimated for studies i= I , ... ,4 only 
H 1 : Common logistic model (2.2) for all studies, I{J; estimated for all studies (Table 2. 7) 
2 
X td.r.) 
p 
Including Trimble and Baird (1978) Excluding Trimble and Baird (1978) 
30.07(25) 
0.22 
18.18(22) 
0.70 
Table 2.1 0. LR tests comparmg a common logistic model (2.4) for all studies ( I{J; 
estimated for each study) with separate logistic models (2.4) fitted to each individual study 
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2.6. Discussion 
2. 6.1 Comparisons with Other Published Models 
Table 2.11 shows fitted livebirth prevalence rates of Down syndrome from studies 
published by Cuckle et al. (1987), Hecht and Hook (1994), Halliday et al. (1995) and 
Hecht and Hook ( 1996) together with those obtained from our analysis. The final column 
of the table gives the overall fitted rate in the absence of prenatal screening and diagnosis 
for a standardised age distribution (England and Wales, 1986-1989; Office of Populations 
Censuses and Surveys (OPCS), 1988-1991 ). This was obtained by accumulating the 
average predicted rate of Down syndrome across the maternal age range 16 to 50 weighted 
by the livebirth distribution of England and Wales for the three years 1986-1989. No 
overall rate is given for the model of Halliday et al. ( 1995) because of the limited range of 
maternal ages for which this model applies. Percentile bootstrap 90% Cls are presented for 
the risk estimates from our full and constrained models. 
The question of which schedule of maternal age-specific rates of Down syndrome to use 
for prenatal screening raises several issues related to the epidemiology of this condition. 
Attempts to pool results over different studies such as those here and those of Cuckle et al. 
(1987) and Hecht and Hook (1994, 1996) assume either implicitly or explicitly that there is 
in fact no background variation in underlying (maternal age-specific) rates except that 
associated with statistical fluctuation. We discuss this point further in Section 2.6.2, but 
note here that even if this assumption is correct, there remains the residual issue of 
potential incomplete ascertainment in many studies. For that reason Hecht and Hook 
( 1994, 1996) restricted their analyses to reports in which it appeared reasonable to infer 
close to complete ascertainment. They specifically excluded the birth certificate studies of 
Hook and Chambers (1977) and Huether et al. (1981) because of major under-
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Maternal Age 
16 21 26 31 36 41 46 Overall 
Cuckle et al. ( 1987); 0.64 0.66 0.78 1.25 3.25 11.59 46.43 1.28 
3 Parameter CPE 
Hecht and Hook ( 1994 ); 0.59 0.62 0.75 1.31 3.65 13.62 55.94 1.35 
3 Parameter CPE 
Hecht and Hook (1994); 0.65 0.67 0.78 1.23 3.27 12.12 43.54 1.28 
5 Parameter CPE 
Halliday et al. (1995); 3.34 14.66 
Logistic 
Hecht and Hook ( 1996); 0.54 0.68 0.84 1.35 3.56 14.29 52.03 1.40 
6 Parameter CPE 
Full Model 0.7 1 0.74 0.87 1.42 3.75 13.62 53.67 1.46 
(90% Cl) (0.68,0.76) (0.71,0.79) (0.85 ,0.93) (1.39, 1.54) (3 .66,4.07) (13 .06,14.63) (49.23,58.20) (1.41 , 1.57) 
Reduced Model 0.69 0.72 0.84 1.38 3.64 13.20 52.00 1.41 
(90% Cl) (0.65,0. 72) (0.68,0.75) (0.82,0.88) ( 1.34, 1.45) (3 .51 ,3.82) (12.50, 13.77) (46.89,55.39) (1.36, 1.48) 
Table 2.11. Comparison of rates per thousand live births estimated by various models 
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ascertainment in their primary data sources. Here we take an alternative approach by 
including these data but adjusting for the extent of incomplete ascertainment which was 
explicitly estimated and acknowledged in these two studies. The inclusion of the study of 
Halliday et al. (1995) also expands significantly the size of the data base for analysis over 
that of Hecht and Hook ( 1996). 
Hecht and Hook (1996) excluded the study of Trimble and Baird ( 1978) because, in their 
view, the described methods suggested likely incomplete ascertainment. Our observations 
here are consistent with that interpretation which they reached on independent grounds. 
Random errors in age reporting may have produced some distortion in this study, 
particularly at the older ages, through an effect similar to that of regression to the mean 
(see Hecht and Hook (1996) for further discussion of this point). Similarly, Hecht and 
Hook (1996) also found lower rates in the Australian study (Staples et al., 1991) than the 
others. In this analysis we estimate the levels of ascertainment in these studies (see Table 
2.5) and assess the level of under-ascertainment. Apart from Trimble and Baird (1978), 
Staples et al. ( 1991) and the birth certificate studies of Hook and Chambers ( 1977) and of 
Huether et al. ( 1981 ), we found no grounds to infer under-ascertainment in the studies 
considered by Hecht and Hook ( 1996) nor in the study of Halliday et al. (1995). 
A striking feature of Table 2.11 is that when only those studies deemed to be complete are 
included or when ascertainment probabilities are modelled, the risks are considerably 
higher than those previously published by Cuckle et al. ( 1987). The widely used model of 
Cuckle et al. ( 1987) and the five parameter model of Hecht and Hook ( 1994) assume 
complete ascertainment in studies where we have found evidence of under-ascertainment. 
1-Jecht and Hook (1996) report further evidence of this from their detailed review of the 
way the original studies were conducted. Taking the maternal age distribution of England 
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and Wales over the period 1986 to 1989, we find that the livebirth prevalence predicted by 
the proposed model is about I 0% higher than that given in Cuckle et al. (1987). In general 
the model of Hecht and Hook ( 1996) is quite consistent with our reduced model which 
mimics the assumptions about ascertainment made by Hecht and Hook (1996). However, 
the rates predicted by this CPE model are lower amongst younger mothers. One 
explanation for this is instability resulting from the use of a quartic expression in the model 
of Hecht and Hook (1996). The proposed model encompassing more data may be 
preferable because of greater precision. 
2.6.2 Age-independent Factors Affecting Birth Prevalence 
The model (2.2) can be viewed as a mixture of an age-specific component, modelled by a 
logistic regression on maternal age, and a constant, age-independent, component. The 
small value of a reflects the constant component which accounts for the birth prevalence 
amongst younger women. Although the birth prevalence amongst this group is small, the 
relatively large numbers of births to women of these ages mean that they account for a 
significant proportion of Down syndrome births. 
As far as we know, apart from maternal age or the presence of an extra or translocated 21 
chromosome in one parent, there are no generally accepted environmental or biological risk 
factors for Down syndrome. However, an inverse association between maternal smoking 
and the birth prevalence has been reported (Hook and Cross, 1985; Cuckle et al., 1990; 
Hook, 1994). There is also some evidence that maternal thyroid disease is positively 
associated with Down syndrome (Khoury et al., 1989). One proposed explanation for the 
apparently protective effect of smoking is that maternal smoking increases the chance of 
miscarriage in affected pregnancies. Should such suggested associations eventually be 
established, then population variation in such factors may of course account for some 
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population difference in rates. Clinical geneticists may need eventually to adjust maternal 
age-specific rate schedules such as those derived here for the presence (or absence) of other 
proven risk factors. 
Nevertheless, the general consistency of rates that we and Hecht and Hook ( 1994, 1996) 
observe among those studies in which ascertainment appears satisfactory suggests that such 
environmental effects upon rates, if they do exist, do not cause marked interpopulation 
variation. This may be because such putative agents (e.g. cigarette smoking or thyroid 
disease) have relatively similar distributions in the populations studied to date. 
A separate but related issue is the question of underlying ethnic and racial variation m 
rates. In only two groups, Mexican Americans (Wilson et al., 1992) and Jews of Asian or 
African origin (Hook and Harlap, 1979), has evidence for an increase in rates over that in 
European populations been reported. Reports suggesting lower rates in non-European 
ethnic or racial groups have appeared intermittently in the literature. (For review and 
references see Hook and Porter, I 977; Hook, 1982; Hook, 1994.) However, lower rates 
have not been found consistently and the possibility of incomplete ascertainment in non-
Europeans' studies has not been satisfactorily excluded. Indeed, despite many suggestions 
of lower rates in those of West African origin, the best study suggests no difference at all 
or even possibly higher rates in African Americans compared with those of European 
origin (Sever et al., 1970; Hook and Porter, 1977). 
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Chapter 3 
Modelling the Prevalence of Down Syndrome at Different 
Gestational Ages 
3.1 Introduction 
It is now well established that the prevalence of Down syndrome during pregnancy 
decreases with gestational age. This was first observed with the introduction of 
amniocentesis when a discrepancy was noted between the rates of Down syndrome 
diagnosed at around 16 weeks of gestation and those observed at livebirth. The biological 
explanation for this difference in rates is that Down syndrome fetuses have a higher risk of 
spontaneous abortion than unaffected fetuses. Emest B. Hook carried out a series of 
studies of women who had a positive prenatal diagnosis but declined abortion (Hook, 1978, 
1983; Hook et al, 1989). The results indicated a spontaneous loss rate of Down syndrome 
fetuses of about 30% after the time of amniocentesis compared with 3.5% for unaffected 
pregnancies (Hook et al .. 1989). 
Following the introduction of CVS in 1983 rates observed during the first trimester were 
compared with those from amniocentesis studies (Hook et al, 1988; Kratzer et al. 1992) 
and those in livebirths (Snijders et al., 1994; Macintosh et al., 1995; Halliday et al, 1995). 
Estimates of loss after the time of CVS (about I 0 weeks' gestation) varied from 31% to 
54%. 
Gestational age-specific prevalence is usually described in terms of relative prevalence 
compared to expected prevalence at livebirth. As noted in Section 1.4, the estimation of 
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prevalence during gestation is an important problem from the point of view of counselling 
pregnant women and assessing screening programmes. The estimation of relative 
prevalences is complicated by the various sources of bias inherent in the available data. 
Biases associated with two different methods of estimation are discussed in Section 3.2.1. 
The grouping of gestational age data into CVS and amniocentesis groups is not explicitly 
dealt with in this chapter but methods for overcoming this coarsening problem are 
proposed in Section 7 .2.2. Another difficulty is the possibility that the loss rate is 
dependent on maternal age. Hook (1983), Snijders et al. (1994), Macintosh et al. (1995) 
and Halliday et al. ( 1995) found no significant association between the rate of spontaneous 
loss of affected fetuses and maternal age. On the other hand, the studies of Hook et al. 
( 1988) and Kratzer et al. ( 1992) report that loss between the gestational ages at which CVS 
and amniocentesis are carried out appears to increase with maternal age. 
Two recent papers have attempted to model prevalence more generally across a range of 
gestational ages. Hook et al. ( 1995) carried out a survival analysis on data which gave the 
number of Down syndrome cases surviving and the number lost by gestational age ( 14 to 
27 weeks) at diagnosis. Maternal age was found to be associated with loss rates only 
among cases diagnosed at or after 18 weeks' gestation. Snijders et al. (1995) modelled 
Down syndrome prevalence observed at 11 and 17 weeks of gestation and at livebirth. 
Finding the increase in rates with maternal age to be parallel in these three groups they 
assumed that there was no association between loss rates and maternal age and fitted a 
smooth curve to the gestational age range I 0 to 40 weeks. 
This chapter deals with the problem of estimating Down syndrome prevalence in terms of 
both gestational age and maternal age. We start in Section 3.2 with an overview of the 
published literature in the area and the original sources of data available. Section 3.3 
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reviews statistical models that have been used including the model of Halliday et al. ( 1995) 
which uses logistic regression on maternal age with gestational age fitted as a three-level 
factor (CVS, amniocentesis or livebirth). Section 3.4 presents a meta-analysis using the 
same model as Halliday et al. (1995). Section 3.5 then goes on to describe an extension to 
the livebirth prevalence models of Chapter 2 with an exponential term for the decreasing 
relative prevalence throughout pregnancy. Several alternative exponential expressions are 
considered and the results are compared with those of Section 3 .4. 
3.2 Overview 
3.2.1 Direct and indirect Methods 
Published estimates of loss rates have been obtained by two methods. One method, 
referred to as the direct method, is to obtain prospective data on the progress of 
pregnancies known to be affected. The other method is to obtain prevalence data at various 
stages during pregnancy and estimate the loss rates by comparing prevalence at various 
gestations with the livebirth prevalence. This method is referred to as the indirect method. 
Table 3.1 summarises the results of the papers introduced in Section 3.1, classified 
according to method. 
One striking feature of Table 3.1 is that there are large discrepancies between loss rates. 
These cannot be accounted for by sampling error and are likely to be the result of study 
bias. The direct method is based on following up women after intervention by CVS or 
amniocentesis and may be affected by bias resulting from losses caused by the 
intervention, leading to overestimates of loss rates. This was recognised in the work of 
Hook et al. (1995) who applied a lagging technique in order to quantify bias caused by 
spontaneous loss following the intervention. With the indirect method, if the livebirth 
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Estimated Spontaneous Loss Between: 
CVS and CVS and Amniocentesis and 
Livebirth Amniocentesis Livebirth 
Direct Method 
Hook, 1978 24% 
Hook, 1983 30% 
Hook et al., 1989 29% 
Hook et al., 1995 50%1 
Indirect Method 
Hook et al., 1988 21% 
Kratzer et al., 1992 13% (age 35)- 47% (age 44) 
Snijders et al., 1994 54% 33% 
Macintosh et al., 1995 54% 32% 
Halliday et al., 1995 31% 17% 18% 
Snijders et al., 1995 47% 31% 
1For fetuses ascertained at 15 to 17 weeks' gestation , corresponding to the average gestation age in other 
amniocentesis groups (Halliday et al., 1995; Snijders et al. , 1995) 
Table 3.1. Summary of published estimates of loss between the times of CVS, 
amniocentesis and livebirth 
prevalence were underestimated, then this would cause positive bias in the estimated loss 
rates. This could occur due to under-ascertainment of Down syndrome cases. Recent work 
of Hecht and Hook ( 1996) and Bray et al. ( 1998) suggests that commonly used models 
underestimate livebirth prevalence. Similarly, selection bias could lead to overestimation 
of prevalence during pregnancy. This will occur if women present for prenatal testing on 
grounds other than raised maternal age (family history or biochemical screening). Bias 
could also result if the pregnancies comprising the CVS or amniocentesis samples formed a 
group with lower risk of spontaneous loss than those used to estimate livebirth prevalence. 
This would lead to inflated prevalence at CVS or amniocentesis. Comparison of these 
rates with those expected at livebirth would overestimate loss rates. This could be the case, 
for example, if the CVS or amniocentesis pregnancies had better prenatal care. 
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3. 2. 2 Prevalence Data 
With the exception of Halliday et al. (1995) the indirect studies were based on pooled 
prevalence data. The ' data map' shown in Figure 3.1 illustrates the various sources of 
CVS, amniocentesis and livebirth prevalence data used in these studies. The livebirth 
sources that appear in this figure were introduced in Chapter 2. Original data collected by 
the authors are given in parentheses (e.g. Philadelphia, Chicago, Milan). These data sets 
often appear in later studies, as indicated by the lines to the right of the figure. 
Source 
cvs 
Mikkelssen and Ayme ( 1987) 
Leschot et al. ( 1989) 
Livebirth 
Cuckle et al. ( 1987) 
Koulischer and Gillerot ( 1980) 
Hook and Lindsjll ( 1978) 
Hook et al. (1988) 
CVS (Philadelphia, Chicago, Milan) 
amniocentesis 
Kratzer et al. (1992) 
modified by 
Hook and 
Cr~~s ( 1989) 
~-
CVS (San Fransisco) -----
amniocentesis ........___, ~ 
livebirth 
Snijders et al. (1994) 
cvs czentrum rur Frauenheilkunde, Harris Birthrighv 
Research Centre for Fetal Medicine) J 
amniocentesis P' 
livebirth ,., 
Macintosh et al. (1995) 
cvs (Danish register) 
Halliday et al. (1995) 
cvs 
amniocentesis 
livebirth 
Snijders et al. (1995) 
cvs 
amniocentesis 
livebirth 
/ 
--
/ 
/ 
; 
Figure 3.1. Sources of CVS and amniocentesis prevalence data in the literature 
This revtew of the prevalence data available in the literature shows that the most 
comprehensive compilation of CVS data is presented by Macintosh et al. (1995). The 
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amniocentesis data used by Snijders et al. ( 1994, 1995) is the largest collection in the 
literature. Neither of these studies include the more recent data published by Halliday et 
al. (1995). 
3.3 Statistical Models 
3. 3.1 The Logistic Model of Halliday et al. (1995) 
Many of the analyses described above (Hook et al., 1988; Snijders et a/, 1994; Macintosh 
et al., 1995; Snijders et al. 1995) used an exponential model to smooth observed Down 
syndrome prevalence rates. The same model was applied to regress prevalence on maternal 
age at different stages of gestation. The slopes of the fitted models were then compared to 
look for an interaction between loss rates and maternal age. This modelling problem is 
essentially no different from that considered in Chapter 2. The reduced maternal age range 
of the CVS and amniocentesis data in fact means that a simpler model could be used than 
when fitting a model to the entire range of 16 to 50 years. 
Kratzer et al. (1992) fitted a logistic model to the age range 35 to 44 with type of test (CVS 
or amniocentesis) as a two-level factor, thereby including gestational age in the model as a 
categorical variable. Using a different notation from Kratzer et al. (1992) we define the 
model as 
( n( m, c) ) log ( ) = flo + fJ1 m+ Y c I - Jr m, c (3 .I) 
where c has levels I for CYS and 2 for amniocentesis. We adopt the constraint y1=0 so that 
y2 represents the log odds ratio (OR) for amniocentesis relative to CVS. In this model f30 is 
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the intercept and /31 represents the log OR for maternal age (per year). Since Down 
syndrome is a comparatively rare condition the ORs derived can be interpreted as relative 
risks (RRs). The advantage of this approach is that it combines all the data in one model, 
allowing more precise estimates and more power to detect significant effects. It is also 
easy to test whether maternal age has a different effect on prevalence at different 
gestational ages by including an interaction term. 
Halliday et al. (1995) extended this model to include livebirth prevalence data so that c has 
three levels representing CVS, amniocentesis and livebirths. In this case y2 and y3 
represent the log ORs for amniocentesis and livebirths relative to CVS. Terms for 
interaction between gestational age and maternal age were also included. In Section 3.4 a 
similar model is fitted, including the large sets of CVS and amniocentesis data pooled by 
Snijders et al. (1994 ). Having established that the two data sets are consistent, we 
investigate the effect of including additional livebirth data with high levels of 
ascertainment. The final model is a meta-analysis of all available amniocentesis and CVS 
data. This work is published in Bray and Wright (1998b). 
3. 3. 2 Filling a Smooth Curve to Gestational Age-Specific Prevalence 
From the model fitted by Halliday et al. ( 1995) (3 .I) we can derive the relative prevalence 
of Down syndrome for only two gestational age groups compared with livebirth 
prevalence. In order to counsel pregnant women presenting for prenatal screening at 
different stages of gestation it is necessary to estimate prevalence as a smooth function of 
gestational age as well as maternal age. This is becoming increasingly important as new 
first trimester screening programmes are developed. While Hook et al. (1995) applied 
survival analysis to the problem of estimating loss rates across a range of gestational ages, 
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Snijders et al. ( 1995) used regression analysis to describe the decrease in prevalence with 
gestation. They assume that Down syndrome prevalence n(m,g) for maternal age m and 
gestational age g is given by (3.2) where n(m) denotes maternal age-specific prevalence 
and h(g) represents gestational age-specific relative prevalence: 
;r(m,g) = ;r(m)h(g) . (3.2) 
Smoothed estimates of n(m) were taken from Hecht and Hook (1994). Observed 
prevalences (relative to term) for groups of CVS, amniocentesis and 1ivebirth data were 
regressed on the mean gestational age of each (11, 17 and 40, respectively) to obtain an 
exponential expression for h(g). The authors do not describe the calculation of relative 
prevalences for the CVS and amniocentesis groups but in the earlier paper by Snijders et 
al. ( 1994) the observed incidences in these two groups were compared with those expected 
on the basis of crude incidences in published live birth data. The relative prevalence at 40 
weeks (term) was taken to be one, but the fitted curve was not constrained at this point. 
In Section 3.5 we fit a multiplicative model (3.2) to all the available data and the 
interaction between maternal age and gestational age is examined. Throughout the analysis 
the modified logistic regression model (2.2) presented in Chapter 2 is used for n(m) to 
describe the dependence of prevalence on maternal age at expected date of delivery (EDD) 
in years. For the gestational age data (in weeks) this livebirth prevalence is multiplied by 
an exponential function h(g) to model the decrease in relative prevalence from conception 
to term. Taking term to be at 39 weeks (Halliday et al., 1995) we constrain the model to 
one at livebirth so that h(39)=1. Several alternative expressions for h(g) are considered, 
including models allowing for an interaction between maternal age and gestational age. 
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These functions are all of the form h(g) = exp{ k(39- g)} where k is some function of the 
time to EDD. 
3.4 Meta-Analysis Using the Model ofHalliday et al. (1995) 
3. 4. 1 Introduction 
Halliday et al. ( 1995) analysed recent data on 183 Down syndrome pregnancies observed 
at CVS, amniocentesis or among livebirths to untested women. The logistic model (3 .I) 
fitted by Halliday et al. (1995) is described in Section 3.3 .I. The authors estimated loss 
rates of 31% between CVS and livebirth and 18% between amniocentesis and livebirth. 
These rates are considerably lower than those reported in the study by Snijders et al. ( 1994) 
of 1 ,264 Down syndrome pregnancies diagnosed at CVS and amniocentesis. Snijders et al. 
(1994) estimated losses of 54% and 33% after times of CVS and amniocentesis 
respectively. Halliday et al. (1995) suggest that improvements in obstetric and perinatal 
care over the last 20 years have led to lower rates of spontaneous loss of Down syndrome 
fetuses and correspondingly higher livebirth prevalence. However, with the relatively 
small san1ple of data included in the analysis of Halliday et al. (1995) the 90% Cl for the 
rate of loss after the time of amniocentesis ranges from 0% to 38%. 
There is bias in the estimates given by Snijders et al. (1994) which partially explains the 
difference observed between these two studies. For each test group expected livebirth 
prevalence was calculated on the basis of crude incidences in livebirths (Cuckle et al., 
1987) and the maternal ages recorded at the times of CVS or amniocentesis. The expected 
prevalence at livebirth was then compared with the observed prevalence at time of CVS or 
amniocentesis to derive estimated loss rates. Since the maternal ages at time of diagnostic 
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procedure were not adjusted to maternal age at EDD the expected livebirth prevalences 
were underestimated and the loss rates presented are overestimates. 
In our analysis logistic models similar to those fitted by Halliday et al. (1995) are used. 
First we establish that the data sets presented by Snijders et al. (1994) and Halliday et al. 
(1995) are consistent with common underling loss rates. Then we present a comprehensive 
meta-analysis of CVS, amniocentesis and livebirth studies in the literature, providing new 
estimates and Cls for loss rates from the times of CVS and amniocentesis. 
The data used can be found in Table 3.2. We note that wherever available data for 
maternal ages up to 50 years were included. The CVS data comprise rates from four 
published studies (Hook et al., 1988; Leschot et al., 1989; Kratzer et al., 1992; Snijders et 
al., 1994) which were pooled by Macintosh et al. (1995) with their own data obtained from 
the Danish cytogenetic register. The pooled rates were checked and corrected from the 
original sources and combined by adding cases and the total number of women undergoing 
karyotyping at each maternal age. Likewise, the pooled amniocentesis data used by 
Snijders et al. (1994) were verified and corrected from the two original studies (Hook et 
al., 1984; Ferguson-Smith and Yates, 1984). The CVS and amniocentesis data of Halliday 
et al. ( 1995) are also included. Livebirth prevalence data for maternal ages from 35 to 50 
years were taken from four studies reviewed by Hecht and Hook (1996) and judged likely 
to have achieved nearly complete ascertainment (studies 5, ... ,8 in Table 2.1 ), and Halliday 
et al. ( 1995). 
3. 4. 2 Consistency of the Two Data Sets 
Restricting analyses to the data presented by Snijders et al. (1994) and Halliday et al. 
(1995) we carried out a LR test to assess whether the two data sets are consistent with a 
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Maternal Amniocentesis Studies 
Age1 
Ferguson-Smith and Yates Hook et al. Halliday et al. Combined 
(1984) (1984) (1995) 
35 19 (5409) 44 (13525) 63(18934) 
36 35 (6103) 55 (11694) 2 (648) 92 (18445) 
37 47 (6956) 54 (9450) 16 (2016) 117 (18422) 
38 64 (7926) 70 (7062) 12 (1638) 146 (16626) 
39 84 (7682) 57 (5298) I 0 ( 1197) 151 (14177) 
40 88(7174) 65 (3883) 9 (878) 162 (11935) 
41 70 (4763) 44 (2323) 8 (533) 122 (7619) 
42 69 (3156) 29 (1404) 9 (308) 107 (4868) 
43 62 (1912) 26 (732) 5 ( 164) 93 (2808) 
44 30 (1015) 11 (433) I (66) 42 (1514) 
45 23 (508) 7 (161) I (40) 31 (709) 
46 19 (232) 3 (67) 0 (10) 22 (309) 
47 2 (66) 4 (29) 0 (4) 6 (99) 
48 0 (35) 3 (9) 0 (I) 3 (45) 
49 I (18) I (5) 2 (23) 
50 0 (I) 0 (I) 
Total 613 (52955) 473 (56075) 73 (7504) 1159 (116534) 
Maternal CVS Studies 
Age1 
Hook et al. Leschot et al. Kratzer et al. Snijdcrs et al. Halliday et al. Macintosh et al. Combined 
(1988) (1989) (1992) (1994) (1995) (1995) 
35 3 (622) 9 (1155) 4 (939) 6 (1391) 22 (4107) 
36 5 (655) I (254) 4 (1057) 5 (lOll) I (236) 7 (1209) 23 (4422) 
37 3 (608) I (251) 11 (1073) 7 (1055) 5 (732) 9 (972) 36(4691) 
38 5 (575) 3 (207) 12 (905) 10 (850) 3 (664) 3 (802) 36(4003) 
39 9 (5 18) 5 ( 139) 14 (754) 15 (717) 10(488) 13 (56 1) 66 (3177) 
40 4 (351) 3 (109) 10 (493) 11 (498) 5 (417) 7 (393) 40 (2261) 
41 5 (234) 2 (49) 12 (326) 7 (315) 7 (224) 6 (279) 39 (1427) 
42 5 ( 137) I (21) 3 (21 0) 7 (222) 4 ( 139) 7 ( 167) 27 (896) 
43 4 (79) I ( 16) 5 (Ill) 8 ( 109) I (84) 6 (81) 25 (480) 
44 3 (37) I (3) 4 (37) 3 (59) I (38) 3 (38) 15 (212) 
45 I (24) 0 (2) 2 (18) 2 (39) I (12) I ( 19) 7 ( 114) 
46 0 (4) 0 (5) I (7) 3 (10) 4 (26) 
47 I (3) 0 (2) 0 (4) I (9) 
48 0 (I) 0 (I) 0 (I) 0 (3) 
Total 48 (3848) 18 (1051) 86(6147) 79 (5814) 39 (3041) 71 (5927) 341 (25828) 
1For all amniocentesis and CVS data (except Halliday et al., 1995) the maternal age at EDD was estimated 
by adding the appropriate proportion of a year before model fitting (see text for explanation) 
Table 3.2. The number of cases of Down syndrome (with total number of pregnancies in 
parentheses) by maternal age, group (CVS or amniocentesis) and study 
common underlying process. The 'full' model involves separate logistic regressions for 
each data set. For the data of Halliday et al. (1995) this model included maternal age at 
EDD and a three-level factor (CVS, amniocentesis or term) for group. For the CVS and 
amniocentesis data of Snijders et al. (1995) a similar model was used but with a two-level 
factor (CVS or amniocentesis). The 'reduced' model assumed a common logistic 
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regression on gestational age and common parameters for CVS and amniocentesis. The 
'full' model provided no significant improvement in fit over the 'reduced' model 
(x23=0.410, P=0.94) leading to the conclusion that there is no evidence to suggest any 
inconsistency between the two data sets. 
3. 4. 3 Estimated Loss Rates 
To emphasise the similarity m loss rates separate estimates of loss for each data set, 
relative to livebirth data from Halliday et al. (1995), were obtained by fitting a logistic 
model including a common maternal age relationship with a five-level factor 
corresponding to each test group in each data set (model I). Estimates of ORs and 
corresponding rates of spontaneous loss for this model are given in Table 3.3 with 90%. 
C1s. There is a considerable degree of overlap between the Cls based on Snijders et al. 
(1994) and Halliday et al. (1995). In this analysis amniocentesis and CVS data are 
compared with a very small sample of livebirth data. In Table 3.4 we present estimated 
ORs and corresponding percentage losses (with 90% Cis) of Down syndrome obtained by 
fitting a similar model while including the additional livebirth studies (model II). Finally, 
we include all the amniocentesis and CVS data in Table 3.2 (model III). We adjusted the 
maternal ages in the pooled data given by Snijders et al. (1994) and Macintosh et al. (1995) 
and produced plots of observed rates at times of CVS and amniocentesis. These plots are 
presented in Figure 3.2 and indicate that maternal and gestational age-specific rates are 
consistent with those derived from the data presented by Halliday et al. ( 1995) (note that 
since the plots are on a log scale zero rates are omitted). 
The estimated ORs and implied rates of loss from model III are given in Table 3.5 with 
90% Cls. The loss rates and their Cls are illustrated graphically in Figure 3.3. Regression 
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coefficients and SEs are given for all models (I - III) in Table 3.6, along with the x.,2 
goodness-of-fit statistics and associated d.f. 
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Figure 3.2. Observed rates of Down syndrome at times of CVS and amniocentesis plotted 
against maternal age at EDD by study 
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Data Set Group OR 90%CI %Loss 90%CI 
(relative to livebirth) 
Halliday et al. Amniocentesis 1.272 (0.97, 1.68) 21% (0%,40%) 
( 1995) cvs 1.618 ( 1.16,2.25) 38% (14%,56%) 
Snijders et al. Amniocentesis 1.243 ( 1.01, 1.52) 20% (1%,34%) 
(1994) cvs 1.783 (1.42,2.24) 44% (30%,55%) 
Table 3.3. ORs and corresponding estimates of loss of Down syndrome fetuses, with 90% 
Cls, based on data from Snijders et al. (1994) and Halliday et al. (1995) alone, with group 
as a five-level factor (model I) 
Data Set Group OR 90%CI %Loss 90%CI 
(relative to Iivebirth) 
Halliday et al. Amniocentesis 1.165 (0.95, 1.43) 14% (0%,30%) 
(1995) cvs 1.479 (1.13,1.94) 32% (11%,48%) 
Snijders el al. Amniocentesis 1.135 (1.05, 1.23) 12% (5%,19%) 
(1994) cvs 1.631 ( 1.43, 1.80) 39% (30%,44%) 
Table 3.4. ORs and corresponding estimates of loss of Down syndrome fetuses, with 90% 
Cls, based on data from Snijders et al. (1994), Halliday el al. (1995) and additional 
livebirth data, with group as a five-level factor (model Il) 
OR 90%CI %Loss 90% Cl 
Maternal Age (per year) 1.305 (1.29, 1.32) 
Amniocentesis (relative to livebirth) 1.134 (1.05, 1.23) 12% 
CVS (relative to livebirth) 1.628 (1.46,1.81) 39% 
(5%,18%) 
(32%,45%) 
Table 3.5. ORs and corresponding estimates of loss of Down syndrome fetuses, with 90% 
Cls, based on all available CVS, amniocentesis and livebirth data, with group as a three-
level factor (model Ill) 
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Figure 3.3. Imputed percentage loss (relative to livebirth) of Down syndrome fetuses with 90% Cis, estimated separately for data from Halliday et al. (1995) and Snijders et al. ( 1994) 
(models I and II), and for the pooled data (model Ill), after time of amniocentesis and time of CVS. Model r is based on data from Halliday et al. ( 1995) and Snijders et al. (1994) alone. 
In modelll additionallivebirth data are included, while in model Ill all available CVS, amniocentesis and livebirth data are pooled. 
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Estimated Log ORs for: 
Maternal Age (yrs) Amniocentesis (relative to livebirth) CVS (relative to livebirth) 
Model Intercept Halliday et al. Snijders et al. Halliday et al. Snijders et aL X 2 d.f. 
(1995) (1994) (1995) (1994) 
I -14.90 0.2568 0.2408 0.2172 0.4809 0.5784 41.28 55 
(0.4084) (0.01016) (0.1680) (0.1241) (0.201 0) (0.1386) 
11 -15.11 0.2643 0.1523 0.1263 0.3914 0.4892 110.6 112 
(0.3104) (0.007859) (0.1233) (0.04807) (0.1653) (0.07852) 
Ill -15.18 0.2663 0.1253 0.4872 121.6 121 
(0.2905) (0.007859) (0.04729) (0.06570) 
1Model I is based on data from Halliday et al. (1995) and Snijders et al. (1994) alone, with group as a five-level factor. In model II additional livebirth data are included, while 
in model lil all available CVS, amniocentesis and livebirth data are pooled with group as a three-level factor. 
Table 3.6. Regression coefficients (with SEs in parentheses) and goodness-of-fit statistics for models I, 11 and 1111 
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3. 4. 4 Model Adequacy 
Standard tests of goodness of fit (see, for example, McCullagh and Nelder, 1989) were 
applied for all models considered and showed no evidence of lack of fit. For the final 
model presented in Table 3.5 the Chi-squared goodness-of-fit test yielded a test statistic of 
x
2
121 =121.61 (P=0.47). As a further test of model adequacy interactions between group 
and maternal age were added to the model. There was weak evidence of an interaction 
Cx\=5.24, P=0.07), although the corresponding parameter estimates did not show a 
consistent trend across gestational groups. A plot of Pearson residuals against age showed 
that they were randomly scattered and gave no reason to believe that observations 
corresponding to higher maternal ages were outlying. Inspection of the leverage and 
Cook's distance for each data point confirmed that none of the observations were 
inappropriately affecting the model. 
3.4.5 Comparisons With Results Previously Published 
Table 3.7 summarises results reported by Halliday et al. (1995) and Snijders et al. (1994) 
for comparison with the results presented here. The results from model I, based on the 
amniocentesis and CVS data of Snijders et al. ( 1994) and Halliday et al. ( 1995) alone 
(Table 3.3) are almost identical to those that would have been obtained by Halliday et al. 
( 1995) had they applied their model to the same maternal age range (35-50 years). Due to 
our modification of the maternal age data, described above, the estimates of loss presented 
by Snijders et al. ( 1994) are higher than those we obtained. 
In Table 3.4 we see that the inclusion of live birth data from Hecht and Hook ( 1996) causes 
a dramatic decrease in estimates of loss, and reduces the uncertainty in the estimates. The 
estimate of loss after amniocentesis obtained from our final model (Table 3.5), including 
all available CVS and amniocentesis data, is considerably lower than any estimate in the 
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Data Source Group OR RR 90%CI 0/o Loss 90%CI 
(relative to livebirth) 
Halliday et al. Amniocentesis 1.220 (0.91,1.61) 18% (0%,38%) 
( 1995) cvs 1.449 (1.02,2.08) 31% (2%,52%) 
Snijders et al. Amniocentesis 1.491 33% 
(1994) cvs 2.196 54% 
Table 3.7. ORs/RRs and corresponding estimates of loss of Down syndrome fetuses 
reported by Halliday et al. (1995) and Snijders et al. (1994), with 90% Cls where available 
literature, including that of Halliday et al. (1995). Possible reasons for this are discussed 
below. The corresponding estimate of loss after CVS is greater than that given by Halliday 
et al. ( 1995) but considerably lower than other estimates in the literature, based on 
unadjusted maternal ages (Snijders et al., 1994, 1995; Macintosh et al., 1995). 
3. 4. 6 Discussion 
Snijders et al. (1994) provide a large collection of published CVS and amniocentesis data. 
Having made appropriate maternal age adjustments we reanalysed this data including the 
recent survey of Halliday et al. ( 1995), the additional CVS data used by Macintosh et al. 
(1995) and several large livebirth prevalence data sets. In addition to the important point 
concerning maternal age correction this analysis differs from that of Snijders et al. ( 1994) 
in two ways. Firstly, the livebirth data used by Snijders et al. (1994) provide rates which 
are lower than those observed in certain studies believed to have achieved high 
ascertainment of cases (see Hecht and Hook, 1996). In this analysis rates at CVS and 
amniocentesis are compared with livebirth data from selected studies with high levels of 
ascertainment. Secondly, the analysis of Snijders et al. (1994) modelled each test group 
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separately rather than combining all available data in one model. As noted by Halliday et 
al. ( 1995), the latter approach yields estimates with smaller SEs. 
The data presented by Halliday et al. (1995) have certain merits in that they are recent, 
have a high level of ascertainment and come from one distinct population and time period. 
However, the comparatively small size of the study suggests that results from an analysis 
of these data alone should not be used in preference to those previously published. We 
have performed a meta-analysis of twelve published data sets including the data of Snijders 
et al. (1994) and Halliday et al. (1995). The resulting estimates are shown in Figure 3.3 
with 90% Cls for comparison with those presented from the models based on Halliday et 
al. (1995) and Snijders et al. (1994) alone and including additional livebirth data. 
The estimate of loss after amniocentesis of 12% from the final model (Table 3 .5) is notably 
lower than that reported by Halliday et al. (1995), while our estimate of loss after CVS of 
39% is somewhat higher than that of 31% in Table 3.7 (Halliday et al., 1995), which falls 
just outside of the 90% Cl computed from our model. In both cases it is clear that the 
inclusion of additional data has resulted in considerably tighter Cls than those based on a 
single data set. 
From the results in Tables 3.4 and 3.5 we see that the estimates of loss after amniocentesis 
and CVS decrease with the inclusion of the additional livebirth data, rather than the 
inclusion of further amniocentesis and CVS data. Direct and indirect methods of 
estimation were discussed in Section 3.2.1. The estimates of loss from our indirect 
analysis are based on live birth prevalence data deemed by Hecht and Hook ( 1996) and 
Bray et al. ( 1998) to be most likely to be complete. A likely explanation for the decrease in 
estimate of loss after amniocentesis is the use of more highly ascertained livebirth data than 
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has previously been used. Halliday et al. (1995) suggested that the difference between 
their estimate (18%) and those previously published could indicate a temporal change. 
However, we note from Table 3.3 that, when compared with the highly ascertained 
livebirth data of Halliday et al. (1995), the estimated loss after amniocentesis was almost 
identical based on either the recent data of Halliday et al. ( 1995) or the data of Snijders et 
al. (1994). The amniocentesis data presented by Snijders et al. (1994) result from pooling 
data from two studies, both dating from nearly fifteen years ago. In our analysis, CVS and 
amniocentesis data are compared with a more extensive set of livebirth data with high 
ascertainment. A slight improvement in ascertainment of cases in livebirth data will lead 
to higher estimates of livebirth prevalence and correspondingly lower estimates of loss 
between amniocentesis and livebirth. We believe that our analysis demonstrates this effect, 
and that the rate of spontaneous loss of Down syndrome fetuses after amniocentesis may be 
considerably lower than has previously been thought. However, there are many other 
sources of bias, such as differential spontaneous loss rates, that we have not been able to 
account for. We would therefore urge caution in the use of estimated loss rates in assessing 
screening performance. 
Although both estimates of loss after time of CVS decrease with the inclusion of additional 
livebirth data, these estimates are naturally more robust to small changes in livebirth 
prevalence than estimates of loss after time of amniocentesis, since they are of greater 
magnitude. The regression coefficient given by Halliday et al. ( 1995) for livebirth relative 
to CVS, when the upper limit of the maternal age range was extended from 43 to 52 years, 
indicated a loss of 39%. This figure is consistent with the corresponding estimate in Table 
3.5 (39%). In addition to the inclusion of more data, the difference between our estimate 
and that of Halliday et al. (1995) can therefore be attributed to a greater maternal age 
range. 1-!alliday et al. (1995) give goodness-of-fit statistics for their model fitted to various 
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maternal age ranges. These provide no evidence of an improvement in fit as the higher 
maternal ages are excluded, and the SE of the relevant log OR actually increases. These 
results, together with our own model checking, lend support to our analysis based on the 
greater maternal age range of 35 to 50 years, and the corresponding estimate of 39% loss of 
Down syndrome fetuses after time of CVS. 
3.5 Multiplicative Model for Maternal and Gestational Age-Specific 
Prevalence 
3. 5.1 introduction 
The multiplicative model (3.2) for maternal and gestational age-specific prevalence was 
described in Section 3.3.2. While the modified logistic model (2.2) is used for the maternal 
age component n(rn) throughout, several functional forms are considered to represent the 
relationship h(g) between relative prevalence and gestational age. As in the preferred 
model of Section 2.4.4, the ascertainment probabilities for the live birth studies with strong 
prior evidence of full ascertainment were constrained to one. The resulting estimates of 
loss after times of CVS and amniocentesis are then compared to those published in the 
literature and derived in Section 3.4.3. 
The CVS and amniocentesis data used in these analyses are the same as those analysed in 
the final model of Section 3.4. Since the methods presented in Chapter 2 for modelling 
livebirth prevalence allow for varying levels of under-ascertainment in individual studies, 
all nine livebirth studies presented in Chapter 2 (Table 2.1) are included. We also note that 
the use of model (2.2) instead of (3 .I) enables the entire maternal age range ( 16 to 50 
years) to be analysed. The data sets used are summarised in Table 3.8. 
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Maternal Gestational Downs I Live-
Age (years) Age Range births1 
Included (weeks) 
cvs 
Data Compiled by Macintosh et al. (1995)2 35-48 8-14 302 22787 
Halliday et al. ( 1995) 36-46 median= IQ 39 3041 
Amniocentesis 
Data Compiled by Snijders et al. ( 1994)2 35-49 15-20 1086 109030 
Halliday et al. (1995) 36-50 median=l6 73 7504 
Livebirth 
Hook and Chambers ( 1977) 16-50 932 1724280 
Huether et al. (1981) 16-48 649.1 1439915 
Trimble and Baird (1978) 18-45 496 341076 
Staples et al. ( 1991) 16-49 592 497743 
Hook and Lindsjo ( 1978) 16-50 438 330423 
Lindsten et al. ( 1981) 16-47 959 737139 
Compiled Data - Koulischer and Gillerot ( 1980), 16-49 656.7 520776 
Koulischer et al. ( 1991) 
Compiled Data - Hamerton et al. ( 1975) and Jacobs 16-47 31 25572 
et al. ( 1981) 
Halliday et al. ( 1995) 36-49 median=39 71 12920 
Total 6324.8 5772206 
1Total for all individually recorded years of maternal age between 16 and 50. Decimals are due to 
adjustments for selective abortion 
'See Section 3.4.1 for details 
Table 3.8. Data sources used for the multiplicative model (3.2) 
3.5.2 Fitted Models 
For comparison with the results found in Section 3.4.3, based on the model of Halliday et 
al. ( 1995), the multiplicative model (3 .2) was first fitted with factors for relative prevalence 
at times of CVS and amniocentesis instead of a smooth curve for gestational age-specific 
relative prevalence. The parameter estimates and Chi-squared goodness-of-fit statistic are 
given in Table 3.9 below. The estimates of a, /30, and /31 refer to the logistic parameters in 
the maternal age model (2.2), while ({JJ> ... ,rp4, 81 and 8z are probability parameters as 
described in Section 2.4.1. The relative prevalences of Down syndrome at times of CVS 
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and amniocentesis, compared to livebirth, are denoted by re and r0 • The implied rates of 
fetal loss between these times and livebirth are also given. 
Parameter ML Estimate 
a 0.0006729 
flo -16.1I4467 
/31 0.2863633 
fP1 0.351 
fP2 0.377 
(/)) 0.899 
fP4 0.884 
f) I O.II3 
~ 0.508 
re I.658 ::::> 40% loss 
'a 1.174::::> 15%1oss 
2 X. (d.f.) 360.498 (322) 
p 0.069 
Table 3.9. Parameter estimates and goodness-of-fit statistic from the multiplicative model 
(3.2) using factors for relative prevalence 
Then the exponential model for relative prevalence (3.3) was used for the gestational age 
component: 
(3.3) 
Initially the gestational ages for the CVS and anmiocentesis test groups were taken to be I 0 
and 16 weeks, respectively (1-lalliday et a!, 1995). Relative prevalences and implied rates 
of loss were calculated at I 0 and 16 weeks and found to be identical to those derived from 
the model using factors, as was the goodness-of-fit statistic. There were no practical 
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differences in parameter estimates. This latter model, however, has the ability to estimate 
relative prevalences for a range of gestational ages, rather than two specific points. 
The use of a smooth curve for gestational age-specific prevalence means that the data do 
not have to be pooled into CVS and amniocentesis groups, assumed to have the san1e 
gestational age. Although exact gestational ages are not known for individual pregnancies, 
information given in the papers about the average gestational age of each test group can be 
employed. Macintosh et al. (1995) imply that the average gestational age of their CVS 
group is about 10 weeks, consistent with the median given by Halliday et al. (1995). 
Snijders et al. (1994) give no such information about their amniocentesis group, but the 
same data are used by Snijders et al. ( 1995) who report a mean of 17 weeks. Therefore the 
model is refitted allowing for this small adjustment. We note that this minor modification 
affects both the gestational age-specific component and the correction of maternal ages to 
age at EDD. The results are given in Table 3.10 with estimates of relative prevalence 
calculated at I 0, 16 and 17 weeks' gestation. 
Since the mean gestational age of the vast majority of the amniocentesis data (94% of 
cases) is 17 weeks the relative prevalences from this model at I 0 and 17 weeks are 
comparable with re and ra in Table 3.9. We observe that the results are, in fact, identical. 
The exponential relative prevalence curve given by the estimates of A.o and A. 1 in Table 3.10 
is shown in Figure 3.4 with observed points superimposed. For each set of data these were 
calculated by dividing the observed number of cases by the number expected based on the 
maternal age distribution and the number of pregnancies tested. 
Figure 3.4 illustrates that, while the quadratic curve (3.3) fits the observed data points well 
in the region of 10 to 17 weeks' gestation, it has the distinct drawback of dropping below 
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Parameter ML Estimate Gestational Age Relative Prevalence 
a 0.0006731 10 weeks 1.658 ~ 40% loss 
fJo -16.117279 
f3t 0.2864356 16 weeks 1.225 ~ 18% loss 
CfJt 0.351 
(/>}. 0.377 17 weeks 1.177 ~ 15% loss 
(/>] 0.899 
CfJ4 0.884 
()I 0.113 
~ 0.508 
ll.o -0.0241418 
A.t 0.0014339 
2 X (d.f.) 360.338 (322) 
p 0.069 
Table 3.10. Parameter estimates and goodness-of-fit statistic from the multiplicative 
model (3.2) using an exponential model for relative prevalence (3.3), allowing different 
gestational ages for each study 
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Figure 3.4. Relative prevalence curve predicted by the quadratic exponential model (3.3) 
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one for later gestational ages. In the following section additional terms are included 
allowing for an interaction between maternal age and gestational age, the significance of 
the individual terms A.o and 11.1 in (3.3) is investigated, and an alternative model IS 
considered for which the fitted relative prevalence curve decreases monotonically to one. 
3. 5. 3 Alternative Models 
Firstly, additional terms were included in (3.3) to allow for an interaction between maternal 
age and gestational age: 
Table 3.11 presents parameter estimates and estimates of relative prevalence from this 
model for a range of gestational and maternal ages. 
There is a trend for greater losses between 10 weeks and term with increasing maternal age, 
but lower rates of loss in later pregnancy for older women. These results seem to suggest 
that a Down syndrome fetus is likely to be lost earlier in pregnancy if the mother is older, 
while for younger mothers the fetus will survive longer and spontaneously abort later in 
pregnancy. A LR test established that there was very slight evidence of such an interaction 
(x22=4.74, P=0.093), although the individual components were not significant (x2 1=0.36 
The form of the exponential component (3.3) was then examined. A simpler exponential 
model without a quadratic term was fitted. The estimates of loss changed substantially, 
and a goodness-of-fit test shows that the model does not fit the data well (x\23=378.538, 
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P=0.018). The estimates of the logistic parameters in n(m) are also affected and a LR test 
statistic ofx21=18.2 demonstrates that the quadratic term is highly significant. 
Gestational 
Parameter ML Estimate Age 
a 0.0006786 10 weeks 
f3o -16.23562 
/31 0.2869496 16 weeks 
lP I 0.351 
IP2 0.377 17 weeks 
IPJ 0.899 
IP4 0.883 
el 0.113 
~ 0.508 
Ao 0.0198864 
AI -0.0003028 
~ -0.0639945 
AJ 0.0025186 
1The implied rates of loss are given in parentheses 
Relative Prevalence1 
Maternal Age (years) 
35 40 45 
1.452 (31%) 1.651 (39%) 1.876 (47%) 
1.310(24%) 1.224(18%) 1.143 (13%) 
1.289(22%) 1.176(15%) 1.072 (7%) 
Table 3.11. Parameter estimates from the multiplicative model (3.2) using an exponential 
model for relative prevalence allowing for an interaction between maternal and gestational 
age (3.4) 
The linear term was then removed from (3.3). The goodness-of-fit statistic for this model 
is x\23=368.618 (P=0.041 ). The LR test for the linear parameter yields a statistic of 
x
2
1=8.3. While the inclusion of the linear term is statistically significant, the quadratic 
term seems to be more important than the linear term. In (3.5) this model is generalised by 
replacing the square in (39-g)2 with an unknown power parameter A1: 
(3.5) 
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Results based on this model are g1ven m Table 3.12. The deviance and number of 
parameters are the same as those presented in Table 3.10 for the model given by equation 
(3.3), yielding an identical goodness-of-fit statistic. The estimates of loss after 10, 16 and 
17 weeks' gestation are also unchanged. Figure 3.5 shows that while the two curves give a 
similar fit to the observed data, the form of h given by (3.5) has the important advantage of 
not predicting relative prevalences below one. 
Parameter ML Estimate Gestational Age Relative Prevalence 
a 0.0006731 10 weeks 1.659 ::::::> 40% loss 
fJo -16.116978 
{J, 0.286428 16 weeks 1.216 ::::::> 18% loss 
rp, 0.351 
q>z 0.377 17 weeks 1.1 77 ::::::> 15% loss 
(/J) 0.899 
tf14 0.884 
e, 0.113 
~ 0.508 
ILo 0.0000005 
..1, 4.093735 
Table 3.12. Parameter estimates from the multiplicative model (3.2) using an exponential 
model for relative prevalence with a power term (3.5) 
Two addition terms for an interaction with maternal age were then included: 
(3.6) 
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Figure 3.5. Relative prevalence curve predicted by the power exponential model (3.5) 
A LR test showed that they were not statistically significant at conventional levels 
Cl2=4.58, P=O.l 01 ). The individual components yielded test statistics of x2 1=0.18 for 1 1 
and x21=0.20 for 13• The parameter estimates and estimates of loss resulting from fitting 
the model (3.6) are given in Table 3.13. 
Unlike the quadratic interaction model (3.4) (see Table 3.11), the estimated loss rates in 
Table 3.13 do not demonstrate an obvious trend across maternal age. Both models predict 
similar loss rates at maternal age 40 (which are not dissimilar to those predicted by the 
corresponding models without interaction terms). For maternal age 35, the relative 
prevalence curve estimated from model (3.6) is much steeper than that estimated from 
(3.4), while for maternal age 45 the opposite is true and the quadratic curve is steeper. 
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Relative Prevalence I 
Gestational Maternal Age (years) 
Parameter ML Estimate Age 35 40 45 
a 0.0006736 10 weeks 1.426 (30%) 1.734(42%) 1.597 (37%) 
fJo -16.115175 
fJJ 0.2863068 16 weeks 1.165(14%) 1.248 (20%) 1.193 (16%) 
(/J) 0.351 
~ 0.377 17 weeks 1.138 (12%) 1.204 (17%) 1.158(14%) 
IPJ 0.900 
(/)4 0.885 
el 0.113 
~ 0.508 
Ao 0.0000019 
AJ -0.0000014 
A-2 3.529475 
A-3 0.5802228 
1The implied rates of loss are given in parentheses 
Table 3.13. Parameter estimates from the multiplicative model (3.2) using an exponential 
model for relative prevalence with a power term and interaction between maternal and 
gestational age (3.6) 
3.5.4 Model Adequacy 
In Section 2.4.5 the modified logistic model (2.2) was refitted excluding the data from 
Trimb1e and Baird (I 978) due to evidence of lack of fit. Here we refit the model presented 
in Table 3.12 making this adjustment to the livebirth data. The resulting estimates are 
given in Table 3.14. The effect of excluding the data from Trimble and Baird (1978) is to 
reduce the estimates of loss after 1 0, 16 and 17 weeks by I% in each case. The model 
provides a good fit to the remaining data Cl305=311.584, P=0.385) and, as in Chapter 2, 
the maternal age-specific risks are hardly affected by this modification to the livebirth data. 
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Parameter ML Estimate Gestational Age Relative Prevalence 
a 0.0006533 10 weeks 1.645 => 39% loss 
f3o -15.931215 
fJJ 0.2820787 16 weeks 1.207 => 1 7% loss 
rpl 0.351 
(/)). 0.378 17 weeks 1.169 => 14% loss 
(/):, 0.899 
el 0.113 
~ 0.509 
An 0.0000004 
-1.1 4.188186 
Table 3.14. Parameter estimates from the multiplicative model (3.2) using an exponential 
model for relative prevalence with a power term (3.5), excluding data from Trimble and 
Baird (1978) 
35.5 Final Model for Maternal and Gestational Age-Specific Risk 
Table 3.15 gives maternal age-specific risks by year (from 16 to 50) and relative 
prevalences by week for gestational ages starting at I 0 weeks' gestation. These 
calculations are based on the parameter estimates given in Table 3.12 obtained by fitting 
model (3.2) with the modified logistic model (2.2) for the maternal age component n(m) 
and the exponential model with a power term (3.5) for the gestational age component h(g). 
Since there was no evidence of an interaction between maternal age and gestational age in 
this model, the expected prevalence at any given maternal age and gestational age can be 
derived by multiplying together these two components. 
3. 5. 6 Comparisons with Results Previously Published 
Comparison of the maternal age-specific risks in Table 3.15 with those from the preferred 
model in Chapter 2 illustrates that including CVS and amniocentesis data in the modelling 
procedure has not notably affected the estimation of maternal age-specific risks. The rates 
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n(m) h(g) 
Maternal Age (yrs) Rate per 1,000 Gestational Age (wks) Relative Prevalence 
16 0.68 10 1.66 
17 0.69 11 1.55 
18 0.69 12 1.46 
19 0.70 13 1.38 
20 0.70 14 1.32 
21 0.71 15 1.26 
22 0.73 16 1.32 
23 0.75 17 1.18 
24 0.77 18 1.14 
25 0.80 19 1.12 
26 0.84 20 1.09 
27 0.90 21 1.07 
28 0.98 22 1.06 
29 1.08 23 1.05 
30 1.21 24 1.03 
31 1.39 25 1.03 
32 1.63 26 1.02 
33 1.95 27 1.01 
34 2.37 28 1.01 
35 2.93 29 1.01 
36 3.67 30 1.00 
37 4.66 31 1.00 
38 5.98 32 1.00 
39 7.73 33 1.00 
40 10.05 34 1.00 
41 13.12 35 1.00 
42 17.17 36 1.00 
43 22.53 37 1.00 
44 29.57 38 1.00 
45 38.78 39 1.00 
46 50.79 
47 66.32 
48 86.23 
49 111.46 
50 142.97 
Table 3.15. Fitted maternal age-specific rates (per thousand) and gestational age-specific 
relative prevalences based on the parameter estimates given in Table 3.12 
presented here are slightly lower than those based on Iivebirth data alone. Comparing the 
estimates of loss after times of CVS and amniocentesis in Table 3.9 (15% and 40%, 
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respectively) with those presented in Table 3.5 from the simpler analysis (12% and 39%) 
we see that estimating factors for relative prevalence using the multiplicative model (3.2) 
results in a slight increase in both estimates of loss. When a smooth curve for relative 
prevalence was estimated instead of factors the results remained unchanged (Tables 3 .I 0 
and3.12). 
Snijders et al. ( 1995) give estimated relative prevalences for a range of gestational ages. In 
Table 3.16 these results are compared with the estimates derived in Section 3.5.5. The 
higher relative prevalences (and corresponding estimates of loss) given by Snijders et al. 
( 1995) may be explained by the fact that maternal ages were unadjusted to maternal age at 
time of EDD. As with the results presented in Section 3.4, the estimates of loss obtained 
here are lower than any in the literature with the exception of the estimate of 31% loss 
between CVS and livebirth (Halliday et al., 1995). Possible reasons for this have already 
been discussed in Section 3.4.6. 
Gestational Age Relative Prevalence 
(wks) Snijders et al. (1995) Current 
10 1.90 1.66 
12 1.70 1.46 
14 1.56 1.32 
16 1.45 1.32 
18 1.37 1.14 
20 1.30 1.09 
25 1.18 1.03 
30 1.10 1.00 
35 1.04 1.00 
Livebirths 1.00 1.00 
Table 3.16. Comparison of relative prevalences of Down syndrome (compared to 
livebirth) predicted by the regression analysis of Snijders et al. ( 1995) and the results from 
the current analyses presented in Table 3.15 
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3.5. 7 Discussion 
The analyses presented in Section 3.5 extend the models fitted in Chapter 2 to include CVS 
and amniocentesis data. All available data were included and several models were 
considered to describe the dependence of prevalence on gestational age. Estimated 
maternal and gestational age-specific rates can be obtained from the results given in Table 
3.15. The fitted maternal age-specific risks are similar to those obtained in Chapter 2, and 
the fitted gestational age-specific relative prevalences appear to fit the data well. In 
Section 3.5.6 these estimates of relative prevalence are compared with estimates in the 
literature and results obtained from the final logistic model fitted in Section 3.4.3. The 
goodness-of-fit statistic for the overall model (X2 322=360.338) was substantially reduced 
when the livebirth data of Trimble and Baird (1978) was excluded but the fitted risks and 
relative prevalences were not notably affected. 
In the concluding chapter we suggest improvements and possible extensions to the models 
fitted in Section 3.5. These include the application of the bootstrap (described in Section 
2.4.3) to derive Cis. We discuss the validity of pooling CVS and amniocentesis data from 
different studies and propose refinements to the modelling procedure. In Section 7.2.2 we 
describe how a Bayesian approach implemented using MCMC could overcome the 
problem of rounding to the means for each group (CVS or amniocentesis) observed in the 
gestational age data. A similar approach is adopted in Chapter 6 to deal with another 
coarsened data problem arising in the rounding ofNT measurements to whole millimetres. 
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Chapter 4 
Markov Chain Monte Carlo Methods 
4.1 Introduction 
This chapter provides a summary of the methods used subsequently in the thesis and 
introduces the notation adopted. The chapter concludes with an example of the application 
of MCMC methods to Down syndrome prevalence data based on the recent paper of York 
et al. ( 1995). 
A variety of different notations have been employed by authors writing about MCMC 
methods. The notation adopted throughout this chapter is based primarily on that found in 
Gilks et al. (1996). Let.f(.) be some function of a random variable X which has density 
n(X). The expectation of.f{X) is the integral 
E[f( X)j = f f(x )1r(x) dx. 
Integrations such as these are encountered by frequentists, integrating over the distribution 
of observables given parameter values, and by Bayesians, integrating over posterior 
distributions of model parameters to make inferences about parameters or to make 
predictions. In certain high-dimensional applications this integration may be difficult or 
impossible to evaluate. MCMC techniques have developed dramatically over the last 
decade to provide a flexible framework for dealing with such problems. Monte Carlo 
integration involves simulating values of X (X1, ••• ,X,, ... ,X11 ) from n(.) and using the sample 
average ..!_ L f( X,) to approximate E[ f( X)]. 
n ' 
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These X, need not be independent, and can be generated by any process which draws 
samples throughout the support of n(.) in the correct proportions. MCMC is Monte Carlo 
integration using a Markov chain, which has n(.) as its stationary distribution, to simulate 
values of X. The Metropolis-Hastings algorithm provides a method of constructing 
Markov chains with the target stationary distribution. 
A Markov chain is generated by sampling a sequence of random variables {Xo.X" ... } where 
X,+ 1 is sampled from a distribution p(X,+ 1IXJ which depends only on the current state of the 
chain, X,. p(.l.) is known as the transition kernel (note that 'P(.I.)' of Gilks et al. (1996) is 
replaced here by 'p(.l.)' to avoid confusion with conditional probabilities, denoted 'Pr(.l.)'). 
The distribution of X, given X0 is denoted p('J(X,IX0). Subject to regularity conditions, 
p('l(.IXo) will eventually converge to a stationary distribution which does not depend on I or 
X0. We denote this stationary distribution by ~(.). 
A Markov chain is irreducible if any set of states can be reached from any other state in a 
finite number of moves. If a Markov chain is irreducible then its stationary distribution, 
providing that it exists, is unique. Supposing that ~(.) is the stationary distribution of an 
irreducible Markov chain, the ergodic theorem states that as n ~ CfJ 
Since early iterations X 1, ... ,.Y'" reflect the starting value X0 they are called the burn-in and 
are discarded before calculating the ergodic average 
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- 1 /,_, =-L:J(X1 ) • 
n-m 1 
(4.1) 
In this chapter the Metropolis-Hastings algorithm is described (Section 4.2) and several 
forms of proposal distribution are introduced (Section 4.3). Practical implementation 
issues are discussed in Section 4.4. Section 4.5 reviews the extensive literature on MCMC 
convergence diagnostics and Section 4.6 describes various tools for drawing inferences 
from MCMC output. The final section reviews the paper by York et al. (1995) and 
provides an illustration of the application of MCMC techniques to double-sampled Down 
syndrome prevalence data. 
4.2 The Metropolis-Hastings Algorithm 
Metropolis et al. (1953) demonstrated how to construct a Markov chain whose stationary 
distribution is the target distribution n(.), and this method was later generalised by Hastings 
(1970). At each time I, the next state X,+ 1 is determined by two steps: 
I. A candidate point Y is sampled from a proposal distribution q(.JX,). Theoretically, the 
distribution q(.J.) can have any form although, as discussed below, it should be chosen to 
optimise convergence and mixing of the chain. 
( ) _ 1r(Y)q(X1 I Y) 2. Let a X,JY- ( ) ( )" Then with probability a(X1JY) setX1+ 1=Y Otherwise, 1r X, q YJ X, 
To show that p(I)(X,JX0) will converge to the target distribution requires proof that the 
stationary distribution of the chain will be n(.) and that p(1)(X,JX0) will converge to the 
stationary distribution. (For further details see Gilks el al., 1996, Roberts, 1996, and 
Tierney, 1996.) In addition to irreducibility and convergence, we require the Markov chain 
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to mix (traverse the entire parameter space) rapidly. The mixing rate can be thought of as 
the speed with which the chain forgets its past. The mixing and rate of convergence 
depend on the relationship between q(.l.) and n(.), and in order to construct a proposal 
distribution that will both converge and mix rapidly it is often necessary to deduce a rough 
estimate of the shape of n(.). A computational consideration is that q(.l.) should be easy to 
sample and evaluate efficiently. 
In the next section we introduce the forms of proposal distribution employed in Chapter 5. 
A detailed discussion of rates of convergence and strategies for choosing q(.l.) can be found 
in Roberts (1996), Tierney (1996) and Gilks and Roberts ( 1996). 
4.3 Choice of Proposal Distribution 
4. 3.1 Metropolis Algorithm 
The Metropolis algorithm, due to Metropolis et al. (1953), considers only symmetric 
proposal distributions. Since, for all X and Y, q(X]Y)=q(YJX) the acceptance probability 
simplifies to 
. { n(Y)} a(X,Y) =mm I, n(X) . 
4. 3. 2 Single-Component Metropolis-Hastings 
Assume that X is a vector of k random variables. Usually X is assumed to be of fixed 
length but variably dimensioned problems have been considered by Green (1994a,b) 
among others. Metropolis et al. (1953) proposed dividing X into components 
{X 1,X2, ••• ,X,} and updating these components one by one so that, in each iteration, X is 
updated in h steps. 
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Let X_; comprise all of X except X; and X,; denote the state of X; at the end of iteration t. 
Similarly, let X, -i denote the value of X_; after completing step i-1 of iteration t+ 1. Then 
one iteration of the single-component Metropolis-Hastings algorithm involves h updating 
steps in which the ith step is as follows: 
I. To update X; in iteration t+ 1 a candidate point Y; is generated from a proposal 
distribution q;(Y;IX,;,X1 _;). Note that the ith proposal distribution q;(.l.,.) generates a 
candidate only for the ith component of X, and may depend on the current values of any 
1l(X;IX_;) IS the full 
conditional distribution for X; under n(.) (Gilks, 1996). With probability a(X,_;,X,;.Y;) 
set Xr+l.i= Y;. Otherwise, set Xr+u=X, i· 
Justification that this algorithm will generate samples from the target distribution n(.) is 
based on the fact that n(.) is uniquely determined by the set of its full conditional 
distributions (Besag, 1974). 
4.3.3 Gihbs Sampling 
Gibbs sampling is a special case of single-component Metropolis-Hastings, in which full 
conditional distributions are used for proposal distributions and the probability of 
acceptance of candidate points is always one. The name 'Gibbs sampling' is due to Geman 
and Geman (1984) who applied the method to Gibbs distributions on lattices. However, 
Gibbs sampling can be used in many other contexts and dominates the statistical literature 
on MCMC applications. 
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The proposal distribution for updating the ith component of X is q;(Y;IX;,X_;)=n(Y;IX_;) 
where n(Y;\X_;) is the full conditional distribution of the ith component of X conditioning 
on all the remaining components. 
4.4 Implementation of MCMC 
4. 4.1 MCMC Convergence 
A primary concern in applying MCMC methods is determining that it has converged to 
stationarity or, in other words, that after an initial bum-in it is reasonable to believe that the 
samples are representative of the underlying stationary distribution of the Markov chain. 
This involves distinguishing between sampling variability in the converged chain and the 
greater variability in the pre-convergence samples. An additional complication arises from 
serial correlation within chains resulting from the Markov process. High autocorrelations 
within the output for one parameter may make a chain look as if it has converged, even 
though it has not yet reached its stationary distribution. (Cross-correlations between 
parameters are another problem. They are caused by poor choice of parameterization or 
over-parameterization and result in ridges in the posterior.) There are two main issues to 
be considered, which are the number of iterations required for: 
• burn-in (m), and 
• run length (n). 
4. 4. 2 Determining Burn-in 
The number of iterations to be discarded as bum-in depends on several factors - the 
starting value X0, the rate of convergence of p<
1)(X,IX0) to n(X,), and how similar p(l)(.l.) and 
n(.) are required to be. Theoretically m can be determined analytically, but normally this is 
not computationally feasible (see Roberts, 1996). 
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An obvious and commonly used qualitative approach is to visually inspect the plots of the 
Monte Carlo output, or functions of the output of interest. Such trace plots are used to 
estimate the degree of mixing. Typically the burn~ in is only a small fraction of the entire 
run. Although starting the chain close to the mode of n(.) avoids a lengthy burn-in it does 
not remove the need for a burn-in, since the chain should still 'forget' its starting position. 
More formal convergence diagnostics for determining m and n are discussed in Section 4.5. 
4. 4. 3 Determining Stopping Time 
The variance of the estimator f is called Monte Carlo var1ance. Estimation of this 
variance is complicated by lack of independence of X1• Informally, we can run parallel 
chains with different starting values and compare f until they agree adequately. More 
formal attempts to estimate the Monte Carlo variance are discussed below. 
The theoretical approach is to analyse the Markov transition kernel of the chain in an 
attempt to predetermine the number of iterations that will ensure convergence in total 
variation to within a specified tolerance of the true stationary distribution (Cowles and 
Carlin, 1996). Note that this is harder than showing that an algorithm will converge, or 
calculating the rate of convergence (Rosenthal, 1993, 1995a, 1995b). Generally, the 
theoretical approach involves sophisticated mathematics and often provides loose bounds, 
suggesting impracticable run lengths. 
The alternative and more common approach is to apply diagnostic tools to the MCMC 
output. Cowles and Carlin (1996) provide a thorough review of these tools. Some are 
designed to assess convergence of univariate quantities, while others measure the 
convergence of the full joint distribution. In the former case, the diagnostic can be applied 
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to any parameter or function of parameters in the model. The latter approach is preferable 
since it is possible for marginal distributions to converge without convergence of the full 
joint posterior. The simplest univariate methods are those of Gel man and Rubin (1992b ), 
Raftery and Lewis (1992) and Geweke (1992). These methods, which are the most 
commonly used, are described in Section 4.5. 
Several methods have been suggested which deal with the full joint distribution (see, for 
example, Ritter and Tanner, 1992, and Roberts, 1992). They require multiple parallel 
chains to obtain samples from the full joint distribution and also make use of the transition 
kernel, necessitating model-specific coding. For slowly converging chains running many 
parallel chains can be impracticable. This issue is dealt with in the following section. 
4.4.4 Number of Chains 
There is considerable debate concerning the number of chains that should be run for an 
MCMC analysis, with respect to both convergence diagnostics and inference (Gilks et al., 
1996). Gelfand and Smith ( 1990) advocate the use of many short chains in order to obtain 
independent samples. However, independence is not required, and this approach ts 
inefficient since a large proportion of the total iterations will be discarded as burn-in. 
Geyer (1992) notes that comparison between chains cannot prove convergence and 
suggests that running one long chain will have the best chance of finding new modes. 
When comparing a single chain of I 0,000 iterations with ten independent chains of I ,000 
iterations, the last 9,000 iterations from the single long chain are all drawn from 
distributions that are likely to be closer to the true target distribution than those reached by 
any of the shorter chains. 
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Gel man and Rubin (1992a,b) adopt an approach between these two extremes. They argue 
that if several long chains are run, then comparison of these chains will reveal differences 
if chains haven't reached stationarity. Andrew Gelman writes " ... with Bayesian posterior 
simulation ... the added information obtained from replication outweighs any additional 
costs required in multiple simulations" (Gelman, 1996). 
Described below are three univariate convergence diagnostics which are available in CODA 
(Best et al., 1995) and can be applied to output from any MCMC algorithm. Although 
each is designed to assess univariate rather than full joint convergence, Gelman and 
Rubin's method and that of Geweke can be applied to -2 times the log of the posterior 
density to summarise convergence of the joint density. It is important to monitor the 
convergence of all scalar summaries of interest (parameters and various predictive 
quantities) from the target distribution. The first method requires several chains, while the 
others are applied to a single chain. 
4.5 Convergence Diagnostics 
4. 5.1 Gel man and Rubin 
Gelman and Rubin ( 1992b) argue that if only one chain is run, there is no way to tell when 
the chain has escaped the influence of the starting point and has traversed all of the target 
distribution. Their method emphasises reducing bias in estimation and employs analysis of 
variance to diagnose approximate convergence. They propose that simulation should be 
continued until the variance between the different chains is no larger than the variance 
within each individual chain. The 'estimated potential scale reduction', JR, is calculated 
to estimate the factor by which the variance of the summary of interest might be reduced 
by continuing simulation. Since the method relies on normal theory approximation to 
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exact Bayesian posterior inference, it may be necessary to transform parameters to 
normality beforehand. 
Over-dispersed starting points are used to highlight lack of convergence and ensure that the 
sequences will not all be stuck in some unrepresentative small region of the parameter 
space. Knowledge of the parameter space and the form of the distribution should be used 
to select starting points for multiple chains which are suitably dispersed in the target 
distribution, and several methods for doing this have been suggested. 
Cowles and Car! in (1996) firstly obtain an over-dispersed estimate of the target distribution 
and subsequently generate from it the starting points for the required number of chains. 
Bradley P. Carlin suggests that a simple rule for initialising five parallel chains for the 
parameter X; is to start chain j at f.J; + (i- 3)a;, j=l , ... ,5, where f.J; and a; are the prior 
mean and SO of X; (Kass et al., 1997). The number of chains required to apply this 
diagnostic remains open to discussion. Cowles and Carlin (1996) suggest that at least ten 
chains are needed, although in practice fewer are often used and Carlin suggests three or 
five (Kass et al., 1997). 
The first step is to discard burn-in iterations from each chain. Cowles and Carlin ( 1996) 
use only the second half of the chain. Following their notation let n be the number of 
remaining iterations from a run of length 2n. Then we can compute the between-sequence 
variance B and within-sequence variance W where B is the variance between the means of 
the parallel chains and W is the average of the within-chain variances. For finite n, W 
should underestimate the variance of the summary of interest X; because the individual 
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sequences have not yet reached all the points of the target distribution. Another estimate of 
the variance is then calculated: 
n -l I 
var( X, ) = - W +-B. 
n n 
When starting points are over-dispersed relative to the target distribution this will be a 
conservative estimate of the variance of X; because B will initially be larger than W. 
Convergence is monitored by estimating the ratio 
between the estimated upper and lower bounds for the SD of X;. This ratio is called the 
'estimated potential scale reduction' because it estimates the factor by which the 
conservative estimate of the distribution might be reduced. The estimate can be corrected 
for san1pling variability (Gelman and Rubin, 1992b) although, in practice, it is extremely 
unlikely that several scalar summaries will all appear to have converged by chance. 
Before the simulation has converged JR will be high, suggesting that further simulations 
could improve inference about the target distribution. Runs should be continued until the 
potential scale reduction is near one for all scalar summaries of interest. Gelman suggests 
the cut-off value of 1.2 (Kass et al, 1997). When JR is below the chosen cut-off for all 
quantities of interest, inference may be carried out using the combined values from all 
chains (without burn-in iterations). 
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Criticisms ofGelman and Rubin's method are: 
I. Finding a starting distribution which is over-dispersed with respect to the target 
distribution requires knowledge of the target distribution 
2. Reliance on nom1al approximation for diagnosing convergence to the true posterior may 
be inappropriate 
3. It is inefficient to run multiple chains and discard a substantial number of bum-in 
iterations from each. 
4.5.2 Raflery and Lewis 
Raftery and Lewis ( 1992) emphasise the importance of being able to quantify the accuracy 
of the estimation of quantiles, since they provide the basis for density estimation and 
provide robust estimates of centre and spread of a distribution. Their method is intended to 
detect convergence and to provide bounds on the variance of estimates of quantiles of 
functions of parameters for any MCMC algorithm. It can determine in advance the number 
of iterations necessary for any given level of precision. 
When usmg MCMC for Bayesian inference the mam requirement is that estimates of 
posterior quantiles of functions of the parameters are approximately correct. Following the 
notation presented by Raftery and Lewis (1996) an initial bum-in of m iterations is 
discarded, a further n iterations are run, of which every kth is stored for use in inference. 
The practice of saving only every kth iteration, with k chosen so that successive draws are 
approximately independent (k> 1 ), is known as thinning. Let U be a function of the 
parameter X; and suppose that we want to estimate the posterior probability Pr( Us;uiX, ;, 
t=m+ 1 , ... ,m+n) to within ±r with probability s. Raftery and Lewis (1996) propose a 
method of finding the approximate number of iterations required to do this, when the 
quanti le of interest is q. 
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Raftery and Lewis (1992) use two-state Markov chain theory and standard sample size 
formulae to determine m, n and k. Their method requires that the algorithm is run for an 
initial Nmin iterations in order to obtain a pilot sample of parameter values (Nmin is 
calculated by CODA). A binary sequence {Z} is formed for each iteration of the chain, 
indicating whether or not the value of the quantity of interest is less than a particular cut-
off. A new binary sequence { z(k)} is then formed by extracting every kth iterate, and k is 
given as the smallest skip-interval for which the behaviour of { z{kl} approximates that of 
a first-order Markov chain. The number of burn-in iterations required, m, is the number of 
iterations that it takes for { z(k)} to approach within a specified convergence tolerance 
(usually 0.001) of its estimated stationary distribution. 
The diagnostic should be applied to each quantity of interest, then the required number of 
iterations corresponds to the largest value of n. The entire pilot sequence is used to 
estimate m, n and k, so a bad starting value can lead to a highly correlated sequence and 
high values of n as well as m. A large value of m suggests slow convergence to the 
stationary distribution, while k> I suggests strong autocorrelations within the chain. When 
there are high correlations between parameters, Gibbs sampling results in high 
autocorrelations within chains. The quantity 
I= m+n 
Nmin 
is a measure of the increase in the number of iterations due to dependence in the sequence. 
A value of I greater than five often suggests there are problems that might be alleviated by 
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changing the implementation, such as a bad starting value, high posterior correlations or 
'stickiness' in the Markov chain. 
Criticisms of this method include: 
I. For any given problem the estimate of the required number of iterations needed ts 
dependent on the initial chain 
2. Convergence must be re-assessed for every quantile of interest 
3. Estimation quality is always reduced by discarding samples (MacEachem and Berliner, 
1994) so thinning may be inappropriate 
4. Brooks and Roberts (1996) have shown that it underestimates the convergence rate. 
4. 5. 3 Geweke 
Geweke ( 1992) suggests that when the aim of the analysis is to estimate the mean of some 
function g of the parameter (or parameters) X;, spectral analysis methodology can be used 
to assess convergence. The values g( X,J are calculated for each iteration t, and the 
resulting sequence is regarded as a time series. Geweke ( 1992) assumes that the nature of 
the MCMC algorithm and of g imply a spectral density Sg( eo) for this time series with no 
discontinuities at frequency zero. Then the estimator 
" Lg(X,;) 
- -"'=:.:..1 __ _ g.,= 
n 
of E[ g( XJ] based on n iterations has asymptotic variance Sx(O)/ n. Geweke ( 1992) uses 
the square root of this asymptotic variance as an estimate of the SE of the mean, called the 
numerical standard error (NSE). Let g( X; ): and g( X; ): be the means based on the first 
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n, and last n8 iterations. Then Geweke's convergence diagnostic is calculated by taking 
the difference between these means and dividing by the asymptotic SE of the difference, 
computed from spectral density estimates for the two pieces of the sequence. Holding 
n.; In and n11 In fixed and given that n A + n8 < n, the central limit theorem implies that 
the distribution of this diagnostic approaches a standard normal distribution as n tends to 
infinity. Suggested values for n.; and n8 are O.ln and 0.5n respectively. Geweke's method 
can be applied to determine both m and n. 
Like the method of Raftery and Lewis (1992), this approach attempts to address the issues 
of both bias and variance. The main disadvantage of this method is that results are 
sensitive to the specification of the spectral window. 
4. 5. 4 Concluding Remarks 
Cowles and Carlin ( 1996) applied these three convergence diagnostics, among others, to 
two numerical examples. The first was a trivariate normal with high correlations. No 
relationship was found between results obtained using the methods of Raftery and Lewis 
(1992) or Geweke (1992). Geweke's diagnostic appeared to be premature in diagnosing 
convergence in four of the five chains considered. In the second example (a bimodal 
mixture of trivariate normals) nine chains were run and each remained in the vicinity of 
one mode. For a subset of four of these chains, two at each mode, Cowles and Carlin 
(1996) found that Gelman and Rubin's diagnostic detected convergence failure while 
Geweke's method suggested satisfactory convergence for one of the chains. When a 
different subset of chains was chosen, comprising four chains stuck at the san1e mode, 
Gelman and Rubin's method failed to detect a problem and Geweke's diagnostic implied 
good convergence in all cases. Carlin points out that for a bimodal problem Gelman and 
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Rubin's diagnostic will always be large if at least one chain is visiting each mode (Kass et 
al., 1997). 
Cowles and Carlin ( 1996) suggest that although apparent disagreement among the various 
methods they considered may be partly explained by different interpretations of the word 
'convergence', their findings demonstrate that the diagnostics considered can fail to detect 
convergence failure, even in simple, low-dimensional problems. They recommend caution 
when using these diagnostics, and suggest that the safest approach is to employ several 
diagnostic tools including both graphical and quantitative methods. Carlin suggests using 
sample traces of a representative subset of the parameter space and annotating these plots 
with Gel man and Rubin's diagnostic and the Jag-! sample autocorrelation of the middle 
chain (Kass et al., 1997). 
Mengersen et al. ( 1998) provide a thorough review of convergence diagnostics and 
describe a related twin Web site which will be updated to keep track of research in the area. 
They classify the methods into three sections- 'Exploration', 'Stationarity Assessment' 
and 'Estimation' -and give examples. Like Cowles and Carlin (1996), Mengersen et al. 
( 1998) find that different diagnostics can give contrasting results. They conclude that, for 
complex problems, many of diagnostics reviewed may be difficult to apply or interpret, 
and recommend the use of a 'package' of methods. 
4.6 Inference 
4. 6.1 Marginal Posterior Summary Statistics 
For components X; of interest the posterior distribution can be summarised in terms of 
means, modes, SDs, correlations, credible intervals and marginal distributions. Means, 
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modes, SDs and correlations can all be estimated by their sample equivalents from the 
Monte Carlo output {x;;, t=m+ 1 , ... ,n} using equation ( 4.1 ). The marginal distribution of 
Xi can be estimated using histograms or kernel density estimation as follows: 
I " Jr(X;)""- LK(X;IX,) 
n- n11=m+t 
where K(.IXJ is a density around Xu This density could be the full conditional distribution 
The following sections describe the calculation of SEs of the posterior mean and methods 
of interval estimation. Throughout this section we assume that inferences are to be drawn 
from one long chain (Geyer, 1992). However, this need not necessarily be the case. 
Gel man ( 1996) suggests that when multiple chains have been run with over-dispersed 
starting points, posterior intervals based on the combined iterations of all chains should be 
reliable since intervals obtained before convergence will be conservative. 
The concept of thinning was introduced in Section 4.5.2. Although this approach can be 
useful when the number of iterations is so large that reducing the number to be kept by a 
factor of k gives important savings in storage and computing time, there is no advantage for 
the purpose of drawing inferences in discarding intermediate draws and even correlated 
draws add some information. 
4.6.2 Standard Errors 
Given the post-convergence samples from a single sampling chain for any summary of 
interest, we can estimate the posterior mean as the sample mean of all our MCMC samples, 
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as described in Section 4.1. However, we cannot simply derive an estimate of the MCMC 
SE of the posterior mean from the sample variance since it would be an underestimate due 
to positive autocorrelation in the samples. When n is large the NSE off,_, is 
NSE(f ,_,) = ~ var" {f){l + 2"f~ t {f)} 
n m r=l 
where p, {f) is the Jag- P. correlation in {!(X,)} . Note that for independent sampling the 
second term in the brackets disappears and that NSE(J,_,) decreases as n increases. Since 
sampling is not normally independent, methods have been put forward for estimating SEs. 
Thinning in order to achieve approximate independence was a proposed solution to the 
problem, but this approach has been shown to be suboptimal (MacEachern and Berliner, 
1994 ). Batching is a simple method that produces conservative SE estimates. Batching 
overcomes the problem of autocorrelation by dividing the sequence Xm+I,Xm+2, ... ,X, into K 
equal length batches. If the batches are sufficiently large then the means of these batches 
b~> ... ,bk, ... ,bK will be approximately uncorrelated. Then we estimate 
N,§E(f-. ) = ~ I "(b - b)2 
. ,_, K(K -I) 7 k • 
4. 6. 3 Credible Intervals 
A 100(1-a)% credible interval for a parameter or function of parameters (}is any interval 
(l, u) satisfying 
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" f n( e) de = 1 - a 
I 
where n( e) is the posterior distribution of e. Although here we consider only univariate e, 
Besag et al. ( 1995) describe a method for calculating rectangular credible intervals in two 
or more dimensions. 
An obvious and convenient method of constructing such an interval for the scalar 
component Xi 1s to calculate the ~ th and (1- ~) th quantiles of {Xu, t=m+!, ... ,n}, 
resulting in an equal tail probability interval. Then 
" f n( X,) dXj = I -a 
I 
as required. A disadvantage of this approach is that it may exclude some values of Xi that 
have high posterior density. 
An alternative is the highest posterior density (HPD) interval defined as 
R = {X,: n( X,) ;?: k} 
where k is chosen such that f n( X,) dX, =I- a. 
11 
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R contains all values of the scalar component of interest which exceed some level k of 
posterior probability. It also has the smallest length of any Bayesian interval with 
probability content (1-a). Note that when the posterior distribution of X; is symmetric and 
unimodal this interval will coincide with the equal tail probability interval. 
Wright ( 1986) describes a method for constructing HPD intervals for a univariate 
component in the case where n(X;) is unimodal. Firstly, note that R=(l, u) where land u 
are the solution to the non-linear system 
;r(l)- ;r(u) = 0 
" f ;r( X;)dX; - I + a = 0 . 
I 
Applying Newton's method Wright (1986) uses an iterative algorithm to determine land u. 
An application of this method is described in the following chapter (Section 5.3.4). 
4.7 Example: York et al. (1995) 
4. 7.1 Bayesian Models 
York el al. (1995) present a Bayesian analysis of data relating to Down syndrome 
prevalence at birth, of which a subset was double-sampled. Two registries were used to 
classify newborns in Norway as Down syndrome or unaffected. The main registry (A) was 
the national medical birth registry. A new notification system (B) was also used to 
ascertain cases in a county representing about 15% of all births in Norway. Since neither 
registry was infallible traditional methods developed for double-sampled data (Tenenbein, 
1970; Chen, 1979) are not applicable. The data are reproduced in Table 4.1. For a ML 
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analysis of these data see Lie et al. (1994). York et al. (1995) undertook an MCMC 
analysis of the same data which accounted for model uncertainty (discussed by Regal and 
Hook, 1991, and Draper, 1995). 
A A 
Double-Sampled Data 
B 8 9 
B 13 27847 
Single-Sampled Data 
233 188790 
Table 4.1. Down syndrome data for 1985-88 ascertained through the national registry A, 
and the subsystem B 
Let B1 denote the probability Pr(A) that a Down syndrome case is ascertained by registry 
A. Then the probability Pr( A) of a case being missed by registry A is I-B1 • We define 
the conditional probabilities Pr(BI A)= B2 and Pr( Bl A)= ()3 • York et al. ( 1995) consider 
three models defined by the following assumptions: 
I. Ascertainment is independent in the two registries ( ~=~) 
11. All cases are ascertained by at least one registration system ( ()3= 1) 
Ill. Dependence between the two registries may be positive or negative (no constraints on 
In all models the probabilities of false-positive ascertainment are fixed at zero. 
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Informative pnors were placed on the unknown parameters (}~> ~ and (}3 and the 
probability of Down syndrome, 1r. These took the form of beta distributions which, for ~ 
and 03, depended on the model M. The prior for 1r was based on raw data from registry A 
for 1979-84. The observed rate of Down syndrome during this period was 0.97 per 
thousand livebirths. The distribution ~r~beta(a",b")=beta(0.0097,9.9903) was chosen to 
have this rate as its expected value and so that the prior knowledge is equivalent to having 
observed I 0 births. Priors for (}1, ~ and (}3 were chosen to reflect belief that the registers 
are more likely to ascertain cases than not. The prior distribution for Pr(A)=(}1 was chosen 
to be beta( 4,2) which has a mean of 2/3. For each model the prior specifications for ~ 
and (}3 were constructed so that the prior mean for Pr(B) also takes the value 2/3. The 
prior specifications for (}~> ~ and (}, are given in Table 4.2 for each of the three models. 
For models I and !I 1r, 01 and ~ are assumed to be mutually independent. For model Ill 1r, 
(}~> ~ and 03 are assumed to be mutually independent. 
4. 7.2 Gibbs Algorithm 
The posterior distribution was evaluated by simulating the model parameters fl=( (}~> ~, (}3, 
1r), correct model M, and unobserved data Z. Each model was assumed to have equal prior 
probability. Z consists of the number of Down syndrome cases in the double-sampled data 
missed by both registries, Z1, and the number of missed cases in the single sample, Z2. The 
Gibbs sampler was used, so the proposal distribution at each step was the full conditional 
distribution on the remaining components (see Section 4.3.3). Let Y denote the observed 
data To avoid confusion with the probability of Down syndrome, Pr(.l.) is used to denote 
full conditional probability density functions. Then the sampling algorithm comprises the 
following three steps for each iteration t: 
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I . generate M1 from Pr( Ml Y, ZH) 
2. then f!., from Pr(f!.l Y, Z,_1, M,) 
Model Prior Specification 
I Pr(A)=e, -beta(a"b 1 )=beta(4,2) 
Pr(BIA) = e2 - beta(a 2_i'b2.1) = beta(4,2) 
Pr(BIA) = e3 = e2 
11 Pr(A) = e, - beta( a,, b1) = beta(4,2) 
Pr(BIA) = e2 - beta(a 2_1" b2_u) = beta( 1.5, 1.5) 
Pr(BIA) = e3 =I 
III Pr(A) = e,- beta(a"b 1 ) = beta(4,2) 
Pr(BIA) = e2 - beta(a 2·""b2.lll) = beta(2.22,1.11) 
Pr( BIA) = e3 - beta(a 3 , b3 ) = beta(2.22, 1.11) 
Table 4.2. Prior specifications for e" ~ and ~ 
Gilks (1996) describes how full conditional distributions can be derived by picking out the 
relevant terms from the joint distribution of the data and parameters. The full conditional 
distributions of the model paran1eters follow beta distributions, while those of the 
unobserved data are both binomial. The parameters of the beta distributions in step 2 under 
the three models are given in Table 4.3. The binomial distributions used in step 3 are given 
by 
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Model Parameter Beta(a,b) Distribution 
a b 
e, a 1+254 b1+9+Z1+Z2 
~ a21+17 b21+13+Z1 
7r aJT+263+Z1+Z2 bJT+216637-Z1-Z2 
Il e, a 1+254 b1+9+Z2 
~ a2_11+8 b2.11+ 13 
7r aJT+263+Z2 bJT+216637-Z2 
III e, a 1+254 b1+9+Z1+Z2 
~ a2m+8 b2.111+ 13 
~ a3+9 b3+Z1 
7r a!T+ 263+Z1+Z2 bJT+216637-Z1-Z2 
Table 4.3. Full conditional distributions for () 
The full conditional distribution of M used in step I is given by 
Pr( Ml Y, zl-1) oc Pr( M) I Pr(Y, zl-11 M,e)Pr(t91 M)d(). 
From this expression we deduce that Pr( MI Y,Z1_1) is defined by the following three 
probabilities: 
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( ) fJ(a2.11 +8,b2,11 +13) Pr M 11 1 Y, Z,_ 1 = k · ( ) fJ a 2.11 , b2.u 
where k is chosen to make the three probabilities sum to unity. 
4. 7.3 Posterior Summaries 
Initially the algorithm was run with M fixed at each of the models in turn. Then the choice 
of model was included in the simulation scheme and the posterior distribution for the 
prevalence of Down syndrome was derived by averaging over models. Posterior 
summaries based on each individual model, and averaged over models, are shown in Table 
4.4 with the posterior probabilities of each model. The model with the greatest posterior 
probability was that which assumed a strong negative association between the two 
registration systems. 
Model Posterior 1000x.1l' Pr(A) Pr(B) 
Probability Mode Mean SD Mean SD Mean SD 
0.312 1.80 1.90 0.300 0.373 0.087 0.552 0.092 
II 0.391 1.50 1.51 0.131 0.226 0.054 0.466 0.081 
1II 0.296 !.57 1.71 0.292 0.303 0.093 0.517 0.091 
Model Averaging 1.53 1.70 0.292 0.295 0.098 0.508 0.095 
Table 4.4. Features of the posterior for Down syndrome prevalence and the error 
probabilities of the two registries 
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4. 7.4 Concluding Remarks 
This example illustrates the power of MCMC methods in applications involving missing 
observations. The problem presented by York et al. (1995) arises from a double-sampling 
scheme in which neither method of data collection was infallible. In addition, some 
configurations of the variables are represented by very few observations. In such situations 
it can be difficult to estimate a large number of parameters with the classical ML approach. 
MCMC techniques offer an attractive alternative since they allow the inclusion of prior 
information and can also take model uncertainty into account. 
The methodology described by York et al. (1995) is applied in the following chapter to a 
meta-analysis of nine Down syndrome prevalence studies. A subset of double-sampled 
data is available in two of the studies. Probabilities of ascertainment and missing data are 
sampled in a similar fashion but the situation is complicated by the dependence of 
prevalence on maternal age. This relationship is described by the model (2.2) and 
parameters for this model are also updated in the simulation scheme. Since full conditional 
distributions are not available for all the quantities to be sampled, more general Metropolis-
Hastings steps are included in the algorithm. Three prior specifications are considered for 
the probabilities of ascertainment in the nine studies. 
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Chapter 5 
Application of MCMC to Modelling Maternal Age-Specific 
Prevalence of Down Syndrome 
5.1 Introduction 
York et al. ( 1995) developed a Bayesian approach to the analysis of data on Down 
syndrome prevalence. The data were collected from both a Norwegian national birth 
registry and a regional registry, neither being infallible. They employed MCMC 
techniques to assess error rates and concluded that the estimated rate of error was 
substantial in both registries (see Section 4.7). In this chapter we present a Bayesian meta-
analysis of livebirth prevalence using data from the nine published studies described in 
detail in Section 2.3.1. (The analysis is also described in Bray and Wright, 1998a.) We 
consider the maternal age range 16 to 50 years and fit the modified logistic model (2.2) 
described in Chapter 2. 
The full data likelihood and prior components of the Bayesian model are described in 
Section 5.2. An MCMC algorithm was implemented in order to simulate both model 
parameters and missing data from the joint posterior distribution and several convergence 
diagnostics were applied and compared (Section 5.3). Approximate marginal posterior 
distributions were then derived for parameters and functionals of interest and summary 
statistics are tabulated in Section 5.4. The primary aim of this work is to enable the 
inclusion of prior information in the analysis. The results are compared with those from 
the ML analysis of Chapter 2. 
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5.2 Modelling Maternal Age-Specific Livebirth Prevalence and Ascertainment 
5. 2. 1 Likelihood 
For convenience the notation introduced in Chapter 2 is re-iterated below: 
• r;111 and n;m denote counts of Down syndrome births and totallivebirths recorded in study 
i for maternal age m 
• r; and n; are the corresponding totals over maternal age m 
• ({J, is the probability that a Down syndrome birth is correctly ascertained in study i (we 
assume this is independent of maternal age) 
• For the birth certificate studies only (i=l ,2), X; and Y; denote births in the cytogenetic 
sample correctly recorded or missed, respectively, on the birth certificate 
• The corresponding maternal age-specific counts, denoted by x,m and y,m, represent 
missing data 
• For i=l ,2 B, is the probability that a Down syndrome birth is included in the cytogenetic 
sample (we assume this is independent of maternal age and ({J, ). 
In addition, for studies with cytogenetic samples we define Z;111 to be the number of Down 
syndrome births to women of age m excluded from the cytogenetic sample and recorded as 
unaffected on the birth certificate. 
Table 2.3 gtves the probabilities associated with variOus outcomes m the studies with 
cytogenetic samples (i= I ,2), given that we exclude the possibility of an unaffected birth 
being classified as having Down syndrome. In Table 5.1 the corresponding counts are also 
included. 
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True 
Outcome 
Down 
Syndrome 
Probability 
Count 
Unaffected Probability 
Count 
Registered as Down Syndrome 
Included Excluded 
Jr(m)tp,.(l- 01) 
[x,m] r1., - [ x1m] 
Registered as Unaffected 
Included Excluded 
Jr(m)(l- tp 1 )B,. n(mXI-tp,XI-0,) 
[Y,..,] [ z,.,] 
1- Jr(m) 
n1"' -r,, -[y,m]-[z,..,] 
Table 5.1. Model for birth prevalence, registration and inclusion in cytogenetic sample (for studies 1 and 2) with full 
data cell counts (missing data are indicated by square brackets) 
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True 
Outcome 
Down 
Syndrome 
Probability 
Count 
Unaffected Probability 
Count 
Registered as Down Syndrome Registered as Unaffected 
7r(m)tp; :!r(m)(l- tp) 
[z;.,] 
I- 1r(m) 
n,.,- r,.,- [z,.m] 
Table 5.2. Model for birth prevalence and registration (for studies 3, ... ,9) with full data cell 
counts (missing data are indicated by square brackets) 
Probabilities and counts for studies with no cytogenetic data (i=3, ... ,9) are given in Table 
5.2. In this table z;, denotes the number of Down syndrome births to women of age m that 
were falsely recorded as unaffected. Note that in both cases z;., represents missing data. 
The full data likelihood is a product over studies i and maternal ages m of multinomial 
probabilities for the cells given in Tables 5.1 and 5.2. 
In Chapter 2 we present estimates obtained by maxtmtsmg an approximate likelihood 
function. Within the classical framework, the prior information resulting from the detailed 
investigation of Hecht and Hook (1996) is used to justify fixing the ascertainment 
probabilities at one in the studies that they identified as complete. Here we adopt a 
Bayesian approach placing sharp priors on these ascertainment probabilities to reflect prior 
knowledge that these studies are most probably complete whilst still allowing for some 
uncertainty. In the Bayesian analysis, which is implemented using MCMC methods, no 
approximations are necessary to define the likelihood. 
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5.2.2 Prior information 
Following Hecht and Hook (1996) our prior assumptions are based on a qualitative review 
of the original study procedures. This review led us to categorise the nine data sets into 
those we believed to have near complete ascertainment (studies 5, ... ,9 in Table 2.1) and 
those of uncertain ascertainment (studies 1, ... ,4 in Table 2.1). 
As noted in Section 2.1, the birth certificate studies of Hook and Chambers (1977) and 
Huether et al. ( 1981) have low levels of ascertainment. Trimble and Baird ( 1978) had only 
one source which was a registry of handicapped persons. Although this registry uses 
multiple sources of ascertainment it is not based on mandatory reporting and is not specific 
to Down syndrome. it seems likely that many cases of Down syndrome might not be 
considered as handicapped and would not be ascertained through this source. The data 
presented by Staples et al. (1991) cover a thirty year period from 1960 to 1989. Although 
multiple sources of ascertainment were used the earlier years of the study relied simply on 
public institutions that may have had dealings with Down syndrome cases. The authors 
suggest that a number of cases may have been missed in the first ten years of the study 
period. We use the data as presented by Hecht and Hook (1996) who, due to evidence of 
under-ascertainment in the 1960-64 quinquennium, exclude data from this period. 
However, this leaves the possibility of incomplete ascertainment in the data collected 
between 1965 and 1969 and suggests that this study should not be assumed to be complete. 
Both the Swedish studies (Hook and Lindsjo, 1978; Lindsten et al., 1981) used multiple 
sources to ascertain cases and the overall incidence suggested by the two studies was 
similar. The data presented by Hook and Lindsjo (1978) come from a survey of all 
community sources concerning the diagnosis of Down syndrome. Lindsten et al. ( 1981) 
obtained data from three different registers - the Medical Birth Registration, the Swedish 
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Register of Congenital Malformations, and the Cytogenetic Register. By analysing the 
number of cases reported to different registers Lindsten et al. ( 1981) estimate that about 
99% of all cases with Down syndrome were ascertained in each year of the study. 
Koulischer and Gillerot (1980), Hamerton et al. (1975) and Jacobs et al. (1974) were all 
hospital-based studies in which the risk of even one case being missed seems to be slight. 
In the study by Koulischer and Gillerot ( 1980) any newborn baby with one or more 
symptoms of Down syndrome underwent chromosome analysis. The Intensive Newborn 
Studies involved chromosome examination of all babies born in the associated population. 
Lastly, the recent study of Halliday et al. (1995) obtained data from the Perinatal Data 
Collection Unit (PDCU), Victorian Department of Health and Community Services. 
Reporting to the PDCU is mandatory for all births of 20 or more weeks' gestation and 
Down syndrome cases are routinely reported from multiple sources. A recent validation 
study of the congenital malformation register at the PDCU demonstrated I 00% 
ascertainment of Down syndrome. 
Analyses were carried out under three prior specifications. In each of these the parameters 
are assumed to be mutually independent. Uniform priors were used for all parameters apart 
from those representing the ascertainment probabilities in the studies with strong prior 
evidence of high ascertainment (studies 5, ... ,9 in Table 2.1 ). The three prior specifications 
for the ascertainment probabilities in these selected studies are given below. 
Prior I: independent uniform priors. 
Prior II: ascertainment probabilities fixed at one, corresponding to complete 
ascertainment. 
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Prior Ill: beta(22,1) prior giving a mode at one and approximately 0.9 probability of 
ascertainment above 0.9. 
Prior I, although somewhat unrealistic in the light of the existing evidence of high 
ascertainment, allows the posterior to reflect the data alone and is useful for comparison. 
Prior II mirrors the analyses of Hecht and Hook (1996) and of Halliday et al. (1995) and 
assumes complete ascertainment in the selected studies. Prior Ill represents a compromise 
between these two extremes and gives highest prior density to full ascertainment in the 
selected studies but allows for ascertainment probabilities below one. 
5.3 Computation 
5.3.1 MCMC Algorithm 
In Chapter 4 n(.) is used to denote the target distribution and n(.l.) denotes full conditional 
distributions under n(.). In the Bayesian context presented here the target distribution is 
the joint posterior distribution of the model parameters, observed data and missing data. 
Since n(m) is generally used for maternal age-specific risks, Pr(.) and Pr(.l.) are used in 
this section to denote posterior and full conditional probability distributions. 
The MCMC algorithm we applied involves a repeated sequence of single-component 
Metropolis-Hastings steps (see Section 4.3.2). In cases where the full conditional 
distributions were available in standard form, samples were drawn from these distributions 
so resulting in a Gibbs step (see Section 4.3.3). Metropolis-Hastings steps with 
multinomial proposal distributions were used to simulate the missing maternal age-specific 
counts of Down syndrome cases included in the cytogenetic samples but registered as 
unaffected. Metropolis steps, with symmetric proposal distributions, were used for the 
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parameters a, fJo and fJ... The full sequence of steps involved in one iteration of the 
algorithm is detailed below. 
With the conditional independence assumptions incorporated in our model, the missing 
maternal age-specific Down syndrome counts X;111 included in the birth registry and in the 
cytogenetic sample only appear in simulations through their total X; . These counts are 
therefore excluded from the simulations. The situation is not so simple with the missing 
Down syndrome counts Y;m. These counts appear in the distribution of the missed Down 
syndrome counts Z;111 at step 2 and are simulated in the first step of our algorithm. ln the 
following explanation, primes are used to denote proposed values. Bold lower case letters 
are used to denote vectors of maternal age counts for a given study. Bold upper case letters 
denote matrices of counts over maternal age and study. We use B for {B"B2 } and cp for 
I. For the cytogenetic samples in the two birth certificate studies (i=l ,2) the vector of 
missing age-specific counts y; of Down syndrome cases, recorded as unaffected but 
included in the cytogenetic sample, was simulated using a Metropolis-Hastings step. 
The proposal distribution used was a multinomial distribution defined over the 35 
maternal age classes with a vector of probabilities proportional to n;
111
tr(m) and index 
Y; . These were accepted with probability 
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where q(y;) represents the probability of drawing the sample Y; from a multinomial 
distribution with a probability vector having elements proportional to n;"'n{m) and an 
index of Y; . Calculation of this acceptance probability is simplified by using the fact 
that 
distribution with index nilll -rim - zim and probability parameter 
2. For each study i and maternal age m, the full conditional distribution of the number of 
Down syndrome pregnancies classified as unaffected and excluded from any 
cytogenetic sample, denoted by Z;"', is binomial with index parameter n;"' - r;"' - Y;m 
and probability parameter n(m)(l-tp;)(I-B;)/{1-n(m)+n(m)(l-tp;)(I-B;)}. The 
vectors z; were simulated using a Gibbs step. 
3. The full conditional distribution of the ascertainment probability lP; for study i is a beta 
distribution with parameters a; + r;. and b; + Y; + z;., in which a; and b; denote the 
parameters of the beta prior distribution assumed for lP;. A Gibbs step was used to 
simulate these probabilities. 
4. For the two birth certificate studies (i= I ,2), the full conditional distributions of the 
probability of inclusion in the cytogenetic sample are beta distributions with parameters 
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I+ X;.+ Y; and I+ r;.- X; + z;.. Again, a Gibbs step was used to simulate these 
probabilities. 
5. The parameter a was updated usmg a Metropolis step with a normal proposal 
distribution for log( a). In this distribution, the mean was the previous value of log( a) 
and the SO was fixed at 0.05. The acceptance probability is given by 
mm 1,------------'---~~ . { Pr(N,R,X,Y,Zia',{J0 ,/J~'~'cp)} 
Pr(N, R, X, Y, Zl a,fJ0 ,/li' ~,Cf.) 
where Pr( N, R, X, Y, Zl a, fJ 0 , fJ1, ~, cp) denotes the full data likelihood. 
6. To improve mtxmg maternal age was centralised by subtracting 35 and, on the 
transformed scale, the intercept flo and the slope fJ 1 were simulated using Metropolis 
steps with N(fJ0 ,0.05 2 ) and N(fJp0.005 2 ) proposal distributions respectively. 
5. 3. 2 MCMC Convergence 
The debate concerning the number of chains that should be run for an MCMC analysis was 
discussed in Section 4.4.4. For the purposes of drawing inferences about features of the 
posterior distribution we adopted the approach of Geyer (1992). For each prior 
specification we ran one chain of 11,000 iterations, the initial I ,000 being discarded as 
burn-in in each case. Starting values were based on ML estimates. To assess convergence 
we have adopted the approach of Gelman and Rubin (1992a) who argue that if several 
chains are run, then comparison of these chains will reveal differences if the chains have 
not reached stationarity. For each prior specification, four additional chains were run for 
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I ,000 iterations. Over-dispersed starting values were chosen for the logistic parameters, 
ensuring over-dispersion of all othe~ parameters in the algorithm within the first few 
iterations. These starting values were approximately I and 1.65 SDs above and below the 
mean of the Monte Carlo sample generated by the long run. 
Software for applying the method of Gel man and Rubin ( 1992b) is available in CODA (Best 
et al., 1995). We have applied this diagnostic to all parameters in the model (see Table 
5.3) and values of ll(m) for selected maternal ages (m=20,30,40,50). Where necessary, 
parameters were transformed since the method relies on normal theory approximation. The 
results suggested that in all cases convergence had been reached by I ,000 iterations and we 
therefore feel confident that our run length and burn-in are sufficient. Time series plots of 
the Monte Carlo output were also examined. These are given, along with JR, for a subset 
of the parameters and age-specific rates under prior Ill in Figures 5.1 and 5.2. 
Parameter Median 97.5% Quantile 
a 1.04 1.08 
f3o 1.03 1.07 
/3, 1.04 1.08 
{{Jj 1.01 1.03 
(/)}_ 1.01 1.04 
({JJ 1.03 1.05 
((J4 1.05 1.10 
logit( ((Js) 1.02 1.03 
logit( ((J6) 1.05 1.12 
logit(((J)) 1.01 1.03 
logit( tpg) 1.01 1.03 
logit( ((J<)) 1.01 1.02 
el 1.01 1.03 
~ 1.01 1.02 
Table 5.3. Median and 97.5% quantile of JR for the model parameters (based on 
iterations 501: 1 ,000) 
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Two other methods available in CODA were also implemented for comparison. The 
method of Raftery and Lewis (1992) was described in Section 4.5.2. Here it is applied to 
the long chain of I I ,000 iterations for each parameter with q, r and s set at the CODA 
defaults. 
Parameter Thinning Burn-in Run Dependence 
Factor (k) (m) Length (11) Factor(/) 
a 22 23853 6.4 
fJo 4 36 39548 10.6 
fJJ 2 24 27358 7.3 
(/J) 3 12 15681 4.2 
fP2 2 6 8754 2.3 
., 18 20052 5.4 (/JJ .) 
(/)4 3 15 18636 5.0 
(/Js 2 18 18020 4.8 
(/)6 5 40 40405 10.8 
(/>) 5 30 36700 9.8 
'PR 6 6509 1.7 
ffJ9 2 10 11798 3.2 
el I ., 4456 1.2 .) 
8;. 2 8 10084 2.7 
Table 5.4. Results of Raftery and Lewis convergence diagnostic (q=0.025; r=±0.005; 
s=0.95) for all model parameters (based on iterations I: 11 ,000) 
For the parameters with the largest dependence factors, the output suggests a considerable 
degree of thinning (kin the range of three to five). While the recommendation is for a very 
small bum-in, due to the starting values being chosen from the ML estimates, the 
recommended run length for most parameters is very large, with a maximum of 40,405 
(over three and a half times the actual run length). For many of the parameters k> I and !> 5 
indicating auto-correlation problems. The diagnostic was reapplied having reduced the 
required accuracy and the probability of attaining that accuracy, and varying the quanti le to 
be estimated. The results are given in Table 5.5. 
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Parameter q=0.025 q=0.25 q=0.50 
k m n k m n k m n 
a I 22 4218 8 48 80560 7 56 115451 
fJo 4 36 6996 8 88 132616 10 100 203280 
{J, 2 24 4838 I I 88 126170 9 81 166563 
rp, 3 12 2772 5 20 34840 4 16 38600 
'P2 2 6 1548 3 12 18714 3 9 25329 
fP3 3 18 3546 7 42 68145 7 49 101738 
fP4 3 IS 3294 6 36 56154 5 35 79065 
f/Js 2 18 3188 8 48 75840 8 64 144744 
fP6 5 40 7150 6 66 100644 9 72 157959 
~ 5 30 6490 7 63 95599 8 72 153032 
(/Jg I 6 1151 2 10 16288 2 8 20556 
(fJg 2 10 2086 3 18 26982 3 IS 34137 
e, 3 788 3 9 18192 3 9 23709 
~ 2 8 1784 3 12 19914 3 12 28863 
Table 5.5. Results of Raftery and Lewis convergence diagnostic (q=0.025, 0.25, 0.5; 
r=±O.O I; s=0.90) for all model parameters (based on iterations I: 11 ,000) 
As we would expect, by reducing the required accuracy and the probability of attaining that 
accuracy, the recommended run length is substantially reduced. Using these values instead 
of the default values suggests that the actual run length of !I ,000 iterations is more than 
sufficient. The effect of varying the quantile to be estimated was then investigated. 
When increasing the quantile to be estimated from 0.025 to 0.25 we see an increase in 
dependence factors with a corresponding increase in recommended thinning. 
Recommended burn-ins for each parameters also increase but are still small, while the 
max1mum run length required is now 132,616 - over 12 times the actual number of 
iterations. 
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For comparison with the Gelman and Rubin diagnostic which was applied to 1,000 
iterations only, the Raftery and Lewis diagnostic was re-run on the first 1,000 iterations 
with accuracy and probability specifications given by q=0.025, r=±0.01, s=0.90. Results 
are given in Table 5.6. 
Parameter Thinning Burn-in Run Dependence 
factor (k) (m) Length (n) factor (I) 
a 20 3805 5.8 
f3o 18 3739 5.7 
[3, 2 26 5130 7.8 
(/JI 1 18 4736 7.2 
Cf>2 5 1039 1.6 
(/)) 38 7358 11.1 
(/)4 8 1494 2.3 
(/Js 2 15 2931 4.4 
(/)6 1 25 4729 7.2 
~ 2 48 8694 13.2 
(/Js 7 1359 2.1 
(/)<) 8 1494 2.3 
e, 5 1039 1.6 
~ 9 1648 2.5 
Table 5.6. Results of Raftery and Lewis convergence diagnostic (q=0.025; r=±0.01; 
s=0.90) for all model parameters (based on iterations I: 1 ,000) 
The diagnostic test results based on the first 1,000 iterations imply that less thinning is 
required than the results obtained using the whole run of 11,000 iterations with the same 
specifications, although there is no obvious reason for this. The suggested bum-ins are 
similar and, although the required run length has increased from 7,150 (<p6) to 8,694 (~), 
the general conclusions drawn are the same whether 1 ,000 or 11,000 iterations are used for 
the test. 
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These results demonstrate that more iterations are required to estimate quantiles near the 
median than extreme quantiles to obtain the same accuracy. It is also evident that the 
results obtained from this diagnostic are highly sensitive to the accuracy and probability 
specifications. Even with the more relaxed values of accuracy (r=±O.O 1) and probability 
(s=O. 9) this diagnostic recommends that our run of 11,000 iterations should only be used to 
estimate extreme quantiles. 
The method described by Geweke (1992) (see Section 4.5.3) was also applied to the long 
chain of 11,000 iterations for each parameter. The values of nA and n 8 were taken to be 0.1 
and 0.5 respectively and the results are given in Table 5.7. 
Parameter z P (2-sided) 
a 1.67 0.09 
f3o -0.53 0.6 
fJJ 0.51 0.6 
(/J) -1.00 0.3 
Cf2 -1.40 0.2 
(/J] -1.68 0.09 
(/)4 0.03 1.0 
(/Js -0.26 0.8 
(/)6 1.09 0.3 
(/>] -0.01 1.0 
(/Jg 2.18 0.03 
fP9 0.76 0.4 
el -2.06 0.04 
fh_ -2.08 0.04 
Table 5.7. Results of Geweke convergence diagnostic (nA=O.I; n8=0.5) for all model 
parameters (based on iterations 1:11 ,000) 
According to Geweke's diagnostic, the algorithm has been run long enough for all 
paran1eters to converge except rp8, 01 and fh_ (using the standard cut-off value for P of 
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0.05). Two other parameters, a and (/J], are of borderline significance (0.05<P<0.1 ). For 
comparison this test was also applied to the first I ,000 iterations. Results are given in 
Table 5.8. 
Parameter z P (2-sided) 
a 2.48 0.01 
fJo 2.89 <0.01 
fJl -2.13 0.03 
lP I -4.47 <0.01 
IP2 -2.51 0.01 
(/J] -4.63 <0.01 
IP4 -4.36 <0.01 
IPs -0.10 0.9 
IP6 -7.67 <0.01 
IP7 -4.69 <0.01 
!pg -0.18 0.9 
IP9 -4.73 <0.01 
el -3.46 <0.01 
~ -2.37 0.02 
Table 5.8. Results of Geweke convergence diagnostic (nA=O.I; n8=0.5) for all model 
paran1eters (based on iterations I: I ,000) 
In this case, using only I ,000 iterations has altered the results considerably. According to 
Geweke's diagnostic none of the parameters, except IPs and rpg, have converged after 1,000 
iterations. 
5. 3. 3 Comparison of Convergence Diagnostics 
Like Cowles and Car! in ( 1996), we have found no relationship between the results from 
different methods. To summarise, Gelman and Rubin's method indicated no problems 
using the generally accepted criterion of JR <1.2. The Raftery and Lewis diagnostic was 
run several times with different specifications. For estimating quantiles close to the 
median the suggested run lengths \Vere impractical, but in each case the parameters 
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requiring most iterations were the logistic parameters, particularly f30 . The implications of 
Geweke's diagnostic method are different again- all the scalar quantities examined have 
converged except rpg, B1 and B;_. Faced with these conflicting results we favour Gelman and 
Rubin's method over the two others considered on the basis of its simplicity and lack of 
dependence on arbitrary specifications. The results from this method, coupled with 
qualitative inspection of the MCMC output, leave us confident that 11 ,000 iterations are 
adequate for this particular algorithm to converge. This is supported by the similarity 
between results obtained from this MCMC analysis (see Section 5.4) and those obtained 
using ML (see Section 2.4.4). 
5. 3. 4 Inference 
For each parameter of interest (the logistic parameters and the probabilities of 
ascertainment in each of the nine studies) the marginal posterior distributions were 
summarised by calculating the modes and means of the Monte Carlo output (iterations 
I ,00 I: 11 ,000). Credible intervals were constructed by first fitting density estimates using 
the reflection method described by Silverman (1986, page 30) to deal with the bounded 
domains. The iterative method described by Wright (1986) (see Section 4.6.3) was then 
applied to obtain 90% HPD intervals. 
5.4 Results 
5. 4. I Ascertainment 
Table 5.9 gives marginal posterior summary statistics and 90% HPD intervals for the 
model parameters under the three prior specifications. Posterior summanes of the 
ascertainment probabilities associated with the nine different studies are shown in Figure 
5.3. For each study the posterior mode and 90% HPD interval are shown, from left to 
right, for priors I, 11 and Ill. For the two smaller data sets- the Intensive Newborn Studies 
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Parameter Prior 
11 Ill 
a Mode 0.000729 0.000689 0.000701 
Mean 0.000731 0.000688 0.000704 
HPD Interval (0.000676,0.000779) (0.000649,0.000725) (0.000662,0.000744) 
flo Mode -I6. I68 -I6.334 -16.221 
Mean -I6. I68 -16.279 -16.25 
HPD Interval (-16.604,-15. 779) (-16.711,-15.856) (-16.671 ,-15.824) 
A Mode 0.2895 0.2922 0.2901 Mean 0.2906 0.2908 0.2907 
HPD Interval (0.2804,0.3007) (0.280 1.0.30 18) (0.2802,0.30 16) 
{)I Hook and Mode 0.105 0.112 0.109 
Chambers ( 1977) Mean 0.105 0.112 0.109 
HPD Interval (0.094,0.117) (0.101,0.123) (0.099,0.120) 
e, Huether et al. Mode 0.481 0.499 0.495 
(1981) Mean 0.481 0.501 0.494 
HPD Interval (0.452,0.512) (0.474.0.5270) (0.467.0.522) 
rp, Hook and Mode 0.328 0.345 0.339 
Chambers ( 1977) Mean 0.326 0.347 0.338 
HPD Interval (0.300.0.351) (0.325,0.367) (0.317,0.361) 
q>z H uether et al. Mode 0.358 0.374 0.368 
(1981) Mean 0.358 0.373 0.367 
HPD Interval (0.332,0.384) (0.349,0.396) (0.343,0.391) 
(/>] Trimble and Mode 0.824 0.879 0.853 
Baird ( 1978) Mean 0.818 0.878 0.857 
HPD Interval (0.740.0.898) (0.806,0.949) (0. 788,0.928) 
rp4 Staples et al. Mode 0.837 0.890 0.868 (1991) Mean 0.838 0.895 0.873 
HPD Interval (0.757.0.919) (0.835,0.957) (0.806,0.942) 
rps Hook and Lindsjo Mode 0.882 0.962 ( 1978) Mean 0.881 0.943 
HPD Interval (0.800,0.970) (0.891.1) 
rp6 Lindsten et al. Mode 0.970 (1981) Mean 0.944 0.977 
HPD Interval (0.889.1) (0.949, I) 
~ Koulischer et al. Mode 0.906 0.975 (1980, 1991) Mean 0.905 0.959 
HPD Interval (0.838.0 985) (0.919.1) 
rpg Intensive Mode 0.773 
Newborn (1975, Mean 0.798 0.951 
1974) HPD Interval (0.636,0. 996) (0.891.1) 
ifJ9 Halliday et al. Mode 0.854 I ( 1995) Mean 0.857 0.956 
HPD Interval (0.741,1) (0.902.1) 
Table 5.9. Posterior means, modes and 90% HPD intervals for the model parameters 
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compiled by Hecht and Hook (1996) and the data from Halliday et al. (1995) - the 
posterior distribution obtained from prior I is quite diffuse and gives considerable 
probabilities to ascertainment levels as low as 0.8. In the face of published evidence of 
high ascertainment, these posterior distributions are quite untenable. On the other hand 
prior Il, which assumes full ascertainment for the selected studies, appears to be 
inappropriate, particularly for the data sets of Hook and Lindsjo (1978) and Koulischer et 
al. (1991 ). Prior Ill provides a good compromise, allowing for under-ascertainment but 
informing the posterior of the high levels of ascertainment believed to be present in the 
selected studies. 
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Figure 5.3. Posterior modes and 90% HPD intervals under priors I, 11 and Ill respectively, 
for each study 
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Just as the assumptions behind prior II mirror the assumptions of the reduced model in 
Chapter 2, in which probabilities of ascertainment were fixed at one for studies i=5, ... ,9, 
the uniform priors used for prior I correspond to the full model in which all probabilities 
were estimated. Comparing the posterior modes and means of the ascertainment 
probabilities given in Table 5.9 under the three priors with the ML results given in Table 
2.5, it is evident that the MCMC approach generally yields lower estimates of 
ascertainment than the ML approach. However, these differences are small compared with 
the SEs of the ML estimates. 
5.4.2 Predictive Probabilities of Down Syndrome 
With knowledge of a, f3o and A, the probability of a Down syndrome pregnancy to a 
woman of maternal age m (completed years) is given by equation (2.2). The corresponding 
predictive probability is given by the expectation of (2.2) with respect to the posterior 
distribution of a , f3o and A. Predictive probabilities were obtained by taking the sample 
mean of (2.2) based on M= I 0,000 MCMC iterations: 
- 1 [ 1-a l ;r(m)=-2..: a,+ ' . 
M , 1 + exp{-(,80, + ,B 11 m)} 
The results, expressed as rates per thousand live births, are given in Table 5.1 0. The overall 
birth prevalences expected in England and Wales over the three year period from 1986 to 
1989, assuming that no pregnancies were terminated, are also given in Table 5.10. These 
were obtained by taking the mean of the predictive probabilities with respect to the 
maternal age distribution of livebirths in England and Wales for the three years from 1986 
to 1989 (OPCS, 1988-1991). 
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Predictive Probability 
Maternal Age Prior I Prior 11 Prior Ill 
16 0.74 0.70 0.71 
17 0.74 0.70 0.72 
IS 0.75 0.70 0.72 
19 0.75 0.71 0.73 
20 0.76 0.72 0.73 
21 0.77 0.73 0.74 
22 0.79 0.74 0.76 
23 0.80 0.76 0.77 
24 0.83 0.78 0.80 
25 0.86 0.81 0.83 
26 0.91 0.85 0.87 
27 0.97 0.91 0.93 
28 1.05 0.98 1.01 
29 1.15 1.08 1.11 
30 1.30 1.21 1.24 
31 1.49 1.39 1.42 
32 1.74 1.62 1.67 
33 2.08 1.94 1.99 
34 2.53 2.36 2.42 
35 3.14 2.92 3.00 
36 3.95 3.67 3.78 
37 5.03 4.67 4.81 
38 6.47 6.01 6.18 
39 8.39 780 8.02 
40 10.95 10.17 10.46 
41 14.35 13.33 13.72 
42 18.86 17.53 18.03 
43 24.83 23.08 23.75 
44 32.70 30.42 31.29 
45 43.03 40.07 41.19 
46 56.51 52.68 54.14 
47 73.95 69.04 70.91 
48 96.30 90.06 92.44 
49 124.55 116.73 119.73 
50 159.68 150.06 153.75 
Overall 1.52 1.42 1.46 
Table 5.1 0. Predictive probabilities of Down syndrome, given maternal age, expressed as 
rates per thousand livebirths 
Figure 5.4 shows the rapidly increasing predictive probability of Down syndrome with 
maternal age for prior III. The corresponding predictive probabilities for priors I and ll are 
practically indistinguishable when superimposed on this graph. Posterior distributions of 
the prevalence for maternal ages 20, 30 and 40 are given in Figure 5.5. As expected the 
priors with higher levels of ascertainment give lower predictive probabilities of Down 
syndrome. Despite the fact that the differences are small relative to the changes with 
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maternal age, they are quite apparent in Figure 5.5. Again, prior III provides a compromise 
between the two unrealistic extremes of priors I and 11. 
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Figure 5.4. Plot of maternal age-specific predictive probabilities under prior III 
The predictive probabilities for prior 11 (Table 5 .I 0) are based on the same assumptions as 
the reduced model (Table 2.6) in Chapter 2. Comparing the two we see that the predictive 
probabilities from the MCMC analysis are slightly higher than the ML estimates and it is 
interesting to note the trade-off between ascertainment probabilities and risk. The 
difference increases with maternal age from 0.01 per thousand livebirths at maternal age 16 
to 2.14 per thousand for mothers aged 50 years. 
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(a) Maternal age 20 
0.60 0.65 
(b) Maternal age 30 
1.10 1.15 1.20 
(c) Maternal age 40 
8.0 8.5 9.0 
0.70 0.75 0.80 
Rate per 1 000 livebirths 
1.25 1.30 1.35 
Rate per 1000 livebirths 
1.40 
Prior I 
Prior II 
Prior III 
0.85 
1.45 
0.90 
1.50 
9.5 10.0 10.5 11.0 11.5 12.0 12.5 
Rate per 1000 livebirths 
Figure 5.5. Posterior distributions of n(m), m=20,30,40, expressed as rates per thousand 
livebirths, under the three prior specifications 
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5.5 Discussion 
In this chapter we have adopted a Bayesian approach to estimating livebirth prevalence of 
Down syndrome, incorporating the ascertainment process within our model. We have 
explored the effects of using different prior specifications on ascertainment rates and 
shown that, when a vague prior is used for smaller studies, the posterior distribution 
attaches unrealistically high probability to low ascertainment rates. This has the effect of 
producing higher predicted prevalence rates than those obtained from more realistic prior 
specifications. 
The use of an informative prior for the ascertainment rates in those studies judged a priori 
to have high ascertainment provides a good compromise between the two extremes of 
assuming full ascertainment and of making no prior assumptions on ascertairunent. The 
resulting maternal age-specific probabilities of Down syndrome are somewhat higher than 
the risks estimated from the preferred model in Chapter 2. The overall prevalence figure 
for a standardised age distribution is 1.46 from the Bayesian analysis with prior Ill (Table 
5.1 0), compared with 1.41 from the ML analysis using the model with constrained 
parameters for studies believed to have achieved high ascertainment (Table 2.11 ). The 
Bayesian approach is particularly attractive in this application because it allows us to 
incorporate this strong prior information on ascertainment rates. 
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Chapter 6 
The Use of Ultrasound Markers in Down Syndrome Screening 
6.1 Introduction 
This chapter is concerned with statistical aspects of ultrasound scanning in the prenatal 
diagnosis of Down syndrome fetuses. The condition has been found to be associated with 
a number of physical abnormalities which can be detected as early as 12 weeks' gestation 
by ultrasound. Although ultrasound scanning cannot give as definite a diagnosis as 
karyotyping, its advantages are that it does not increase the risk of miscarriage and results 
are available immediately. 
In Section 6.2 a brief description of the physics of ultrasound is followed by a review of 
common second trimester ultrasound markers for Down syndrome and their screening 
efficiency. The remainder of the chapter is concerned with the association between Down 
syndrome and abnormal nuchal fluid in the first trimester. Brizot et al. (1994) suggest that 
screening for Down syndrome using NT and maternal age alone could achieve a detection 
rate of 85% with a false-positive rate of 5%. This compares favourably with an estimated 
detection rate of 60% for biochemical screening at the same false-positive rate (Wald et al., 
1988). Section 6.3 begins by describing the measurement of NT and the problem of 
rounding to whole millimetres which occurs, particularly in older data sets. The precision 
of recording may also depend on the operator and many of the available data sets are a 
mixture of measurements to the nearest tenth of a millimetre or rounded to whole 
millimetres. The situation is further complicated by the dependence ofNT on gestation, as 
measured by CRL. This coarsening problem is addressed using the MCMC techniques 
described in Chapter 4. New methodology for modelling such data is presented and 
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applied to both real and simulated data. In Section 6.4 the MCMC algorithm is extended to 
model jointly data on unaffected and Down syndrome pregnancies. Finally, we calculate 
predictive probabilities of Down syndrome given NT, CRL and maternal age. 
6.2 Ultrasound Markers for Down Syndrome 
6. 2.1 Ultrasound Scanning 
Based on the principles of underwater detection of ships, ultrasound is used in medical 
imaging to produce pictures of structures within the body. An abdominal transducer is 
placed in contact with the skin and a beam of ultrasonic waves passes through the tissue. 
Part of the beam is reflected at each tissue interface. As the beam is pulsed electrical 
signals are sent to the machine to be amplified and analysed. The beam is moved through a 
section of tissue to build up a two-dimensional matrix which is displayed on a television 
monitor. By repeating the process many times every second a real-time image can be 
produced. 
Fluids do not reflect ultrasound beams and therefore appear black on the monitor. 
Conversely, bone reflects, scatters and absorbs all the sound, allowing none to pass 
through. Although interpretation is operator dependent, scans of the fetus are very accurate 
in assessing fetal maturity and in diagnosing malformation. Ante-natal scanning is one of 
the principal areas of ultrasound imaging. 
6.2.2 Down Syndrome Markers 
During the second trimester each chromosomal defect develops its own syndromal pattern 
of abnormalities. Down syndrome markers include abnormalities in the hands, feet, heart, 
brain, kidneys and intestine. Studies of the most commonly found features - nuchal 
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oedema, mild hydronephrosis (dilation of the renal pelvises), relative shortening of the 
femur and cardiac abnormality - are summarised below. Hyperechogenic bowel is also 
included as it has recently been studied as an additional marker for detecting Down 
syndrome. For a more detailed review see Snijders and Nicolaides (1996, Chapter 1). 
The term 'nuchal oedema' refers to an abnormal accumulation of fluid beneath the skin at 
the back of the neck. Benacerraf et al. ( 1985, 1987) reported an association between 
nuchal oedema and Down syndrome and this finding is supported by Lynch et al. (1989). 
Donnenfeld et al. (1994) carried out a prospective multi-centre study of I ,382 women 
undergoing amniocentesis at 14 to 20 weeks' gestation to investigate the value of nuchal 
skinfold thickness as a screening test for Down syndrome. No statistically significant 
difference was found between the unaffected (median=3.1 mm) and Down syndrome 
fetuses (median=3.2mm). With a cut-off of 5mm, using nuchal skinfold thickness as a 
screening test yielded a detection rate of 8% and a false-positive rate of 1.2%. This study 
suggests that using nuchal skinfold thickness alone would provide an unreliable screening 
test for Down syndrome. 
Benacerraf et al. (1985) carried out a study of fetuses at 15 to 21 weeks' gestation and 
estimated the value of relative femur length as a marker for detecting those with Down 
syndrome. They reported that, if the ratio of the actual femur length to the expected length, 
based on the biparietal diameter, was s0.91, then the sensitivity (probability that an 
affected pregnancy will be correctly diagnosed) and specificity (probability that an 
unaffected pregnancy will be correctly diagnosed) were 68% and 98%, respectively. 
According to Snijders and Nicolaides ( 1996, Chapter 1 ), later studies have reported lower 
sensitivities and specificities. 
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The overall prevalence of fetal uniary tract abnormalities is about two to three per thousand 
pregnancies. Jones et al. (1988) report that uniary tract defects are commonly found in 
many chromosomal defects. The largest published series of renal defects is presented by 
Nicolaides et al. ( 1992a). In this series the chromosomal defect most commonly associated 
with mild hydronephrosis was Down syndrome. 
Hyperechogenic bowel is found in one in two hundred mid-trimester fetuses (Dicke and 
Crane, 1992; Bromley et al., 1994), and is sometimes caused by chromosomal defects. 
Snijders and Nicolaides (1996, Chapter I), however, report that among 280 fetuses they 
observed with hyperechogenic bowel, chromosomal defects were only found in those 
fetuses with additional, often multiple, abnormalities. 
Echocardiography can be used to aid prenatal assessment of the fetal cardiac function and 
structure (Nora and Nora, 1978). Since heart defects are found in 50% of fetuses with 
Down syndrome such abnormalities are also an important marker for Down syndrome. 
In this section we have described some of the most common second trimester 
ultrasonographic markers for Down syndrome. It has been established that the risk of a 
chromosomal defect increases with the number of abnormalities identified (Nicolaides et 
al., 1992c). Benacerraf et al. (1994) proposed a scoring system for the risk of trisomies 
according to the presence or absence of certain anatomic abnormalities. Amongst 45 
fetuses with Down syndrome, a sonographic score of 2::2 identified 73% of cases. The 
false-positive rate was reported to be 4%. 
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6.3 Application of Gibbs Sampling to Nuchal Translucency Data 
6.3.1 Nuchal Translucency as a Marker for Down Syndrome 
NT is an ultrasonographic feature which may be observed m the first trimester of 
pregnancy and is a common phenotypic expression of Down syndrome, among other 
chromosomal abnormalities. Whether the feature is seen in a chromosomally normal or 
abnormal fetus, it usually resolves during the second trimester, rarely developing into 
nuchal oedema. The extent of the accumulation of fluid is quantified from an ultrasound 
scan by measuring the NT which appears as a dark region behind the neck of the fetus. 
This is illustrated in Figure 6.1 . 
Figure 6.1. Ultrasound image of NT 
To obtain an NT measurement the sonographer measures the maximum thickness of the 
subcutaneous translucency between the skin and the soft tissue overlying the cervical spine 
(Nicolaides et al. , 1992b ). The white crosses in Figure 6.1 show the position of the 
electronic calipers determined by the ultrasonographer in order to measure the NT at its 
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widest point. NT measurement is now an established basis for prenatal screening in the 
first trimester of pregnancy (see, for example, Brizot et al., 1994). However, a 
disadvantage of using NT for screening compared to the traditional biochemical markers is 
that accurate measurement ofNT requires highly skilled operators and the results are prone 
to operator variability. Pandya et al. (1995) carried out a prospective study to assess the 
repeatability of measurement of NT at I 0 to 14 weeks' gestation. The study involved 200 
women, all of whom were scanned by two of four participating operators. The results 
showed that the repeatability was unrelated to the size of the NT and, when the mean of 
two measurements was used, the intra-observer and inter-observer repeatabilities were 
0.54mm and 0.62 mm, respectively, 95% of the time. 
The procedure for screening is complicated by the fact that NT increases with gestation. 
To use NT as a marker for Down syndrome measurements are adjusted for CRL, which 
acts as a proxy for gestational age. Reference centile charts which show the centiles of the 
conditional distributions ofNT on CRL provide a simple graphical way of establishing the 
atypicality of a particular case (see, for example, Snijders and Nicolaides, 1996, Chapter 
3). A potential problem with the use of NT measurements is the considerable rounding 
error which occurs in some centres. The aim of the analysis presented in this section is to 
produce reference centiles for NT from a coarsened data set. Methods of dealing with 
coarsened data are discussed in Section 6.3.2. In Section 6.3.3 we describe a mixture 
model for data rounded to a varying number of decimal places. The data are analysed 
within the Bayesian framework using the Gibbs algorithm outlined in Section 6.3.4. 
Section 6.3.5 demonstrates the method applied to simulated data and in Section 6.3.6 we 
use real data to construct reference centiles for NT. 
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6. 3. 2 Methods for Dealing with Coarsened Data 
We use data collected from Frimley Park Hospital by the Harris Birthright Research Centre 
for Fetal Medicine (Snijders and Nicolaides, 1996, page 134) which include measurements 
of NT and CRL in n=5,610 unaffected pregnancies. These are recorded to differing 
degrees of precision; some are rounded to the nearest millimetre whilst others are recorded 
to tenths of millimetres. Figure 6.2 shows a histogram ofNT measurements and illustrates 
the tendency for the measurements to be heaped at integer values. 
0 
0 
I() 
~ 
0 
0 
0 
~ 
0 
0 
I() 
0 
0 
• 
2 3 
NT(mm) 
Figure 6.2. Histogram ofNT measurements from Frimley Park Hospital 
4 
Leaving aside the complications caused by the rounding, a standard approach to the 
analysis would be to fit a regression model of NT on CRL. Initial analysis of the data 
suggests a simple linear regression of log transformed NT on CRL and this is the model we 
adopt for the unrounded NT values. 
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It is clear from Figure 6.2 that the effect of rounding is substantial and this aspect of the 
data needs to be incorporated into our model. The extensive literature on grouped and 
rounded data goes back as far as Sheppard ( 1898). A detailed review of frequentist 
approaches to dealing with grouped and rounded data is given by Heitjan (1989). More 
recently Heitjan and Rubin (1991) present a general model for coarsened data, including 
rounded, heaped, censored and missing data. They define a coarsened at random condition 
under which the coarsening mechanism can be ignored in Bayesian and likelihood based 
inference. Heitjan (1994) defines a coarsened completely at random condition for 
frequentist ignorability. The results are extended to general sample spaces by Jacobsen and 
Keiding ( 1995). 
Applications of Gibbs sampling to models for grouped data are described by Gelfand, 
Smith and Lee (1992). The data dealt with here are somewhat more complicated in the 
sense that the grouping is not known for values recorded as integers. An integer m could 
result from rounding to the nearest millimetre, grouping over the interval (m-0.5, m+0.5), 
or it could result from rounding to the nearest tenth, grouping over the interval (m-0.05, 
m+0.05). This heaping of the data also occurs in applications dealing with ages which are 
reported in mixtures of whole years, months or multiples of six months. The coarsening at 
random condition does not hold in this case and it necessary to model the rounding 
process. 
In Section 6.3.3 we propose a model in which the measurements arise from a mixture of 
unknown proportions of values rounded to the nearest tenth and values rounded to the 
nearest whole millimetre. In Section 6.3.4 we describe a Gibbs sampling algorithm in 
which missing data on the type of rounding and the unrounded NT dimension are sampled. 
The approach is similar to that described by Gelfand, Smith and Lee (1992). In Section 
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6.3.5 the method is applied to simulated data, and in Section 6.3.6 the Frimley Park data 
are analysed. We conclude with a discussion of extensions of the model to other situations 
in Section 6.3.7. 
6.3.3 A Mixture Model for the Rounding Process 
We model the rounding process using the conditional independence assumptions shown in 
Figure 6.3 (for an introduction to graphical models see, for example, Spiegelhalter et al., 
1996, or Spiegelhalter, 1998). In Figure 6.3, z; is a latent indicator variable that 
determines whether the true dimension for observation i is rounded to whole millimetre 
values ( z; = l) or to tenths of millimetre values ( z; = 0 ). Conditionally on the mixing 
parameter a, z; has a Bernoulli distribution taking values one with probability a and 
zero otherwise. Given f3 = (/3 0 ,/3 1 f and a 2 , the true NT Y; is generated from a simple 
linear regression model of log(y;) on CRL I; so that log(y;) is normally distributed with 
mean /30 + /311; and variance a 2 • Given Y; and Z; the recorded NT X; is determined by 
X -;
round(y;) if z; = I 
-
1 
round(lOy;)ifz;= 0 
10 
where round(.) is a function which rounds to the nearest integer. We assume a non-
informative improper prior specification of the form Pr( a,/3, a 2 ) oc ~. 
a 
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Figure 6.3. Graphical model for rounded data 
6. 3. 4 Gibbs Algorithm 
Gibbs sampling techniques (see Section 4.3.3) are now used extensively in applied 
Bayesian statistics (see, for example, Smith and Roberts, 1993, or Gilks et al., 1996). 
These computer intensive methods are particularly useful when dealing with coarsened 
data such as those considered here because they allow us to simulate the latent z; s and the 
true Y; s. Standard full-data techniques can then be applied to simulate the parameters a , 
fJ = ({30 ,{31 )r and a- 2 • Computational considerations led us to partition the unknown 
quantities into the following four components: 
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T 
• the vector y = (y"y2 , ••• ,y,) oftrue responses 
T 
• the vector z = (z"z2 , ••• ,z,) of indicators 
• the mixing parameter a 
• the regression model parameters f3 = (/30 , /31 f and (Y 2 • 
The full conditional distributions used in each step of our algorithm are detailed below. 
I. In the full conditional distribution of y, the y, s are mutually independent and log(y,) 
has a truncated normal distribution with mean /30 + ~1, and variance (Y 2 with truncation at 
1- \-
log(x, -0.511 o=·) and log(x, + 0.511 o=·). 
2. In the full conditional distribution of z, the z, s are mutually independent with marginal 
distributions as follows. If x, is not an integer then z, = 0 and if x, is an integer and 
lx,- y,l >0.05 then z, =I. Otherwise z, has a Bemoulli distribution with probability 
parameter a . 
3. The full conditional distribution of a is a beta distribution, beta(a,b), with parameters 
a= I+ L z, and b =I+ n- L z, . 
4. Standard distribution theory applies to the full conditional distribution of ( (Y 2 ,fJ) and is 
specified in terms of a scaled inverse-x2 distribution for (Y 2 and a normal distribution for 
the conditional distribution fJI(j 2 (Gelman et al. 1995, Chapter 8): 
(Y 2 1 y - lnv - X2 ( n - 2, s 2 ) where i is the residual mean square from the least squares 
regression of log(y) on t, 
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their covariance matrix. 
The Gibbs sampling scheme outlined above was implemented in S- Plus (MathS oft, 
1996). For purposes of inference 3,300 iterations of the algorithm were run. For the 
Frimley Park data two additional runs of 300 iterations were carried out from over-
dispersed starting values. These short runs were used to assess convergence both 
graphically and by using the method of Gel man and Rubin ( 1992b ). As an additional 
check on convergence the method proposed by Geweke (1992) was applied to the marginal 
distribution of each parameter in the full 3,300 iterations. None of the diagnostics 
suggested any convergence problems. 
6. 3. 5 Simulation Study 
To compare the mixture model with the naive approach which ignores coarsening we 
generated data from a model with 200 observations at each of three given sites (t= 1 ,2,3). 
T T 2 2 The true parameter values were a=0.6, J3=(f30 ,/J1 ) =(-0.2,0.4) and CJ =0.1. 
These values were chosen to produce a situation where the rounding affected the apparent 
slope and intercept of the regression. In particular, at t=1 the median of y is about 1.2 so 
that integer rounding leads to values of =l. At t=3 the median of y is about 2.8. The 
effect of the rounding is to make the regression slope steeper. 
The posterior distributions are shown as histograms in Figure 6.4. The vertical lines show 
the true parameter values and the smooth curves show the posterior distributions obtained 
by ignoring the rounding and using standard regression techniques (Gelman et al. 1995, 
Chapter 8). For this simulated data set the mixture model produces a posterior distribution 
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that is quite consistent with the original parameters. On the other hand, ignoring the 
coarsening process leads to poor performance and posterior distributions that attach low 
posterior density to the true parameter values. As anticipated from the true model the slope 
in this case is exaggerated. Of course, it would be possible to devise other cases in which 
the slope would be unaffected or reduced by the coarsening. 
0.36 0.40 
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sd 
0.44 
beta1 
0.12 
0.48 
0.14 
-0.38 -0.32 -0 .26 -0.20 -0.14 
betaO 
0.50 0 .55 0 .60 0 .65 
alpha 
Figure 6.4. Marginal posterior distributions from the mixture model (histograms) and the 
model ignoring rounding (smooth curve) with true values shown by vertical lines. 
6. 3. 6 Analysis of Nuchal Translucency Measurements 
This section describes the analysis of the Frimley Park Hospital data. The aim of this 
analysis is the production of reference centiles for the predictive distribution of NT. Figure 
6.5 shows the first 300 of the 3,300 iterations of the Gibbs sampler together with results 
obtained from two other runs of 300 iterations with over-dispersed starting values. Gelman 
and Rubin' s (1992b) 'estimated potential scale reduction' JR. is superimposed. These 
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Figure 6.5. Convergence monitoring plots, with .JR , for f30, /31, CY and a. 
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values are all close to one and suggest that convergence has been achieved within the first 
300 iterations. Convergence appears very rapid even starting from poor initial values. 
Discarding the first 300 iterations as burn-in we obtained posterior marginal distributions 
from M=3,000 iterations. Table 6.1 gives posterior summaries from the analysis of the NT 
data. 
Parameter Mean SD 90% HPD Interval 
a 0.5074 0.0074 (0.494 7 ,0.5203) 
f3o -0.1924 0.0253 ( -0.2342,-0.1490) 
A 0.0091 0.0004 (0.0083,0.0097) 
(J' 0.2910 0.0033 (0.2854,0.2967) 
Table 6.1. Posterior means, SDs and 90% HPD intervals from the Frimley Park NT data 
(unaffected pregnancies only) 
Centiles for NT given CRL were calculated as follows. Given /30 , A, a 2 and t, the 
probability density of NT, Pr(yl /30 ,/31, a 2 , t), is a lognormal density. The predictive 
density is the mean of Pr(ylf30 ,f31,a2 ,t) over the Gibbs samples. Denoting the sequence 
of Gibbs samples by (a;,/3o; .• /3
1
;.a;), i=l,2, ... ,M, this predictive density is given by 
The corresponding predictive distribution 
function at y • is 
(6.1) 
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The centiles shown m Figure 6.6 were obtained numerically from this predictive 
distribution function. The observed data for unaffected and Down syndrome pregnancies 
are also plotted. To provide a truer picture of the data the points for unaffected pregnancies 
were jittered by adding uniform random numbers between -0.5 and 0.5 for CRL, and -0.05 
and 0.05 for NT. We see from Figure 6.6 that only 7 of the 19 Down syndrome 
observations lie between the I stand 99th reference centiles. 
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Figure 6.6. Plot of NT on CRL for unaffected and Downs syndrome pregnancies, with 1st, 
50th and 99th centiles from the predictive distribution function (6. 1) for unaffected 
pregnancies 
6. 3. 7 Discussion 
In this section we have modelled heaped data using a mixture model to represent two 
different levels of rounding. Our analysis of the simulated data demonstrates the dangers 
140 
of ignoring coarsening and ease with which rounding can be accommodated in the analysis 
using the Gibbs sampler. The model we have proposed could be extended in a number of 
ways to deal with other situations. For example, the number of components in the mixture 
could be increased and the mixing proportion a could be made to depend on y. In Section 
6.4 we include another regression for Down syndrome pregnancies. 
We have used the mixture model to produce reference centile curves for NT measurements 
obtained by ultrasonographers. The measurement of NT requires highly skilled operators 
to get an appropriate image in the first place and then to obtain the measurement. In the 
future some of the subjectivity could be removed by application of image analysis to 
perform the measurement. 
6.4 Nuchal Translucency Screening 
6. 4.1 ModeL\'for Down Syndrome and Unaffected Pregnancies 
The analysis described in Section 6.3 deals with unaffected pregnancies only. We have 
calculated reference centiles and noted that a large proportion of Down syndrome NT 
observations lie above the 99th centile. For the purposes of screening based on NT and 
maternal age we also need to model the distribution ofNT given CRL in Down syndrome 
pregnancies. The Frimley Park Hospital data set includes 19 Down syndrome 
observations. In this section we extend the model used in Section 6.3 to deal with both 
unaffected and Down syndrome pregnancies. 
Initially three extra parameters PoD, f3w and a-D 2 were included for the intercept, slope 
and variance in the Down syndrome group (note that D and U are used to distinguish 
between Down syndrome and unaffected pregnancies). The additional 19 observations 
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were appended to the vectors x, y and z. The parameters f3 0 = (/300 ,{Jw f and a v 2 were 
then sampled in step 4 of the Gibbs algorithm (described in Section 6.3.4) in the same way 
as those for unaffected pregnancies. Posterior summaries obtained from 1 ,000 iterations 
(I 00 discarded as bum-in) are shown in Table 6.2. Comparison with Table 6.1 shows that 
inclusion of data from affected pregnancies does not notably affect the posterior summaries 
for unaffected pregnancies. 
Parameter Mean SD 
a 0.5070 0.0074 
Down Syndrome flan 2.6900 1.2117 
flw -0.0270 0.0207 
a" 0.5783 0.1062 
Unaffected flou -0.1914 0.0255 
flw 0.0090 0.0004 
a" 0.2909 0.0035 
Table 6.2. Posterior means and SDs for Down syndrome and unaffected pregnancies from 
the Frimley Park NT data (allowing different slopes, intercepts and variances in the two 
groups) 
We see that the small sample of Down syndrome cases in this data set leads to a negative 
value for the posterior mean of the slope in affected pregnancies, which is medically 
untenable. A possible solution would be to place a strong prior on flw to constrain it to be 
positive or zero. However, from a physiological point of view it is reasonable to assume 
that the slope in the Down syndrome group is the same as that in the unaffected group. 
This is a standard approach to modelling Down syndrome markers, where data on affected 
pregnancies are usually comparatively sparse. For example, in their well-known analysis 
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of biochemical markers, Wald et al. (1988) assume that the conditional probability density 
of transformed values (expressed as multiples of the unaffected median) are multivariate 
normal with differing mean vectors and covariance matrices. They assume that the mean 
vector for Down syndrome pregnancies differs from the unaffected mean vector by an 
additive constant. 
6.4.2 Gibbs Algorithm 
Assuming a common slope /31 but different intercepts and variances in the two groups, the 
f3 = (/3 011 ,f301pf3 1 f. Steps I to 3 of the algorithm for sampling y, z and a remain 
unchanged by the inclusion of observations relating to Down syndrome pregnancies. In 
Section 6.3.4 we update a 2 and f3 = (/3 0 ,/31 f in one Gibbs step. However, the full 
conditional distribution of ( au 2 ,a JJ 2 ,fJ) cannot be obtained from standard theory in the 
case considered here. Before deriving full conditional distributions for a 1/, a 0
2 
and f3 
we introduce the necessary notation. 
Let nu and n0 denote the numbers of unaffected and Down syndrome pregnancies, 
respectively. T Also let t = (t~> ... , t,,
1
, t,
11
+1, ... , t,) where n=nu+n0 . Then, writing 
Y = iog(y) , we assume that 
Y] fJ, a~1 , a;J, t ~ N( XfJ, L:) where X is then by 3 design matrix 
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1 0 
X= 0 I 
"u+l 
0 t, 
and 2: is an n by n diagonal matrix comprising the following four components (/111 denotes 
an m by m identity matrix): 
Full conditional distributions can be obtained by picking out the relevant terms from the 
joint distribution of the variables (Gilks, 1996)0 Assuming a prior of the form 
( 2 2) 1 fu 0 2 Pr a,/3, au, a 0 oc 2 2 we find that the ll conditional distribution of au IS auoa 0 
0 2 -( 
1~1 +I) ( I 2 J 02 - I 1111 2 proportional to a 11 • exp ---2 n11 s11 where 5 11 - -,L { Y;- (/3011 + j31t;)} 0 From 2au nu i=l 
this we deduce that the full conditional distribution of a~, is an inverse-;<? distribution: 
2 2( 2) a 11 I /3, y, t - Inv - X n11 , s11 0 
Similarly, 
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Using the same method we see that that the full conditional distribution of fJ 1s 
proportional to exp{-~(Y-XfJfL- 1 (Y-XfJ)}. Rearranging the expression m the 
exponent 
We replace step 4 in the algorithm described in Section 6.3.4 with two Gibbs steps. The 
first samples er~, and er;J from the inverse-x2 distributions described above. The second 
samples fJ = (/3 011 ,f30n ,{31 f from its multivariate normal full conditional distribution. 
As in Section 6.3, inference was based on M=3,000 iterations after discarding bum-in. 
Convergence was checked graphically and using the method of Gelman and Rubin 
( 1992b ). Two additional runs of 300 iterations were started from over-dispersed parameter 
values - the Gelman and Rubin statistic .JR was 1 or 1.01 for all the parameters in the 
model. Time series plots of the iterations for each parameter also demonstrated rapid 
convergence and good mixing. 
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6. 4. 3 Predictive Probabilities of Down Syndrome 
Posterior summaries of all model parameters are shown in Table 6.3. Comparison with 
Table 6.2 shows that constraining the slope parameter in the Down syndrome group to be 
equal to that in the unaffected group reduces the posterior SD of flo/J by a factor of eight. 
The posterior mean of this estimate is also reduced but, as we would expect, is higher than 
fJ 011 • This reflects the higher NT measurements observed in Down syndrome pregnancies. 
None of the other parameters are notably affected by this constraint apart from ry JJ which 
has increased slightly. 
Parameter Mean SD 
a 0.5067 0.0074 
{J, 0.0090 0.0004 
Down Syndrome flon 0.5905 0.1462 
(Y /) 0.6223 0.1128 
Unaffected flou -0.1908 0.0256 
(Y{/ 0.2909 0.0034 
Table 6.3. Posterior means and SDs for Down syndrome and unaffected pregnancies from 
the Frimley Park NT data (assuming a common slope and different intercepts and variances 
in the two groups) 
Aitchison and Dunsmore (1975, Chapter 11) discuss the differences between estimative 
and predictive diagnosis. The estimative method requires an estimate f!. of the parameters 
f!. based on a set of training data - these could be ML estimates or posterior means such as 
those in Table 6.3 -and a prior distribution n(.) for the probability of the unknown disease 
category. Then the plausibility of this disease category (Down syndrome in this case, 
denoted by D) is assessed by applying Bayes's theorem: 
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Pr( Dl y' ,t', m' ,data) oc Pr(y', t', m'l D, ~)n-(m') 
where/,/ and m' are observations ofNT, CRL and maternal age. 
One problem with this method is that it takes no account of the sampling variability in the 
estimate e and estimated misclassification rates for future patients are often too low. 
Aitchison and Dunsmore (1975, Chapter 11) present an example concerning the 
classification of sufferers of Conn's syndrome into two causal types on the basis of eight 
tests. The results are expressed in terms of odds. In this example the estimative method 
leads to exaggerated evidence in favour of a particular type and, generally speaking, the 
estimative method appears to give much more extreme odds than the predictive method. 
The difference between the two methods is particularly noticeable where there is limited 
past experience in the training data and the uncertainty in ~ is greatest. 
• • • Given observations y , t and m , we approximate the predictive probability of Down 
syndrome from the MCMC output as follows: 
( • •. ) I~ ( ..• ) Pr Dly ,I ,m ,data = -L. Pr Dly ,t ,m J1; 
M i=l 
where V denotes an unaffected pregnancy and n( m') is the maternal age-specific risk for 
age m' derived in Chapter 2 (Table 2.6). 
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Fixing maternal age at 35 years, these probabilities are plotted in Figure 6.7 for three 
different values of CRL. Similar graphs could be constructed for any given maternal age 
and for any values of CRL. Figure 6. 7 shows that the predictive probability of Down 
syndrome increases with NT, as we would expect, and decreases with increasing CRL (as 
the expected NT increases with gestation). 
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Figure 6.7. Predictive probabilities of Down syndrome against NT at maternal age 35 
We note that for values ofNT close to zero the model attaches high predictive probabilities 
of Down syndrome. This counter-intuitive behaviour reflects the inadequacy of the model 
in the tails of the distribution. This type of problem is often encountered in biochemical 
screening (see, for example, Reynolds, 1994). It results from trying to make predictions 
outside of the range of the data (there are no NT observations below lmm in the Down 
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syndrome group) and the greater estimate of variance m the Down syndrome group 
compared with the unaffected group. 
Finally, we use predictive probabilities to discriminate between affected and unaffected 
pregnancies. Measurements of NT, CRL and maternal age are available in two data sets 
where the true pregnancy outcomes are also known, allowing us to estimate detection rates 
and false-positive rates. Both sets of data were collected by the Harris Birthright Research 
Centre for Fetal Medicine (Snijders and Nicolaides, 1996, page 134). The St. Peter's 
Hospital study includes data on 17 Down syndrome pregnancies. Predictive probabilities 
were calculated for these observations and I ,000 observations relating to unaffected 
pregnancies. The screening cut-off of 4.14 per thousand (equivalent to I in 242) was 
chosen to yield a false-positive rate of approximately 5%. The corresponding detection 
rate was 76%. Data on many more Down syndrome pregnancies are available in the multi-
centre study co-ordinated by the Harris Birthright Research Centre. Based on I ,000 
unaffected pregnancies from this study, the cut-off corresponding to a false-positive rate of 
5% was found to be 6.69 per thousand (equivalent to I in 149). Screening based on this 
cut-off detected 87% of the 123 Down syndrome pregnancies in the data set. 
6. 4. 4 Discussion 
In this section we have extended the work in Section 6.3 to deal with both unaffected and 
Down syndrome pregnancies. The regression of log(NT) on CRL is assumed to have a 
different intercept and variance in each group, but common slope. Under these 
assumptions the joint posterior distribution of the model parameters was obtained using the 
Gibbs sampler. The MCMC output was then used to calculate predictive probabilities of 
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Down syndrome for a woman aged 35 years at three different CRLs across a range ofNT 
values. 
The performance of screening based on NT and maternal age was assessed by calculating 
predictive probabilities for pregnancies of known outcome in two data sets. In each case 
cut-offs were chosen to yield a false-positive rate of approximately 5%. The detection 
rates obtained were higher than those achieved by biochemical screening or the 
ultrasonographic marker scoring system of Benacerraf et al. (1994) (see Section 6.2.2). 
Brizot et al. ( 1994) propose a screening program in which karyotyping is offered to women 
aged <40 years if the NT measurement is greater than or equal to 3mm, and to all women 
above this age. The authors predict a detection rate of at least 85% for a false-positive rate 
of 5%. Findings based on our Bayesian predictive analysis of the St. Peter's Hospital data 
are not inconsistent with those suggested by Brizot et al. (1994). Moreover, our analysis of 
the larger multi-centre study suggests a detection rate of 87%, which is in close agreement 
with Brizot et al. ( 1994 ). 
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Chapter 7 
Conclusion 
7.1 Maternal Age-Specific Prevalence of Down Syndrome 
7.1.1 Maximum Likelihood Approach 
Chapter I introduces several statistical problems involved in screenmg for Down 
syndrome. The first of these is the under-ascertainment of Down syndrome cases m 
livebirth prevalence studies. Chapter 2 presents a double-sampling approach to modelling 
livebirth prevalence data which is applied to nine data sets published in the literature. The 
ascertainment rate in each study and maternal age-specific risks are jointly estimated using 
ML. The estimated rates are then compared with those previously published. The results 
suggest that under-ascertainment is considerable in certain studies assumed previously to 
have achieved complete ascertainment. 
Several criticisms could be made of the work in this chapter, particularly concerning the 
quality of data analysed. The data sets included in the meta-analysis were collected in 
different countries over time-spans of up to 24 years, many of which began thirty years 
ago. Checking the accuracy of reporting and consistency of methods in these studies is 
therefore difficult. In addition, our analyses assume that there are no temporal or spatial 
differences in rates (see the discussion in Section 2.6.2). However, the maternal age-
specific risks published by Cuckle et al. (1987) are still used for counselling and the 
assessment of screening programs, and are embedded in the majority of present-day Down 
syndrome screening algorithms. As noted in Section 2.6.1, these risk estimates are about 
I 0% lower than those found in Chapter 2 and published by Hecht and Hook (1994, 1996) 
who also acknowledge the under-ascertainment in many of the published studies. The 
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magnitude of this discrepancy illustrates the need for revised rate schedules despite the 
obvious limitations of the available data. 
Figure 2.1 shows the fitted rates for each data set with observed rates superimposed. 
Although the model seems to fit all data sets well there is a trend in certain studies for the 
model to predict rates that are higher than those observed at the lower end of the maternal 
age range. We note that for the purposes of screening, although there are comparatively 
few births to older women so that it is not easy to find a model that fits well in this region, 
accuracy of maternal age-related risks is of greater importance at the extreme high end of 
the maternal age range than for very young mothers. It is possible that under-reporting in 
young mothers accounts for the somewhat dubious fit of the logistic model in this age 
range. Below we discuss the validity of the assumption made in Section 2.4.1 that the 
probability of a Down syndrome case being ascertained is independent of maternal age. 
Lie et al. (1994) carried out a ML analysis of the double-sampled Down syndrome 
prevalence data presented in Section 4.7. Erickson and Bjerkedal (1981) compared 
ascertainment in the main registry used by Lie et al. (1994 ), the Medical Birth Registry of 
Norway, with that of the Swedish study by Hook and Lindsjo (1978), thought to have 
achieved high ascertainment. They found that the proportion of ascertainment in the 
Swedish study was 1.6 times higher for maternal ages less than 25, and 1.3 times higher for 
age 26 and above. This provides evidence that ascertainment in the Norwegian registry is 
lower for the low maternal age groups than for the rest of the maternal age range. 
York et al. (1995) considered models in their Bayesian analysis of the same data which 
allowed for a relationship between maternal age and probabilities of ascertainment in both 
registries. Their results suggested the possibility of an interaction between maternal age 
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and the probability that a case is ascertained by the secondary registry, although the 
ascertainment probabilities did not change in any systematic way across the age categories. 
In view of these findings, a possible extension of the model fitting in Chapter 2 could 
include and test for an interaction between maternal age and the ascertainment 
probabilities. 
Another possible extension to the model is the inclusion of parameters for the probability 
of false-positive reporting in the birth certificate studies of Hook and Chambers (1977) and 
Huether et al. (1981) (see Section 2.4.4). These probabilities are also likely to be 
dependent on maternal age since clinicians will expect to find Down syndrome births in 
older women but not younger women. This bias will affect the pattern of false-positive 
reporting on birth certificates. 
7.1.2 MCMC Approach 
Chapter 4 provides an introduction to MCMC methods, while Chapter 5 describes the 
application of such techniques to the models developed in Chapter 2 for livebirth 
prevalence data. Three prior specifications were considered relating to different 
assumptions concerning the levels of ascertainment achieved in the various studies. The 
results were found to be comparable with those reported in Chapter 2. 
The comments and criticisms in Section 7 .1.1 apply likewise to the work presented in 
Chapter 5. Meanwhile the MCMC approach suggests further extensions to the analyses 
already carried out. For example, we note in Section 2.3.1 that the studies published by 
Hook and Fabia (1978) and Young, Williams and Newcombe (1980) were excluded due to 
grouping of livebirth totals into five-year intervals. These five-year totals could be treated 
as grouped data. This problem is similar to that considered in Chapter 6. 
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In Section 7.1.1 above we discuss the possibility of false-positive reporting in the birth 
certificate studies of Hook and Chambers ( 1977) and Huether et al. ( 1981 ). A simple 
MCMC algorithm was implemented to investigate the rates of false-positive reporting in 
these two studies. In this exploratory analysis the probability 1! of Down syndrome was 
not dependent on maternal age. For the data of Hook and Chambers (1977) the posterior 
mean indicates a false-positive rate 0.03%. A similar analysis of the data of Huether et al. 
(1981) suggested a false-positive rate of 0.0 I%. These results are much lower than the 
false-positive rates estimated by Johnson et al. (1985). Their findings could be 
incorporated in the analysis through informative priors. If time allowed these preliminary 
analyses would be extended to include maternal age and the algorithm generalised to 
perform a meta-analysis of all nine studies, as in Chapter 5. The possibility of false-
positive reporting in other studies could then be considered. 
Another relevant area of work is that of model averaging. In their analysis of double-
sampled prevalence data York et al. (1995) considered various models describing different 
dependence structures between the probabilities of ascertainment by each of the two 
registries. They included a Gibbs step in the MCMC algorithm to sample the correct 
model, each being given equal prior probability, from its conditional distribution given the 
observed and unobserved data. A similar approach could be implemented in Chapter 5 to 
include the alternative models considered in Section 2.5. 
7.1.3 Altering Screening Programmes 
The results from Chapter 2 and Chapter 5 consistently suggest that the rate schedules 
presented by Cuckle et al. (1987) substantially underestimate the true prevalence of Down 
syndrome. If a particular screening centre were to change the age risk model from that of 
Cuckle et al. (1987) to one proposed here or to that of Hecht and Hook ( 1996) then risks 
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given to individual pregnancies would increase by about I 0%. As none of the Down 
syndrome biochemical markers appear dependent on maternal age this would apply 
regardless of the number or type of other markers used. If a screening programme uses a 
risk cut-offto categorise women as being at high or low risk then, unless the screening cut-
off was adjusted accordingly, the proportion of women deemed to be at high risk would 
mcrease. 
Using the age distribution of England and Wales over the period 1986 to 1989 (OPCS, 
1988-1991 ), and assuming that maternal age and biochemical screening has a sensitivity of 
65% and specificity of 5%, we estimate that the proportion of women categorised at high 
risk would increase from 5% to 6% if the maternal age-specific risks given in Table 2.6 
were implemented. If a risk cut-off were employed of I in 250 at term, we estimate that 
this would need to be increased to approximately I in 220 to maintain the same proportion 
of women at high risk. 
7. I. 4 Changes in Medical Practice 
Obstetric practice is constantly improving and, unless terminated deliberately, pregnancies 
should have better prospects of survival now than those reported in some of the earlier 
studies included in our analysis. Halliday et al. (1995) argue that, because the rate of 
miscarriage is higher in affected pregnancies than in unaffected pregnancies, it might be 
expected that in an unscreened population the prevalence should be larger nowadays than 
at the time of the earlier studies. They make comparisons with the prevalence estimates 
given by Cuckle et al. (1987) to support this argument. Our analysis suggests that the low 
prevalence estimates of Cuckle et al. (1987) are likely to be the result of under-
ascertainment rather than improvements in obstetric practice. 
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The widespread use of prenatal screening and the termination of affected pregnancies in 
populations for which there are reliable data means that data collected nowadays is of 
limited use in estimating birth prevalence in an equivalent unscreened population. The 
situation is complicated by the fact that affected pregnancies are more likely to miscarry 
than unaffected pregnancies and, moreover, that it is plausible that affected pregnancies 
destined to miscarry are more readily detected by screening tests and subsequently 
terminated than affected pregnancies destined to survive to birth. Until detailed 
longitudinal data are collected on many hundreds of thousands of pregnancies, the data 
collected historically will continue to provide the basis for estimating livebirth prevalence. 
7.2 Gestational Age-Specific Prevalence of Down Syndrome 
7. 2.1 Summary and Criticisms 
In Section 1.4 we discuss the raised rates of spontaneous loss in Down syndrome 
pregnancies compared with unaffected pregnancies. Various models for gestational age-
specific risks are explored in Chapter 3 and resulting estimates of spontaneous loss rates 
amongst Down syndrome fetuses are compared with those in the literature. In Section 3.4 
the logistic model used by Halliday et al. (1995) is fitted to pooled data from several 
studies, while Section 3.5 describes the extension of the models in Chapter 2 to include a 
term for gestational age. The estimates of loss after times of CVS and amniocentesis from 
both these models are generally lower than those in the literature and possible reasons for 
this are discussed. 
There are several aspects of the work in this chapter which could be improved. While the 
analyses in Section 3.4 are carried out in GLIM 4, which provides SEs for all estimates, the 
non-linear models used in Section 3.5 are fitted in 8-Plus. In Chapter 2 SEs for 
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parameter estimates and Cis for maternal age-specific risks are obtained via bootstrapping. 
The same methodology could be applied to the extended model to provide Cis for the 
estimates of maternal age-specific rates and gestational age-specific relative prevalences in 
Table 3.15, or for the final maternal and gestational age-specific prevalence for a range of 
maternal and gestational ages. 
Whereas, in Chapter 2, under-ascertainment of Down syndrome cases in livebirth 
prevalence data is acknowledged within the modelling procedure, in Chapter 3 we assume 
that all cases are correctly diagnosed by CVS or amniocentesis. While it is probably 
reasonable to assume that these deterministic tests are error-free, there may be other 
concerns regarding the CVS and amniocentesis data used throughout this chapter. The 
pooling of data from different studies raises the question of centre effects other than under-
ascertainment. In particular, this type of data may be subject to biases if the groups of 
women tested in each centre were not comparable. For example, although each study 
should comprise of women opting for a test on the grounds of raised maternal age only, 
certain studies may include women presenting because of increased risk (such as familial 
incidence). Despite these concerns, the exploratory plots and tests described in Section 
3.4.2 and 3.4.3 found no evidence of inconsistency between data sets. Furthermore, 
Macintosh et al. (1995) performed a test for heterogeneity between the five CVS studies 
pooled in their analysis and found no evidence of centre effects (--/ 4=2.4, P=O.l8). 
The adjustments to the livebirth data for Down syndrome cases diagnosed and terminated 
prenatally, described in Section 2.3.2, could be refined by substituting the probability of 
survival after amniocentesis implied by the parameters ~ and A.1 in place of the estimate of 
0.7, which was taken from Hook (1983) and assumed to be a known constant. The 
probability of survival is simply the reciprocal of the relative prevalence function (3.5). If 
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the gestational age of each such case were available the probability of survival would 
depend on gestational age. Otherwise, the average gestational age at amniocentesis of 17 
weeks (Snijders et al., 1995) could be used. Although this is an interesting modification 
from a modelling point of view, it is unlikely to have an important effect on the results 
since the number of cases diagnosed prenatally is comparatively small. It is also worth 
mentioning here that the probability that a Down syndrome case would be recorded on the 
birth certificate in the study of Huether et al. ( 1981 ), also used in the adjustments for 
prenatally diagnosed cases and taken to be a known constant (0.365), could similarly be 
replaced by the unknown parameter ~- Note that this latter point applies likewise to the 
analyses of Chapter 2. 
The exact gestational ages for the CVS and amniocentesis data described in Table 3.2 are 
not given in the original papers. Therefore the gestational age for a given pregnancy is 
taken to be the average for the relevant test group (CVS or amniocentesis) in that study, 
resulting in loss of precision. If individual gestational ages were available such 
approximations would not be necessary and model fitting could be substantially improved. 
The analyses in Chapter 3 are based on observed prevalences at average gestational ages of 
I 0, 16 and 17 weeks and at livebirth. Therefore the estimated relative prevalence curves 
should not be extrapolated to gestational ages below I 0 weeks. If CVS data were available 
at known gestational ages before 10 weeks' gestation then the fitted relative prevalence 
curve could be used to estimate relative prevalences for earlier gestational ages. 
7. 2. 2 MCMC Approach 
In Chapter 5 MCMC techniques are applied to the models for livebirth prevalence fitted in 
Chapter 2. A Bayesian approach could also be applied to the models presented in Chapter 
3 for maternal and gestational age-specific prevalence, allowing the inclusion of prior 
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information. In Chapter 6 MCMC techniques are applied to a coarsened data problem 
arising in the measurement of NT, an ultrasound marker for Down syndrome. A similar 
approach could be used to overcome the problem outlined above of gestational age 
grouping of the CVS and amniocentesis data. 
In the case of the gestational age data the information available varies according to the 
study. The CVS and amniocentesis data sets considered (see Table 3.8) are presented by 
Snijders et al. (1994), Macintosh et al. (1995) and Halliday et al. (1995). For the first two 
of these we know both the range of gestational ages (15-20 and 8-14 weeks, respectively) 
and the means (17 and I 0 weeks, respectively). Halliday et al. ( 1995) do not give ranges 
of gestational ages for their data, but we know that the median gestational age of the CVS 
group is I 0 weeks, and the median of the amniocentesis group is 16 weeks. The algorithm 
could include steps to simulate the gestational ages of each observation in each data set, 
given the available data and the model parameters. As in Section 3.5.2, we note that any 
such change to the gestational age of an observation affects both the gestational age-
specific component of the likelihood and the correction of the corresponding maternal age 
to age at EDD. 
7.3 Nuchal Translucency as a Marker for Down Syndrome 
In Chapter 6 we tackle the problem of rounding of NT measurements usmg MCMC 
techniques. We present a mixture model for the rounding process and simulate the mixing 
proportion along with the model parameters and missing data. Full conditional 
distributions could easily be obtained for all of the quantities to be sampled so that the 
MCMC algorithm comprised only Gibbs steps. This resulted in fast convergence and rapid 
mixing of all parameters. 
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The model presented in Section 6.3.3 assumes that log(NT) is normally distributed with 
mean linearly dependent on CRL (which is a measure of gestational age). Although the log 
transformation seems satisfactory the assumption of normality is obviously open to 
question, particularly in the tails of the distribution. If either this assumption, or that of 
homogeneity of variance, were found to be violated then alternative models could be 
considered. The algorithm developed in Section 6.3.4 was first validated by carrying out a 
simulation study in which the data were chosen so that ignoring rounding led to an 
exaggerated estimate of the slope (Section 6.3.5). Other simulation studies were performed 
to check that the algorithm worked in a range of situations. More detailed studies could 
investigate the conditions under which ignoring rounding leads to substantially different 
results to those obtained from the Gibbs analysis which takes rounding into account. 
In Section 6.3.6 the algorithm was applied to real data from unaffected pregnancies only, 
then it was extended to include a regression of log(NT) on CRL for Down syndrome 
pregnancies. The slope parameters were assumed to be the same in the two groups. This 
assumption was necessitated by the small number of Down syndrome cases in the data set 
considered. Further work could investigate alternative methods of modelling the 
distribution ofNT in Down syndrome cases without enforcing this constraint on the slope. 
The Gibbs output from the extended algorithm described in Section 6.4.2 was used to 
calculate predictive probabilities of Down syndrome given NT for maternal age 35 years at 
three different CRLs. A problem was encountered for small values of NT where the 
predictive probabilities were unrealistically high. Although reasons for the problem were 
discussed no attempt was made to overcome it. This is obviously a very important area in 
which improvement needs to be made. 
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Other suggestions for further work include increasing the number of components in the 
mixture and allowing the mixing proportion to depend on the true NT value. Finally, 
centre effects should be included so that the algorithm can be used to perform a meta-
analysis of data from several centres. Clearly, the mixing proportion would be allowed to 
differ between centres. The simplest way to include centre effects in the regression model 
would be to assume equal slope but different intercepts, reflecting a multiplicative change 
on the untransformed scale. More complicated models could also be considered. 
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